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Guaianolides, the largest class of sesquiterpene lactones, possess a wide range of 
biological activities, particularly in the areas of anti-inflammation and anticancer. The allenic 
Pauson-Khand reaction (APKR) is a rhodium (I) catalyzed [2 + 2 + 1] cyclocarbonylation 
reaction of allene-ynes and has been established as a viable methodology for accessing the 
guaianolide 5,7,5-tricyclic framework. However, allene-yne precursors with methyl substituted 
allenes and alkynes have been poorly tolerated. Optimization of high dilution APKR conditions 
is described for these methyl substituted allene-ynes, which give direct access to C4 and C10 
methyl substituted bicycle[5.3.0]decadienones, consistent with the guaianolide framework. 
This APKR approach was also applied to continuing the synthesis of highly oxygenated 
guaianolide analogs, capable of inhibiting NF-ĸB. The α-methylene-γ-butyrolactone moiety is 
incorporated into allene-yne tether prior to the APKR. Given the potent NF-ĸB inhibitory 
properties demonstrated by our analogs, derivatives were synthesized in effort to examine the 
biological mechanism of inhibition. Installation of alkyne ligation handles onto the base-sensitive 
guaianolide analogs, for use in biomechanistic studies, was achieved using the acid mediated 
Nicholas reaction. This method was also established for the general installation of alkyne ligation 
handles onto hydroxyl, sulfhydryl, amino, and carboxyl groups. Synthesis and biological 
evaluation of an α-methyl-γ-butyrolactone guaianolide analog established the importance of the 
α-methylene-γ-butyrolactone moiety for potent NF-ĸB inhibition.  
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1.0  AN ALLENIC PAUSON-KHAND APPROACH TOWARDS 6,12-
GUAIANOLIDES 
This chapter is partially based upon results published in: Wells, S. M.; Brummond, K. M. 
Conditions for a Rh(I)-catalyzed [2+2+1] cycloaddition reaction with methyl substituted allenes 
and alkynes. Tetrahedron Letters, 2015, 56, 3546-3549. Memorial Symposium-in-Print for Harry 
Wasserman. 
1.1 INTRODUCTION 
For decades, natural products (NPs) have been a rich source of inspiration for the 
development of new drugs, as their structural frameworks are considered to be privileged for 
biological activity.1 One class of NPs, sesquiterpene lactones (SLs), are a large group of 
metabolites with 15-carbon frameworks, consisting of 3 isoprene units (5 carbons), and a lactone 
ring.  SLs exemplify high structural diversity and a wide range of biological properties, with 
potent anti-inflammatory and anticancer effects being of particular interest.2 Currently a few SLs 
are undergoing clinical trials for cancer therapies (Figure 1). Thapsigargin (1.1) is a potent 
sarco/edoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor which leads to apoptosis. A 
prodrug derivative of 1.1, under the name of Mipsagargin, has been developed to target the blood 
vessels of cancer cells and is undergoing phase II clinical trials.3 Artemisinin (1.2) is an 
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antimalarial compound, originally extracted for this use in the 1970’s by Youyou Tu, who was 
awarded a share of the 2015 Nobel Prize in Physiology or Medicine for this effort.4  Artemisinin 
has also shown anticancer activity, and is undergoing clinical trials for breast and colorectal 
cancers.2 Finally, a dimethylamino analog of parthenolide (1.3) is being tested for targeting 
human leukemia stem cells.5  
 
Figure 1. Medicinally relevant sesquiterpene lactones. 
Even with these successful examples and prevalent biological activities of other SLs, 
realization and development for the class of molecules as potential pharmaceuticals has been 
slow overall. One major contribution to this slow progression is the presence of reactive α-
methylene-γ-butyrolactones (1.4) in a vast majority of the SLs, and as seen in parthenolide (1.3). 
This moiety is present in 3% of all NPs.6 Despite this evolutionary prevalidation, the α-
methylene-γ-butyrolactone (1.4) has been classified as a covalent modifier, due to its ability to 
undergo hetero-Michael addition reactions with biological nucleophiles (Scheme 1). While thiol 
alkylating events are often responsible for the biological activities of α-methylene-γ-
butyrolactone containing SLs, these events are also contribute to the toxicity of the compounds.7 
 
Scheme 1. Mechanism for a Michael-type addition of a sulfhydryl group to an α-methylene-γ-butyrolactone (1.4). 
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Conventional non-covalent drugs inhibit their target protein through reversible, non-
covalent binding interactions. Covalent inhibitors undergo these non-covalent interactions, but 
also undergo a bond-forming reaction with the protein to form a stable linkage that is irreversible 
within the protein’s half-life.8  This mode of inhibition has traditionally been avoided due to the 
safety concern that poor selectivity of the electrophilic groups inherently leads to toxicity. 
However, many successful drugs operate by a covalent mechanism, including aspirin and 
penicillin. In fact, at this time, there are at least 42 approved drugs that operate by a covalent 
mechanism.8c The mechanisms of action for many of these drugs were discovered after their 
clinical abilities had been established. Covalent inhibitors are only recently becoming the focus 
of drug development programs due to their potential for increased biochemical efficiency 
compared to non-covalent drugs; covalent binding may lower the development of drug 
resistance, allow for lower dosages, overcome competing endogenous non-covalent interactions, 
and could address targets with shallow binding sites.8c To overcome the inherent toxicity risks, 
development teams are focusing on selectivity for specific binding sites and tuning the reactivity 
of the covalent modifiers for specific covalent binding events.8b For all potential covalent 
inhibitors, the mechanism of action and possible non-specific, or off-target activity must be 
thoroughly examined.  
One event that lead to increased interest in SLs as potential drug targets, despite their 
covalent modifier classification, was the discovery that helenalin (1.7) (Figure 2), along with 
other SLs, inhibits the central transcription factor NF-ĸB, which plays a major role in immune 
response, cell proliferation, cell death, and inflammation.9 Inhibition of NF-ĸB has emerged as a 
potential strategy for cancer therapy, as overstimulation of NF-ĸB has been shown to affect all 6 
hallmarks of cancer; self-sufficiency in proliferative growth signals, insensitivity to growth 
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inhibition, evasion of apoptosis, limitless replicative potential, induction of angiogenesis and 
finally, induction of invasion and metastasis.10 Parthenolide (1.3) was also shown to inhibit NF-
ĸB and activate p53, a DNA-binding transcription factor that leads to tumor suppression, 
simultaneously, thereby increasing its therapeutic potential.11 The NF-ĸB inhibition potential of 
SLs lead to a series of studies to determine their mechanism of inhibition (See Section 4.1). 
 
Figure 2. Selected SLs representing families that inhibit NF-ĸB, and the 6,12-guaianolide analog 1.10 proposed as a 
lead inhibitor by Merfort. 
 
SL subclasses are divided by carbocyclic frameworks. Compounds in the germacranolide, 
furanoheliangolide, guaianolide, pseudoguaianolide, hypocretenolide, and eudesmanolide 
families have all been shown to inhibit NF-ĸB (Figure 2). A quantitative structure activity 
relationship (QSAR) study performed by Irmgard Merfort evaluated the structural and chemical 
features of 103 SLs in these families and their ability to inhibit NF-ĸB. For all the SL families, 
inhibition ability greatly correlated with the presence of alkylating centers such as the α-
methylene-γ-butyrolactone. While the QSAR study resulted in limited correlations for many of 
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the SL families, guaianolides were identified as having good correlation coefficients for other 
structural coding parameters, such as lipophilicity. Merfort later proposed a potential lead SL 
analog 1.10 for potent NF-ĸB inhibition consistent with the guaianolide framework.7  
Guaianolides represent the largest natural product class of SLs. This family is made up of 
a 5,7,5-fused ring system with methyl or methylene groups at the C4, C10, and C11 positions. 
Guaianolides can be categorized further into 6,12- and 8,12-guaianolides, based upon the 
position of the lactone ring (Figure 3).12 The only difference between guaianolides and 
psuedoguaianolides is the placement of one of the methyl substituents, which is found on C5 for 
pseudoguaianolides rather than C4. The 6,12-guaianolides have become the focus of our 
synthetic efforts, consistent with the proposed lead structure 1.10. 
 
Figure 3.  Frameworks of the guaianolide and pseudoguaianolide SL families. 
Our focus on the 6,12-guaianolide framework was also validated by a chemical space 
analysis performed by Oprea and coworkers that identified a 6,12-guaianolide as a lead NP in 
underrepresented chemical space with medicinal potential.13 The biologically relevant chemical 
space was analyzed by comparing the physiochemical properties (size, shape, polarizability, 
lipophilicity, polarity, flexibility, rigidity, and hydrogen bonding capacity) of NPs, with bioactive 
medicinal compounds from the database WOMBAT. This allowed for identification of regions 
occupied by NPs, with favorable physiological properties, but were lacking occupancy by 
medicinally relevant molecules. A 6,12-guaianolide was identified as a lead in one of these 
underrepresented regions. In addition, Euclidean distances (EDs) were calculated between NPs 
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and approved drugs (GVKBIO drug database) based upon the physiological properties. Lead 
compounds were identified by short EDs and by using the literature to identify compounds with 
either similar biological activities or modes of action. Two 6,12-guaianolides, 11βH,10-epi-8-
deoxycumambrin B (1.11) and 10-epi-8-deoxycumambrin B (1.13), were shown to have short 
EDs of 1.04 and 1.11, respectively, from formestane (1.12), which is an approved aromatase 
inhibitor (Figure 4). Guaianolides 1.11 and 1.13 have also been shown to effectively inhibit 
aromatase enzyme activity in human placental microsomes.14 Therefore, compounds of this 
nature were recommended for analog generation. 
 
Figure 4. Euclidean distances between the drug formestane (1.12) and NPs 1.11 and 1.13 in chemical space. 
1.1.1 Previous approaches toward the 6,12-guaianolide framework 
Another challenge in the development of SLs, including 6,12-guaianolides, as 
therapeutics is limited bioavailability from their plant sources.2 Therefore, synthetically useful 
methods are required. Described in this section are common ways that researchers have 
approached construction of the characteristic 5,7,5-fused, tricyclic ring system.  
6,12-Guaianolides have been accessed via semisynthetic methods, where the guaianolide 
framework is obtained from an alternative sesquiterpene that is more readily available, either by 
synthesis or isolation. Two main semisynthetic approaches have been employed, with the 
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guaianolide framework being achieved from either the germacranolide or eudesmanolide SL 
frameworks (Figure 5). 
 Parthenolide (1.3), a germacranolide with potent biological activity, can be extracted 
from the root bark of Magnolia delavayi in bulk quantities (3.1-8.0%), and is also commercially 
available, making it a common starting material for biomimetic semisynthesis.15 Parthenolide 
(1.3) was utilized as the starting material in a 3-step synthesis of arglabin (1.15), which has a low 
bioavailability from its natural source of Artemisia glabella (0.27% yield).15b The transformation 
from the germacranolide framework of 1.3 to the 6,12-guaianolide framework of micheliolide 
(1.14) is achieved under the acidic medium of p-TSA in DCM. Epoxidation of 1.14, followed by 
dehydration afforded arglabin (1.15) in an overall 45% yield (Scheme 2). 
 
Figure 5. Semisynthetic approaches to the 6,12-guaianolide framework. 
 
Scheme 2. Three step synthesis of arglabin (1.15) from parthenolide (1.3). 
(-)-α-Santonin (1.16), is an abundant and commercially available eudesmanolide and 
represents the most widely used method for accessing guaianolides. Photochemical 
rearrangement of 1.16 in the presence of a protic solvent, such as acetic acid, affords guaianolide 
analog 1.17 (Scheme 3).16 This transformation has been applied to numerous guaianolide natural 
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product syntheses, including achillin (1.18), (-)-estafiatin (1.19), and dimerized guaianolide (+)-
absinthin (1.20).17 Structural variations of santonin (1.16) have also undergone photochemical 
rearrangements. For example, in efforts towards the synthesis of thapsigargin analogs, 
photoirradiation of 1.21 in the presence of acetic acid gave 1.22 in 93% yield. Hydroazulene 1.22 
was taken on to give 7,11-dihydroxyguaianolide analog 1.23 (Scheme 4).18 This strategy of 
constructing 5,7-hydroazulene core, followed by installation of the lactone ring near the end of 
the synthesis is a common approach toward 6,12-guaianolides. 
 
Scheme 3. Access to the guaianolide framework from (-)-α-santonin (1.16) and representative natural products 
synthesized via this method. 
 
 
Scheme 4. Photochemical rearrangement of 1.21 toward 7,11-dihydroxyguaianolide analog 1.23. 
In addition to semisynthesis, development of total synthetic methods for the construction 
of guaianolides from commercially available building blocks is an important area of research. 
Multiple routes to building the 5,7,5-fused ring system have been employed. The Favorskii 
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rearrangement is a common strategy for the stereoselective synthesis of functionalized 5-
membered rings, and has been applied in the early stages of multiple guaianolide total syntheses. 
In the synthesis of (+)-cladanthiolide (1.29),19 functionalization of R-carvone (1.24) affords 1.25, 
which under basic conditions rearranges to afford 5-membered ring (-)-1.26 in 80% yield.20  This 
synthesis also features a unique construction of the 7-membered ring of 1.28, which is obtained 
from 1.27 in 99% yield via a radical cascade. 
 
Scheme 5. Access to highly functionalized 5-membered ring (-)-1.26 via the Favorskii rearrangement and a radical 
cascade approach toward (+)-cladanthiolide (1.29). 
 
The 2007 total synthesis of thapsigargin (1.1), accomplished by Ley and coworkers, also 
begins with the Favorskii rearrangement; (+)-1.26 was prepared from S-carvone. However, the 7-
membered ring was constructed using a ring closing metathesis (RCM). RCM precursor 1.30 
was reacted with Grubb’s second generation catalyst in DCM for 21 h to afford the 5,7-fused 
ring system 1.31, which was taken on to complete the synthesis of thapsigargin (1.1) in 42 steps 
overall (Scheme 6).21  
RCM has become a popular method for 7-membered ring construction within 
guaianolides and is not unique to the described thapsigargin synthesis. The total synthesis of 
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arglabin (1.15) also showcases this approach; RCM precursor 1.32 containing both 5-membered 
rings undergoes RCM to form the 7-membered ring of 1.33 (Scheme 7).22  
 
Scheme 6. RCM approach for 7-membered ring formation in the total synthesis of thapsigargin (1.1). 
 
Scheme 7. RCM approach to arglabin (1.15). 
The 5,7-hydroazulene core of guaianolides has also been accessed by ring expansion of a 
5,4,5-fused ring system. α-Diol oxidative cleavage of 1.34 using Pb(OAc)4 affords 1.35,  which 
was used to access (-)-estafiatin (1.19) (Scheme 8).23 
 
Scheme 8. Synthesis of (±)-estafiatin (1.19) via an oxidative ring expansion. 
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Another strategy to synthesize guaianolides involves forming the 5,7-hydroazulene core 
from a commercially available 7-membered ring, followed by installation of the lactone ring. 
One example of this method is the transformation of tropylium cation 1.36 to hydroazulene 1.38 
via a [2 + 2] cycloaddition, ring expansion, and elimination sequence. 1.38 was taken on towards 
geigerin (1.40). Interestingly, this synthesis also features a 6,12-guaianolide framework 1.39 as 
an intermediate in route to the 8,12-guaianolide 1.40 (Scheme 9).24  
More recently, perhaps due to a resurgence in the interest in the guaianolides for 
pharmaceutical applications, researchers have been developing diversity oriented approaches 
towards the guaianolide framework, rather than attempting to synthesize specific targets.25 This 
has especially been observed for synthetic efforts towards the 5,7-hydroazulene core of the 
guaianolide framework, as the lactone is typically the most accessible ring.  
 
Scheme 9. Total synthesis of (±)-geigerin 1.40 from tropylium ion 1.36. 
Novel approaches for the synthesis of 7-membered rings are being applied to 
cyclopentane containing systems in order to demonstrate their feasibility for synthetic efforts 
toward the hydroazulene portion of guaianolides. For example, addition of stabilized alkenyl 
nucleophiles, such as Grignard reagents, to (1-methoxycarbonylpentadienyl)iron(1+) cation, 
followed by oxidative decomplexation, affords divinylcyclopropanes, which then undergo a 
Cope rearrangement to give functionally dense 7-membered rings.26 This methodology was 
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applied to the formation of 5,7-fused ring system 1.43 by employing cyclopentenyl nucleophile 
1.41 (Scheme 10).27 Alternatively, the Michael-aldol-retro-Dieckmann (MARDi) cascade 
multicomponent reaction is an anionic 2-carbon ring expansion of the Dieckmann ester 1.45, for 
the synthesis of stereodefined cycloheptanols.28 Reaction of ester 1.45 and cyclopentene 
carbaldehyde 1.46 with DBU, followed by selective reduction of one ester moiety affords 1.47, 
taken on to give the guaianolide framework 1.48 (Scheme 10).29 Both of these methodologies 
were described as showing feasibility for synthesis of more biologically relevant guaianolide 
analogs.  
 
Scheme 10. Application of novel 7-membered ring syntheses to guaianolide analogs. 
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1.1.2 Development and applications of the allenic Pauson-Khand reaction 
The Pauson-Khand reaction (PKR) is a formal [2 + 2 + 1] cyclocarbonylation reaction 
between an alkyne, an alkene, and a carbon monoxide molecule (Scheme 11, A). The first 
example, reported in the early 1970’s, was an intermolecular cyclocarbonylation between a 
dicobalt hexacarbonyl complexed alkyne and norbornene to generate a fused cyclopentenone.30 
The discovery of an intramolecular version of the reaction significantly increased the synthetic 
utility by rendering the reaction regioselective and expanding the scope beyond strained alkenes. 
Many researches have embraced the challenge of increasing the efficiency and scope of the PKR, 
which is now one of the most popular methods for cyclopentenone formation. These advances 
include development of catalytic conditions, alternative metal mediators (including but not 
limited to Rh, Mo, Ru, Ti, Fe, Ir, and Zr), asymmetric conditions, effective intermolecular 
reactions, and solid supported protocols.31   
A variation of the PKR where the alkene is replaced with an allene emerged in the late 
1990’s. The allenyl moiety contains two pi bonds, both of which could undergo the 
cyclocarbonylation reaction. Reaction with the distal double bond leads to the formation of 4-
alkylidene cyclopentenone 1.52, where reaction with the proximal double bond results in α-
alkylidene cyclopentenone 1.53 (Scheme 11, B). 
 
Scheme 11. General intramolecular Pauson-Khand reaction and allenic Pauson-Khand reaction. 
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At first, regioselectivity between the distal and proximal double bond of the allene was 
substrate dependent. A cobalt carbonyl mediated allenic Pauson-Khand reaction (APKR) of 
allene-ynes, promoted by NMO, gave mixtures of the corresponding 4-alkylidene and α-
alkylidine cyclopentenones, except for trisubstituted allenes, which gave the α-alkylidene 
system.32 When mono-, 1,3-di-, and 1,1,3-trisubstituted allenyl alkynes were reacted with 
stoichiometric amounts of molybdenum carbonyl, selective reaction with the proximal double 
bond afforded α-alkylidene cyclopentenones, while 1,1-disubstituted allenyl alkynes reacted 
selectively with the distal double bond to afford 4-alkylidene cyclopentenones.33  
However, in an effort to identify reaction conditions that would allow for double bond 
selectivity independent of the substrate, it was discovered that catalytic rhodium biscarbonyl 
chloride dimer ([Rh(CO)2Cl]2) reacted selectivity with the distal double bond whereas 
molybdenum carbonyl reacted selectively with the proximal double bond.34 For example, when 
diester allene-yne 1.54 is reacted with [Rh(CO)2Cl]2 (5 mol%), dienone 1.55 is formed 
selectively, and when 1.54 is reacted with Mo(CO)6 (125 mol%), exocyclic methylene 1.56 is 
afforded (Scheme 12).34b  
 
Scheme 12. Diverging reactivity of 1.54 when using [Rh(CO)2Cl]2 and Mo(CO)6. 
This observation was later explained through density functional theory computational 
modeling of potential energy pathways with both metal mediators. For both metals, the generally 
accepted mechanism of 1) coordination of the metal to the alkene and alkyne, 2) oxidative 
addition, 3) carbonyl insertion, and 4) reductive elimination was used (Scheme 13). For the 
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rhodium catalyzed pathway, it was determined that oxidative addition of the allene-yne to the 
Rh(I) to give Rh(III) complex A2 had the highest energy barrier of the entire pathway (16.8 
kcal/mol), and was therefore the rate determining step. As a result, the product is determined at 
an early stage in the reaction where the rhodium has a square planar geometry as seen in A1. 
Coordination to the distal double bond is favored by 5.5 kcal/mol over the proximal double bond, 
eventually leading to formation of the 4-alkylidene 1.52. In contrast, calculations for the 
molybdenum pathway showed that CO insertion from B2 to B3 is the rate determining step. For 
oxidative addition, molybdenum has a trigonal bipyrimidal geometry (B1), and therefore, 
reaction with the proximal double bond of the allene is energetically preferred by 4.8 kcal/mol 
over the distal double bond. Even the highest energy in this pathway, for the CO insertion step, is 
2.5 kcal/mol more favorable that the oxidative addition with the distal double bond. This leads to 
the experimentally observed selective formation of α-alkylidine cyclopentenones (1.53).35 
 
Scheme 13. Diverging mechanisms of the APKR with rhodium and molybdenum lead to regioselectivity. 
The observed regioselectivity displayed for rhodium catalyzed Pauson-Khand reactions 
of allene-ynes motivated the application to fused 5,7-bicyclic ring systems from an extended 
carbon tether. Synthesis of these bicyclo[5.3.0]decadienones had only been previously achieved 
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as a mixture of products or with a narrow substrate scope. Brummond34b, 36 and Mukai37 
independently exploited the selectivity of Rh(I) catalysts for the distal double bond to 
demonstrate the generality of this method for the synthesis of 5,7-fused systems (see Scheme 
14for selected examples). A variety of allene and alkyne substitutions were tolerated including 
mono-, di-, and tri-substituted allenes, as well as both terminal and substituted alkynes. Mukai 
focused on allenes substituted with phenylsulfonyl groups due to their ease of preparation (1.61-
1.64). Various functionalities in the tethers were also well-tolerated, including diesters (1.57, 
1.58, 1.61), carbonyls (1.59), heteroatoms (1.62), and oxygen substituents (1.64). 
 
Scheme 14. Synthesis of bicyclo[5.3.0]decadienones via a Rh(I)-catalyzed allenic Pauson-Khand reaction. 
By incorporating cyclohexane rings into the allene-yne tethers, Brummond also 
demonstrated the capability of the APKR to access linearly and angularly fused 6,7,5-tricylic 
frameworks (Scheme 15).36a, 38 Some of these examples are among the highest yielding APKR 
results, as seen for the synthesis of 1.66 and 1.68, formed in 85% and 91% yield respectively.38 
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The potential of the APKR for application to biologically relevant carbocyclic frameworks was 
demonstrated by the cyclocarbonylation of allene-yne 1.69 to afford 1.70; this example was 
performed in an effort towards the synthesis of NP guanacastepene A (1.71).39  
The dienone moiety generated by the APKR is also optimally positioned for further 
functionalization of the 5,7-ring system towards biologically relevant systems. This has been 
demonstrated by functionalization of the dienone C1-C10 π-bond via hydrogenation, 
dihydroxylation, and epoxidations, as well as by addition to the carbonyl.38-40 In addition, the 
potential of the APKR and functionalization of dienone moiety towards natural products was 
demonstrated in the total syntheses of (+)-ingenol (1.74) and (+)-phorbol (1.75), performed by 
Baran and coworkers (Scheme 16).41 APKR precursor 1.72 was constructed from (+)-carene in 5 
steps.  The APKR reaction was successfully performed on gram scale using [Rh(CO)2Cl]2 (10 
mol%) with CO(g) in xylenes to afford dienone 1.73 in 73% yield. This cycloadduct was 
functionalized to efficiently afford (+)-ingenol (1.74) in 8 steps (14 steps overall), as well as (+)-
phorbol (1.75) in 13 steps (19 steps overall).  
 
Scheme 15. Selected examples of the APKR towards linearly and angularly fused 6,7,5-tricyclic frameworks. 
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Scheme 16. An APKR approach toward the total synthesis of (+)-ingenol (1.74) and (+)-phorbol (1.75). 
1.1.3 An allenic Pauson-Khand approach toward guaianolides. 
As mentioned, the synthesis of tricyclic fused ring systems are among the highest 
yielding APKR examples. In turn, the Brummond group proposed that the 5,7,5-fused ring 
system of 6,12-guaianolides, represented by 1.76, could be accessed in a similar fashion from a 
lactone containing allene-yne tether 1.77 (Scheme 17).  Some hesitation with respect to the 
reactivity of α-methylene-γ-butyrolactones, and their stability in the APKR was acknowledged 
during the design of this approach.42 Motivation toward this approach was also encouraged by 
the influential work of Dennis Hall, who developed an allylboration/ lactonization sequence for 
the synthesis of substituted α-methylene-γ-butyrolactones. 
 
Scheme 17. Retrosynthetic analysis of 6,12-guaianolide framework 1.76. 
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To establish the feasibility of the proposed route to the 6,12-guaianolide framework, 
allene-yne 1.80 was made (Scheme 18). The lactone ring was formed via an allylboration/ 
lactonization reaction between allylboronate 1.78 and phenylpropynal as a mixture of the trans- 
and cis-lactone rings (4:1 ratio). The TBDPS group was removed by treatment with TBAF to 
afford alcohol 1.79. The allene moiety of 1.80 was installed in 3 steps from 1.79. The trans- and 
cis- lactones can either be separated as 1.79 or as the allene-yne 1.80. The isomers of 1.80 were 
subjected separately to the APKR to afford trans-1.81a and cis-1.81b, both in 90% yield. The α-
methylene-γ-butyrolactone was unaffected throughout the sequence of reactions from 1.79 to 
1.81, including the high yielding APKR. 
 
Scheme 18. An APKR approach to the 5,7,5-fused ring system 1.81. 
The APKR approach was also successfully applied to guaianolide analogs 1.83 and 
1.84,43 with increased oxygen functionality and therefore, molecular complexity (Scheme 19).44 
This redox economical synthesis expands the scope of both the allylboration/lactonization as 
well as the APKR chemistries. For more information on this synthesis, see Section 2.1.  
It should be noted that Mukai and coworkers have also utilized the APKR in the synthesis 
of an 8,12-guaianolide natural product, (+)-achalensolide (1.87) (Scheme 20).40 However, the 
APKR was performed on allene 1.85 using a phosphine ligated Rh(I) catalyst, 
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[Rh(CO)(dppp)2]Cl to form the hydroazulene core 1.86. The lactone was installed at a later stage 
in the synthesis, typical of previous approaches toward guaianolides (Section 1.1.1). 
 
Scheme 19.  Synthesis of highly-functionalized guaianolide analogs 1.83 and 1.84 via the APKR. 
 
Scheme 20. An APKR approach to 8,12 guaianolide (+)-achalensolide (1.87). 
1.1.4 Low yielding APKR examples with methyl substituted allene-ynes 
As mentioned, the conversion of α-methylene-γ-butyrolactone containing allene-yne 
tether 1.80a, with a phenyl substituted alkyne, to the guaianolide analog 1.81a is among the 
highest yielding APKR examples to date. The success of this example, as well as the synthesis of 
highly functionalized guaianolide analogs 1.83 and 1.84, establishes the feasibility of this 
approach toward the guaianolide framework. To show the generality of the approach, the scope 
of the APKR precursor 1.80 was expanded to include alternative alkynyl and allenyl 
substitutions (Scheme 21). Pentyl and trimethylsilyl substituted alkynes (1.80c and 1.80d) also 
gave excellent yields; 1.81c and 1.81d were formed in 81% and 92% yields respectively. 
However, the efficiency of the APKR for a terminal alkyne and a methyl substituted alkyne was 
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significantly decreased; 1.81e was afforded in a moderate 67% yield while 1.81f was produced in 
51% yield. The intolerance of methyl substitutions was further magnified when allene-yne tether 
1.80g encompassing a methyl substituted alkyne as well as a methyl substitution on the proximal 
allene carbon gave the corresponding dienone product 1.81g in only 42% yield.42   
The low efficiency of methyl substituted and terminal alkynes has also been observed in 
previously reported APKR examples. For the synthesis of 5,7,6-linearly fused ring systems, 
trimethylsilyl groups on the alkyne afforded the cycloadducts 1.89a and 1.89b in excellent yields 
(87% and 91%), however terminal and methyl substituted alkynes gave significantly lower yields 
of 27% and 29% for 1.89c and 1.89d respectively (Scheme 22).38 
 
Scheme 21. Scope expansion for guaianolide analogs 1.81 reveals sensitivity to methyl substitutions. 
 
Scheme 22. Synthesis of 5,7,6-ring systems 1.89a-d. 
The 6,12-guaianolide framework includes methyl substitutions at the C4 and C10 
positions. For our allenic Pauson-Khand approach to this framework, the C4 and C10 methyl 
substitutions of 1.76 correlate directly to the substituents on the proximal carbon of the allene 
and the terminus of the alkyne of the allene-yne precursor 1.77 (Scheme 17). Therefore, for this 
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approach to be optimized for the synthesis of guaianolide analogs, an efficient reaction for 
methyl substituted substrates is required. Reported herein are our investigations for optimizing 
the APKR for these methyl substituted allenes and alkynes, as well as terminal alkynes.  
1.2 OPTIMIZATION OF THE APKR FOR METHYL SUBSTITUTED ALLENE-YNE 
TETHERS 
1.2.1 Model system substrate design 
To optimize the allenic Pauson-Khand reaction for allene-ynes with methyl substitutions 
on the proximal carbon of the allene and on the alkyne terminus, we designed a simple dienone 
system 1.90 as a model for this transformation. Due to the nature of the guaianolide framework, 
we desired an all-carbon 5,7-ring system, with methyl substituents at the C4 and C10 positions. 
We envisioned that dienone 1.90 would be accessed from allene-yne 1.91 via the APKR 
(Scheme 23). The design of the diester tether found in allene-yne 1.91 was inspired by previous 
work in our group using diester containing allene-yne tethers,34b, 36c and from the work of 
Rapoport for malonic ester synthesis using tricarboxylates.45 The allene-yne 1.91 could be 
accessed from the three building blocks of 2-butyn-1-ol (1.92), which is a precursor for the 
allene moiety, sodium methanetricarboxylate 1.93, and propargyl bromide 1.94. 
 
Scheme 23. Retrosynthetic analysis of dienone 1.90. 
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1.2.2 Synthesis of allene-yne 1.91 
Conversion of 2-butyn-1-ol 1.92 to allene-yne 1.91 was executed in 6 steps in an overall 
36% yield (Scheme 24). A Johnson-Claisen rearrangement of 1.92 in the presence of triethyl 
orthoacetate and propionic acid provided allenyl ester 1.93 in 71% yield.46 Reduction of ester 
1.93 with lithium aluminum hydride in diethyl ether at 0 °C gave alcohol 1.94 in 95% yield 
which was then converted to mesylate 1.95 in 94% yield using triethyl amine and 
methanesulfonyl chloride. Next, the mesylate group was replaced by the methane tricarboxylate 
anion to afford 1.96 in 69% yield. Conversion of tricarboxylate 1.96 to the malonate species 1.97 
was accomplished in 97% yield using sodium ethoxide in THF. Finally, deprotonation of 1.97 
with sodium hydride, followed by the addition of propargyl bromide produced the allene-yne 
tether 1.91 in 86% yield. 
 
Scheme 24. Synthesis of allene-yne tether 1.91. 
1.2.3 Optimization of APKR with 1.91 
With allene-yne 1.91 in hand, the APKR was optimized for this substrate. These efforts 
are described within and organized by the various reaction parameters examined (Table 1).  
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Result of previously developed APKR conditions. Initially, the APKR reaction conditions 
previously developed in our group were employed. Allene-yne 1.91 was heated at 90 °C in 0.1 M 
toluene with 15 mol% [Rh(CO)2(Cl)]2, under a CO atmosphere for 1.5 h, which afforded dienone 
1.90 in 27% yield (Entry 1). A significant byproduct was also produced and isolated from the 
reaction mixture (Rf = 0.38, 20% EtOAc in hexanes). Analysis of the byproduct by 1H NMR 
spectroscopy did not allow for structure determination but did reveal signals similar to those 
present in the 1H NMR spectrum for dienone 1.90. Large signals were observed at 4.21 and 1.23 
ppm corresponding to the –OCH2CH3 groups of the ethyl esters. It was clear that the allene 
moiety had reacted due to the disappearance of the signal representing the allene hydrogens seen 
at 4.63 ppm for 1.91. However, small signals were observed in the aromatic region ranging from 
8.22-7.07 ppm. These observations led to a hypothesis that an intermolecular reaction was 
occurring. 
Table 1. Optimization of the APKR for methyl substituted allene-yne 1.91. 
 
Entry Rh(I) Rh(I) mol% Temp. (°C) Solvent Conc. (M) Time Yield (%) 
1 [Rh(CO)2Cl]2 15 90 Toluene 0.1  1.5 h 27 
2 [Rh(CO)2Cl]2 15 90 Toluene 0.1 1.5h 32a 
3 [Rh(CO)2Cl]2 15 90 Toluene 0.01 1.5 h 53 
4 [Rh(CO)2Cl]2 15 110 Toluene 0.01 25 min 57 
5 [Rh(CO)2Cl]2 15 75 DCE 0.01 30 min 40 
6 [Rh(CO)2Cl]2 10 110 Toluene 0.01 b 81 
7 [Rh(CO)2Cl]2 5 110 Toluene 0.01 b 80 
8 [Rh(CO)2Cl]2 2 110 Toluene 0.01 b 62 
9 [Rh(CO)2Cl]2 1 110 Toluene 0.01 b 63 
10 [Rh(CO)2Cl]2 0.1 110 Toluene 0.01 b 23 
11 [Rh(CO)(dppp)2]Cl 10 110 Toluene 0.1 21 h 27 
12 [Rh(CO)(dppp)2]Cl 10 110 Toluene 0.01 21 h 46 
13 [Rh(CO)Cl(dppp)]2 10 110 Toluene 0.01 6 h 29 
aTriphenylphosphine polymer bound was used as a Rh(I) scavenger prior to evaporation of reaction solvent. b1.91 was added 
dropwise over 1.5 h and reaction was complete 15 min after addition period. 
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Wender has reported that terminal allenes, such as those found in allene-yne 1.91, were 
ineffective in Rh(I) catalyzed [5+2] intermolecular cycloadditions between allenes and vinyl 
cyclopropanes (VCPs).47 Computational analysis lead to the proposal that this limitation was a 
result of two terminal allenes undergoing an intermolecular dimerization, with Rh(I), to form 
rhodacycle 1.100 (Scheme 25). This process was shown to be irreversible and therefore poisons 
the Rh catalyst.48 Allenes with terminal methyl substitutions, however, readily underwent the 
desired [5 + 2] cycloaddition for the formation of 7-membered ring 1.99. This is reasoned that 
the steric nature of the methyl substitution increases the energy barrier for the competing allene 
dimerization. This report, as well as other synthetic reports of intermolecular reactions between 
allenes and alkynes provide precedent for the proposed intermolecular competing pathway, 
resulting in disappearance of the allene functional group.49  
 
Scheme 25. Allene dimerization as a competing process for the [5 +2] cycloaddition of terminal allenes with VCPs. 
Analysis of the byproduct by ESI mass spectroscopy revealed a base peak with an exact 
mass of 581.3099 ([M+H]) when run in the positive ion mode. The same mass spectroscopy 
analysis of allene-yne 1.91 and dienone 1.90 revealed [M+H] molecular ion peaks with exact 
masses of 293.1751 and 321.1687 respectively. Homodimerization of allene-yne 1.91 would 
result in a substrate with an exact mass of 584.3350 (C34H48O8), while the mass of a rhodacycle 
consistent with 1.100 proposed by Wender and Houk would have a theoretical exact mass of 
778.1992 (C36H48O10ClRh). The mass data obtained for the byproduct does not assist with 
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determining a structure, but it supports the speculation a competing intermolecular process, 
evidenced by the near doubling of the mass compared to allene-yne 1.91 and cycloadduct 1.90.  
Scavenger for Rh(I) catalyst. Upon completion of the reaction, the traditional protocol for 
reaction work up involves filtration of the toluene reaction solution through a celite plug, rinsing 
with diethyl ether, followed by solvent evaporation. The celite filtration is not sufficient for 
removal of the rhodium catalyst, evidenced by the presence of baseline impurities, consistent 
with the coloration and TLC observations of the [Rh(CO)2Cl]2. We hypothesized that 
concentration of the cyclocarbonylation adduct in the presence of rhodium could lead to 
problematic substrate/catalyst interactions, thereby lowering the overall yield of dienone 1.90. To 
efficiently remove the rhodium prior to concentration, polymer bound triphenylphosphine was 
tested as a rhodium catalyst scavenger. After completion of the cyclocarbonylation reaction, the 
reaction solvent was cooled to rt, followed by addition of polymer bound triphenylphosphine. 
Stirring at room temperature for 14 h completely scavenged the rhodium, as evidenced by 
disappearance of the baseline TLC spot. The polymer was removed via vacuum filtration prior to 
evaporation of the reaction solvent. While this procedure only marginally increased the yield of 
1.90 to 32% yield (Entry 2), polymer bound triphenylphosphine was utilized as a scavenger in 
the work up of subsequent experiments.  
Concentration, Solvent, and Carbon Monoxide. Next, a screening of reaction 
concentrations were performed on small scale reactions (5 mg of 1.91, 0.017 mmol). We 
predicted that lower concentrations would reduce formation of the byproduct based upon our 
hypothesis that it is a result of an intermolecular process. Reaction monitoring was performed by 
TLC analysis; relative amounts of 1.90 and the undesired byproduct were compared.  First, 
toluene was employed at various concentrations including the standard 0.1 M, 0.02 M, and 0.01 
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M. TLC observations revealed that as the reaction concentration was diluted, the amount of 
dienone 1.90 formed increased, while the formation of the unknown byproduct decreased. These 
qualitative observations were confirmed quantitatively when the APKR reaction of allene-yne 
1.91 was performed at 0.01 M in toluene on a larger scale (45 mg of 1.91, 0.15 mmol) at 90 °C 
with 15 mol% [Rh(CO)2Cl]2 and a CO atmosphere. The yield of dienone 1.90 increased to 53% 
(Entry 3). Increasing the temperature to 110 °C shortened the reaction time from 1.5 h to 25 min, 
and slightly increased the yield of 1.90 to 57% (Entry 4). 
 TLC screening was also performed for different solvents including toluene, THF, and 
DCE while maintaining a 0.01 M concentration. Use of THF resulted in increased formation of 
the byproduct, and decreased formation of 1.90. DCE was comparable to toluene based upon 
TLC observations, however, when utilized for a larger scale, this solvent resulted in a lower, 
40% yield, of 1.90 (Entry 5). Toluene was determined to be the optimal solvent. 
 A comparison between the use of 100% CO gas and 10% CO in argon gas was made. 
TLC observations revealed that the partial carbon monoxide atmosphere decreased formation of 
1.90. Therefore, use of 100% CO gas was maintained for subsequent experiments. 
 Due to the increased yield observed lowering the reaction concentration, the reaction was 
further diluted by employing a drop-wise, syringe-pump addition procedure. This strategy 
minimizes the concentration of allene-yne 1.91, while avoiding the use of uneconomical amounts 
of solvent.50 To this end, allene-yne 1.91, dissolved in toluene, was added dropwise over 1.5 h, 
using a syringe pump, to a refluxing solution of [Rh(CO)2Cl]2 (10 mol%) in toluene (0.01 M 
overall with respect to 1.91), under a CO atmosphere. The reaction was complete 15 min after 
the addition period; 1.90 was obtained in 81% yield with no byproduct observed (Entry 6). 
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Catalyst Loading. Next, the catalyst loading was examined while using the dropwise 
addition of allene-yne 1.91 to the Rh(I) catalyst in toluene. Lowering the loading to 5 mol% 
maintained a high, 80% yield of 1.90 (Entry 7). However, lower catalyst loadings resulted in 
decreased yields; catalyst loadings of 2 mol %, 1 mol %, and 0.1 mol % gave 1.90 in 62%, 63%, 
and 23% respectively (Entries 8-10). Therefore, 5 mol% was determined to be the optimal 
amount of [Rh(CO)2Cl]2 needed for this type of transformation. 
Alternative Rh(I) catalysts. Mukai and coworkers have reported the use of alternative 
Rh(I) catalysts [RhCl(CO)dppp]2 and [Rh(CO)dppp)2]Cl for overcoming low-yielding APKR 
results.51 In particular, their synthesis of (+)-achalensolide (1.87) utilizes the APKR for 
conversion of methyl substituted allene-yne 1.85 to dienone 1.86 (Scheme 26). Use of 
[Rh(CO)2Cl]2 afforded 1.86 in only 14% yield. Alternatively, use of [RhCl(CO)dppp]2 increased 
the yield of 1.86 to 61%, while [Rh(CO)dppp)2]Cl gave the best yield of 96%.40 
 
Scheme 26. Comparison of various Rh(I) catalysts for the formation of dienone 1.86. 
Comparisons were made between [Rh(CO)2Cl]2 and these alternative Rh(I) catalysts for 
the APKR of methyl substituted allene-yne 1.91. Allene-yne 1.91 was reacted with 
[Rh(CO)(dppp)2]Cl, a rhodium monomer catalyst generated from 10 mol% rhodium (1,5-
cyclooctadiene) chloride dimer ([Rh(cod)Cl]2) and 50 mol% 1,3-bis(diphenylphosphino)propane 
(dppp), under a CO atmosphere in toluene (0.1 M);52 these conditions afforded dienone 1.90 in 
27% yield after stirring for 21 h (Entry 11). Lowering the concentration of the reaction to 0.01 
M, using the same catalyst, afforded 1.90 in 46% yield (Entry 12). Both of these results are 
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comparable to the yields of 1.90 obtained while using [Rh(CO)2Cl]2 at the same concentrations 
(Entries 2 and 3). However, the longer reaction times and the more tedious procedure required 
when using [Rh(CO)(dppp)2]Cl favor use of [Rh(CO)2Cl]2. Rhodium dimer catalyst 
[RhCl(CO)dppp]2, generated from 10 mol% [Rh(cod)Cl]2 and 20 mol% dppp,52 was also 
employed; at 0.01 M concentration, 1.90  was afforded in only 29% yield (Entry 13).  
1.2.4 Application of high dilution conditions to synthesis of bicyclo[5.3.0]decadienones 
Next, we examined the generality of the syringe-pump, “high dilution” conditions on a 
series of allene-ynes with methyl substituents on the proximal allene carbon and either methyl 
substituted or terminal alkynes. This allene-yne series was prepared with a variety of 
functionalities present in the allene-yne tethers. Diester-containing allene-yne 1.101, with a 
terminal alkyne, was prepared in a manner analogous to allene-yne 1.91; malonate 1.97 was 
reacted with sodium hydride, followed by propargyl bromide to afford 1.101 in 87% yield 
(Scheme 27). 
 
Scheme 27. Synthesis of diester allene-yne tether 1.101 with a terminal alkyne. 
The diester tethers 1.91 and 1.101 were manipulated to afford additional allene-yne 
substrates (Scheme 28). The esters were reduced using lithium aluminum hydride to afford diols 
1.102a and b in 65% and 98% respectively. The diols were protected using camphor sulfonic 
acid and dimethoxypropane in acetone to afford acetonide containing tethers 1.103a and b in 
76% and 85% yields respectively. 
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Scheme 28. Transformation of diester allene-ynes 1.91 and 1.101 to acetonide containing allene-ynes 1.103a,b. 
Heteroatom-containing tethers were prepared from allenyl-alcohol 1.94 (Scheme 29).36c 
To prepare oxygen containing tethers, the Williamson ether synthesis was employed. 
Deprotonation of alcohol 1.94 with sodium hydride followed by reaction with 1-bromo-2-butyne 
resulted in formation of allene-yne 1.104a in 52% yield. Alternatively the corresponding 
alkoxide of 1.94 was reacted with propargyl bromide to afford terminal alkyne-containing tether 
1.104b in 77% yield. Nitrogen containing tethers 1.105a and b were prepared in 68% and 64% 
respectively, using Mitsunobu reaction conditions with alcohol 1.94, DIAD, triphenylphosphine, 
and the corresponding tosylated propargyl amine. 
 
Scheme 29. Synthesis of heteroatom containing allene-yne tethers 1.104 and 1.105. 
The prepared allene-yne tethers were subjected to the optimized high dilution APKR 
conditions (Scheme 30). When diester tether 1.101, with a terminal alkynyl group, was added 
dropwise over 1.5 h to a solution of [Rh(CO)2Cl]2 (5 mol%) in toluene (0.01 M), under a CO 
atmosphere at 110 °C (Conditions A), dienone 1.106 was afforded in 92% yield. For comparison, 
a 0.01 M solution of 1.101 in toluene was heated with 5 mol% [Rh(CO)2Cl]2, under a CO 
atmosphere, without the dropwise addition (Conditions B) which afforded 1.106 in only 50% 
yield. Therefore, the dropwise addition of the allene-yne to the reaction medium resulted in 42% 
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yield increase for 1.106. A comparison of Conditions A and B were also made for the reaction of 
acetonide tether 1.103a, with a methyl substituted alkynyl group. The dropwise Conditions A 
afforded dienone 1.107a in 87% yield, a 60% increase compared to the 27% yield of 1.107a 
obtained when adding the allene-yne all at once (Conditions B). Acetonide 1.103b with a 
terminal alkynyl group also successfully afforded dienone 1.107b in 78% yield using the 
dropwise conditions.  
When diol 1.102a was reacted under the optimized conditions dienone 1.108a was 
afforded in a moderate 59% yield. Unfortunately, when diol 1.102b with a terminal alkyne was 
reacted, the corresponding dienone 1.108b was not obtained. Other examples involving the 
presence of hydroxyl groups in Pauson-Khand precursors have resulted in significantly reduced 
yield.51 We presume that the hydroxyl groups may be reacting with the rhodium catalyst, rending 
it useless for the cyclocarbonylation pathway. 
 
Scheme 30. Result of high dilution conditions on a variety of allene-ynes. Conditions A high dilutions 
conditions where the allene-yne was added by a syringe pump over 1.5 h. Conditions B added the allene-yne all at 
once. 
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Tethers containing either a nitrogen or oxygen atom were examined next. Tosyl amine 
tethers 1.105a,b were well tolerated in the APKR reaction and afforded dienones 1.109a and b in 
92% and 73% respectively. However, allene-yne ethers 1.104a,b only afforded the 
corresponding dienones 1.110a and b in moderate yields (49% and 44% respectively). Other 
reports have also observed diminished yield for the synthesis of oxabicyclic compounds using 
the APKR reaction compared to the corresponding azabicyclic compounds.36c, 53  
Finally, 1,3-disubstituted allene containing tether 1.111, previously prepared in our 
group, was reacted under the high dilution conditions (Scheme 31).36c While 1,3-disubstitued 
allenes have been tolerated previously in the APKR, we wanted to determine if the yield of 
dienone 1.112 could be improved using the dropwise conditions.  Allene-yne 1.111 was added 
dropwise over 1.5 h to a solution of [Rh(CO)2Cl]2  (5 mol%) in toluene (0.01 M) at 110 °C. After 
the addition period, an additional 3 h of stirring was required to afford dienone 1.112 in 70% 
yield (Scheme 31). Dienone 1.112 was previously reported to be prepared in 71% yield from 
1.111 under more concentrated conditions (10 mol% [Rh(CO)2Cl], 0.1 M toluene, 90 °C). 
Therefore, the dilute, dropwise conditions did not alter the effectiveness of the reaction. The 
longer required reaction time may have minimized the positive dilution effects of the dropwise 
conditions.   
 
Scheme 31. Reaction of 1,3-diubstituted allene 1.111 in the APKR with dilute, dropwise conditions. 
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1.2.5 Efforts towards a large-scale allene-yne synthesis and APKR reaction for Organic 
Syntheses. 
Based upon the success of this drop-wise addition modification and the APKR in general 
for the synthesis of bicyclo[5.3.0]decadienones, we sought to perform the synthesis of dienone 
1.90 on a large scale, suitable for publication in Organic Syntheses. Two separate procedures, 
seen in Scheme 32, were invited for submission to the journal. The first procedure was to 
synthesize 10g of allenyl-mesylate 1.95 (59 mmol) from 2-butyn-1-ol (1.92) via the Johnson-
Claisen rearrangement, reduction, and mesylation reactions, showcasing the allene functional 
group as a robust building block for subsequent transformations. The second procedure involved 
the synthesis of allene-yne 1.91 and subsequent APKR for the formation of 5 g of dienone 1.90.  
 
Scheme 32. Original Organic Syntheses procedures for the APKR synthesis of bicyclo[5.3.0]decadienones. 
For procedure 1, scale-up of the Johnson-Claisen reaction toward allenyl ester 1.93 was 
required. This reaction was performed successfully at 28.5 and 45.0 mmol scales, affording 1.93 
in 61% and 71% respectively (Table 2, Entries 1 and 2). However, issues arose when the reaction 
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was attempted at a larger, 117 mmol scale, required to meet the synthesis goal. This procedure 
only gave allenyl ester 1.93 in 33% yield (Entry 3).  
Table 2. Result from large scale conversion of 2-butyn-1-ol (1.92) to allenyl ester 1.93. 
 
Entry mmol of 2-butyn-1-ol (1.92) Time Yield 1.93 (g) Yield 1.93 (%) 
1 28.5 5 h 2.44 g 61% 
2 45.0 6.5 h 4.52 g 71% 
3 117.0 6.5 h 5.41 g 33% 
 
The poor yield at the larger scale for the formation of 1.93, as well as the volatility of the 
corresponding allenyl alcohol, formed after reduction of 1.93, ultimately led us to redesign the 
Organic Syntheses proposal using a more robust substrate. Our group has shown that the 
Johnson-Claisen rearrangement of propargyl alcohol 1.116 (Scheme 33) affords the 
corresponding allenyl ester in high yields.43 Due to this fact, and the high yielding APKR 
examples observed for tosylamide containing allene-yne tethers 1.105a,b, we planned to 
synthesize azabicyclic dienone 1.113, according to the retrosynthetic analysis seen in Scheme 33.  
The remainder of this effort was successfully carried out by Joe Burchick, another member of the 
Brummond group. 
 
Scheme 33. Retrosynthetic analysis for dienone 1.113. 
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1.2.6 Synthesis of Bicyclo[6.3.0]dienones 
The optimized “high dilution” conditions were also applied to the synthesis of 
bicyclo[6.3.0]dienones by extending the allene-yne tether of the APKR precursor by one carbon. 
Synthesis of bicyclo[6.3.0]dienones via the APKR has been limited. A report published by 
Mukai in 2005 is limited to phenylsulfonyl-substituted allene-yne tethers 1.117 to afford the 
fused 5,8-bicyclic systems 1.118 (Scheme 34).54 The phenylsulfonyl-substituted allenes are 
popular for the APKR because they are readily available. For all systems, optimized conditions 
were determined and used either [Rh(CO)2Cl]2 or [RhCl(CO)dppp]2, in refluxing solvent 
(xylenes or toluene). An unsubstituted, all-carbon, tether afforded 1.118a in 23% yield. 
Efficiency of the reaction was improved by incorporating a diester into the allene-yne tether, 
which afforded 1.118b in 43% yield. The presence of a phenyl ring in the tether further improved 
the efficiency of the reaction; 1.118c and 1.118d were afforded in 90% and 83% respectively. 
However, the location of the phenyl group within the tether was an important factor. 
Bicyclo[6.3.0]undecadienones have more readily been synthesized by a Rh(I) catalyzed 
cyclocarbonylation reaction of a bis(sulfonylallene). For example, dienone 1.120 was prepared 
from bis(allene) 1.119 in 70% yield along with 1.121 as a byproduct (Scheme 35).55  
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Scheme 34. Previous syntheses of bicyclo[6.3.0]undecadienones via the APKR. 
 
Scheme 35. Synthesis of bicyclo[6.3.0]dienone 1.120 from bis(sulfonylallene) 1.119. 
Our group has also attempted the synthesis of bicyclo[6.3.0]undecadienones via the 
APKR, but has had little success. For example, allenyl acetate 1.122b, with a five-carbon tether 
between the allene and the alkyne, was subjected to APKR conditions and afforded the 
cyclocarbonylation product 1.123b in only trace amounts, as determined by 1H NMR 
spectroscopy (Scheme 36).36b For comparison, the corresponding bicyclo[5.3.0]decadienone 
1.123a was afforded in 62% yield under the same conditions. 
 
Scheme 36. Attempted synthesis of bicyclo[6.3.0]undecadienone 1.123b.  
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To test the high dilution conditions for the synthesis of bicyclo[6.3.0]undecadienones, we 
synthesized allene-yne 1.125, where the allene and alkyne were connected by a five-carbon, 
diester-containing tether. Initial attempts to react allenyl malonate 1.97 with sodium hydride 
followed by 1-bromobut-3-yne (1.124) were unsuccessful, resulting in recovery of malonate 1.97 
(Scheme 37). Potassium iodide was also employed in attempt to increase the reactivity between 
1.97 and the alkyl halide, but this effort was also unsuccessful. Alternatively, 1-bromobut-3-yne 
1.124 was reacted with sodium methantricarboxylate and potassium iodide in a mixture of DMF 
and toluene to afford tricarboxylate 1.126 in 54% yield. In turn, decarboxylation of 1.126 with 
sodium ethoxide gave malonate 1.127 in 73% yield. Finally, deprotonation of malonate followed 
by reaction with allenyl mesylate 1.95 afforded allene-yne 1.125 in 61% yield.  
With allene-yne 1.125 in hand, we began exploring the APKR for the formation of 5,8- 
fused bicyclic dienones. First, the optimal conditions determined for the synthesis of the 5,7- 
bicyclic dienones were employed. Allene-yne 1.125 was added drop-wise (over 1.5 h) to a 
solution of [Rh(CO)2Cl]2 in toluene (110°C, 1 atm CO). After the addition period, an additional 
6 h of stirring was required to consume 1.125. Dienone 1.128 was isolated in 14% yield. By 
decreasing the temperature to 90 °C, yield of 1.128 was improved to 22% but a significantly 
longer reaction time (16 h) was required (Scheme 38). The column was flushed with 100% ethyl 
acetate to collect baseline material. Analysis of this baseline material by 1H NMR spectroscopy 
revealed decomposition, however, broad signals were observed at 4.19 and 1.24 ppm, consistent 
with the ethyl ester functional groups. Changing the solvent to THF resulted in complete 
decomposition while changing the CO atmosphere to 10% CO in argon resulted in a decreased 
yield of 1.128 (determined by TLC). While the yield of 1.128 was low in these reactions, this 
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represents the first synthesis of a bicyclo[6.3.0]dienone without a phenylsulfonyl substitution via 
the APKR.  
 
Scheme 37. Synthesis of extended allene-yne diester tether 1.125. 
 
 
Scheme 38. Synthesis of bicyclo[6.3.0]undecadienone 1.128 via the APKR. 
1.3 CONCLUSION 
In summary, optimized conditions were developed for the synthesis of 
bicyclo[5.3.0]decadienones with methyl substitutions at the C4 and C10 positions via the APKR 
reaction. A model allene-yne, 1.91, with methyl substitutions on the proximal carbon of the 
allene, a methyl substituted alkyne, and an all carbon tether was synthesized and used for this 
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optimization process. Traditional APKR conditions developed previously in the group resulted in 
low yields of dienone 1.90 and the formation of an unidentified byproduct, hypothesized to be a 
result of a competing intermolecular process. High yields of 1.90 were obtained after 
implementing a syringe-pump, “high dilution” protocol. These conditions also eliminated the 
formation of the byproduct, supporting the hypothesis of a competing intermolecular reaction.  
The optimized APKR conditions were applied to a series of allene-ynes. Improved yields 
for allene-ynes containing a terminal alkyne were also observed using the dilute conditions 
compared to more concentrated reactions. Diester, acetonide, and tosyl amide containing tethers 
resulted in high yields of the corresponding dienones. Oxygen and diol containing tethers gave 
moderate yields, with the exception of diol tether 1.102b, which did not successfully afford the 
corresponding dienone. These conditions for the high yielding synthesis of 
bicyclo[5.3.0]decadienones with methyl substitutions at C4 and C10 via an APKR further 
establishes this approach as a viable synthetic method for generation of guaianolide analogs.  
1.4 EXPERIMENTALS 
1.4.1 General Methods 
All commercially available compounds were used as received unless otherwise noted. 
Dichloromethane (DCM), diethyl ether (Et2O), and tetrahydrofuran (THF) were purified by 
passing through alumina using the Solv-Tek ST-002 solvent purification system. Toluene was 
freshly distilled from calcium hydride prior to use. N,N-dimethylformamide (DMF) was distilled 
prior to use and stored over 4 Å molecular sieves. Deuterated chloroform (CDCl3) was stored 
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over 4 Å molecular sieves. Carbon monoxide (CO) was purchased from Matheson Tri Gas and 
the purity level was Matheson Purity (99.99%). Triphenylphosphine polymer bound was 
purchased from Aldrich as a copolymer of styrene and divinyl benzene. Purification of the 
compounds by flash column chromatography was performed using silica gel (40-63 μm particle 
size, 60 Å pore size) purchased from Sorbent Technologies. TLC analyses were performed on 
Silicycle SiliaPlate G silica gel glass plates (250 μm thickness). 1H NMR and 13C NMR spectra 
were recorded on Bruker Avance 300 MHz, 400 MHz, or 500 MHz. Spectra were referenced to 
residual chloroform (7.26 ppm, 1H, 77.16 ppm, 13C).  Chemical shifts are reported in ppm, 
multiplicities are indicated by s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quartet), p 
(pentet), and m (multiplet). Coupling constants, J, are reported in hertz (Hz). All NMR spectra 
were obtained at rt.  IR spectra were obtained using a Nicolet Avatar E.S.P. 360 FT-IR. ES mass 
spectroscopy was performed on a Waters Q-TOF Ultima API, Micromass UK Limited or a 
Thermo Scientific Q Exactive high resolution mass spectrometer. 
1.4.2 Experimental procedures detailed in published papers 
Characterization data, including 1H and 13C NMR spectra, and details of the preparation 
for the compounds shown in Figure 6 were previously published and can be found in the 
Supporting Information of Wells, S. M.; Brummond, K. M. Conditions for a Rh(I)-catalyzed 
[2+2+1] cycloaddition reaction with methyl substituted allenes and alkynes. Tetrahedron Letters, 
2015, 56, 3546-3549.  
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Figure 6. Previously published compounds for which synthetic procedures and characterization data can be found in 
Tetrahedron Lett. 2015, 56, 3546-3549. 
 
1.4.3 General Procedures 
General Procedure 1A: A High Dilution Allenic Pauson-Khand Reaction (APKR). A 
flame-dried, 2-necked, round-bottomed flask equipped with a stir bar, a condenser topped with a 
septum pierced with a nitrogen inlet needle, and a septum in the side arm was charged with 
[Rh(CO)2Cl]2 (0.05 equiv) and toluene (0.0013 M with respect to the Rh(I) catalyst). The 
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apparatus was evacuated through a needle connected to the vacuum gas manifold and then filled 
with CO with a balloon (3 x). The flask was placed in a pre-heated oil bath (110 °C).  In a 
separate flask, allene-yne (1 equiv) was dissolved in toluene (0.04 M with respect to the allene-
yne). The allene-yne solution was drawn into a syringe and added to the Rh(I) solution dropwise 
over 1.5 h using a syringe pump. After the addition was complete, heating and stirring were 
maintained until the reaction was complete, as evidenced by TLC.  The oil bath was removed 
and the reaction was allowed to cool to rt. Triphenylphosphine polymer bound (~3.0 mmol/g, 1 
equiv) was added and the reaction was stirred for 14 h. The polymer was removed by vacuum 
filtration and rinsed with diethyl ether (10 mL).  The filtrate was concentrated under reduced 
pressure rotary evaporation, and the residue was purified by silica gel flash column 
chromatography to yield the bicyclo[5.3.0]decadienone. 
General Procedure 1B: APKR Conditions B (Scheme 30). A flame-dried, 2-necked, 
round-bottomed flask equipped with a stir bar, a condenser topped with a septum pierced with a 
nitrogen inlet needle, and a septum in the side arm was charged with the allene-yne (1 equiv), 
dissolved in toluene (0.01 M). The apparatus was evacuated through a needle connected to the 
vacuum gas manifold and then filled with CO gas with a balloon (3 x). [Rh(CO)2Cl]2 (0.05 
equiv) was added by temporarily removing the septum in the side arm. The apparatus was again 
evacuated and filled with CO gas (3 x). The flask was placed in a pre-heated oil bath (110 °C) 
and stirred until the reaction was complete, as evidenced by TLC. The oil bath was removed and 
the reaction was allowed to cool to rt. Triphenylphosphine polymer bound (~3.0 mmol/g, 1 
equiv) was added and the reaction was stirred for 14 h. The polymer was removed by vacuum 
filtration and rinsed with diethyl ether. The filtrate was concentrated under reduced pressure 
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rotary evaporation, and the residue was purified by silica gel flash column chromatography to 
yield the bicyclo[5.3.0]decadienone. 
1.4.4 Experimental procedures with compound characterization data 
Diethyl 1,3-dimethyl-2-oxo-2,4,6,7-tetrahydroazulene-5,5(1H)-
dicarboxylate (1.112). Follows general procedure 1A: Toluene (6.0 mL), 
[Rh(CO)2Cl]2 (2 mg, 0.0043 mmol, 0.05 equiv), allene-yne 1.111 (25 mg, 0.086 mmol, 1 equiv) 
in toluene (2.5 mL). Reaction stirred for 3 h after addition period. Polymer bound triphenyl 
phosphine (25 mg) was added and stirred overnight. The crude residue was purified by silica gel 
flash column chromatography (18% EtOAc in hexanes) to afford the title compound (19 mg, 
70%) as a clear oil. Characterization matches that previously reported for 1.112.36c 
Data for 1.112. 
1H NMR (400 MHz, CDCl3) 
5.81 (t, J = 5.7 Hz, 1H), 4.23-4.15 (m, 4H), 3.21 (s, 2H), 2.77-2.68 (m, 1H), 2.53-
2.46 (m, 2H), 2.39-2.32 (m, 2H), 1.84 (s, 3H), 1.28-1.22 (m, 6H), 1.26 (d, J = 7.5 
Hz, 3H) ppm;  
TLC  Rf = 0.31 (20% EtOAc in hexanes) 
  Silica gel, UV visible, KMnO4  
Triethyl pent-4-yne-1,1,1-tricarboxylate (1.126). A flame-dried, 2-necked, 
round-bottomed flask equipped with a stir bar, a condenser topped with a 
nitrogen inlet adaptor, and a septum in the side arm was charged 1:1 mixture of DMF and 
toluene (6 mL) and sodium methanetricarboxylate (380 mg, 1.49 mmol, 1 equiv). 1-Bromobut-3-
yne (0.14 mL, 1.49 mmol, 1 equiv), dissolved in a 1:1 mixture of DMF and toluene (1 mL) was 
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added to the reaction flask all at once via syringe, followed by the addition of potassium iodide 
(272 mg, 1.64 mmol, 1.1 equiv) The reaction flask was lowered into a pre-heated oil bath (80 °C) 
and stirred for 14 h. The oil bath was removed and the reaction contents were cooled to rt. 
Saturated NH4Cl (8 mL) was added and the mixture was transferred to a separatory funnel. The 
organic later was separated and the aqueous layer was extracted with diethyl ether (3 x 8 mL). 
The combined organic extracts were dried with MgSO4, filtered, and concentrated under reduced 
pressure rotary evaporation. The crude residue was purified by silica gel flash column 
chromatography (10% EtOAc in hexanes) to yield the title compound as a clear oil (229 mg, 
54%). Characterization data matched that previously reported for 1.126.56 
Data for 1.126. 
1H NMR (400 MHz, CDCl3) 
4.26 (q, J = 7.2 Hz, 6H), 2.51-2.44 (m, 2H), 2.43-2.37 (m, 2H), 1.97 (t, J = 2.4 
Hz, 1H), 1.29 (t, J = 7.2 Hz, 9H) ppm; 
TLC  Rf = 0.26 (20% Et2O in hexanes) 
  Silica gel, KMnO4  
Diethyl 2-(but-3-yn-1-yl)malonate (1.127). To a single-necked, round-
bottomed flask equipped with a stir bar and septum pierced with a nitrogen inlet 
adapter was added ethanol (5 mL). Freshly cut sodium (77.3 mg, 3.38 mmol, 1.2 equiv) was 
added piecewise to the ethanol. The solution was stirred until all sodium had dissolved. The stir 
bar and septum were removed and the excess ethanol was removed using reduced pressure rotary 
evaporation followed by drying on a high vacuum for 1 h. The stir bar and septum with nitrogen 
inlet needle were replaced and the flask was charged with THF (14 mL) and cooled to 0 °C on an 
ice/water bath. Tricarboxylate 1.126 (800 mg, 2.81 mmol, 1 equiv), dissolved in THF (2.5 mL), 
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was added to the reaction dropwise over 5 min. The reaction stirred for 2.5 h and was quenched 
by the addition of 1 M HCl (15 mL). The mixture was transferred to a separatory funnel. The 
organic layer was separated and the aqueous layer was extracted with DCM (3 x 12 mL). The 
combined organic layers were dried over magnesium sulfate, filtered and concentrated using 
reduced pressure rotary evaporation. The crude residue was purified by silica gel flash column 
chromatography (8% ethyl acetate in hexanes) to yield the title compound as a clear oil (437 mg, 
73%). Characterization data matched that previously reported for 1.127.57 
Data for 1.127. 
1H NMR (300 MHz, CDCl3) 
4.27-4.12 (m, 4H), 3.57 (t, J = 7.2 Hz, 1H), 2.30 (td, J = 7.2, 2.6 Hz, 2H), 2.12 (q, 
J = 7.2 Hz, 2H), 1.99 (t, J = 2.6 Hz, 1H), 1.27 (t, J = 7.2 Hz, 6H) ppm; 
TLC  Rf = 0.34 (10% EtOAc in hexanes) 
  Silica gel, KMnO4  
Diethyl 2-(but-3-yn-1-yl)-2-(3-methylpenta-3,4-dien-1-yl)malonate 
(1.125). To a flame-dried, 2-necked, 100 mL, round-bottomed flask with a 
stir bar, condenser topped with N2 inlet adaptor, and a septum in the side arm, 
was added THF (22 mL), DMF (22 mL), and sodium hydride (98 mg of a 60% dispersion in 
mineral oil, 2.45 mmol, 1.3 equiv). The suspension was cooled to 0 °C on an ice/water bath. 
Malonate 1.127 (400 mg, 1.88 mmol, 1 equiv) was dissolved in DMF (1 mL), added dropwise to 
the suspension, and stirred for 1 h. The ice bath was removed. Allenyl mesylate 1.195 (398 mg, 
2.26 mmol, 1.2 equiv) was added followed by potassium iodide (375 mg, 2.26 mmol, 1.2 equiv). 
The reaction flask was lowered into a pre-heated oil bath (80 °C) and stirred overnight. The 
reaction was cooled to rt and quenched by the addition of saturated NH4Cl (30 mL). The mixture 
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was diluted with 15 mL of diethyl ether and transferred to a separatory funnel. The organic layer 
was separated and the aqueous layer was extracted with diethyl ether (2 x 10 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated using reduced pressure rotary 
evaporation. The crude residue was purified by silica gel flash column chromatography (5% 
EtOAc in hexanes) to afford the title compound (333 mg, 61%) as a clear oil.  
Data for 1.125.  
1H NMR (400 MHz, CDCl3) 
4.63 (sextet, J = 3.2 Hz, 2H), 4.22-4.16 (m, 4H), 2.19-2.15 (m, 4H), 2.04-2.00 (m, 
2H), 1.97-1.94 (m, 1H), 1.85-1.79 (m, 2H), 1.68 (t, J = 3.2 Hz, 3H), 1.25 (t, J = 
7.2 Hz, 6H) ppm; 
13C NMR (100 MHz, CDCl3) 
206.0, 171.2, 97.8, 83.5, 75.2, 68.8, 61.5, 56.9, 31.8, 30.6, 28.1, 19.0, 14.2, 14.1 
ppm; 
HRMS  (TOF MS AP+) 
 [M + H]+ calcd for C17H25O4, 293.1753; found, 293.1783; 
IR  (thin film) 
  3292, 2979, 1959, 1728, 1447, 1255, 1187, 1095, 1027 cm-1; 
TLC  Rf = 0.42 (20% Et2O in hexanes) 
Silica gel, KMnO4  
Diethyl (Z)-9-methyl-2-oxo-1,2,4,5,7,8-hexahydro-6H-
cyclopenta[8]annulene-6,6-dicarboxylate (1.128). Follows general 
procedure 1A: Toluene (15.0 mL), [Rh(CO)2Cl]2 (8 mg, 0.0021 mmol, 0.1 equiv), allene-yne 
1.125 (20 mg, 0.021 mmol, 1 equiv) in toluene (5.0 mL). The solution heated at 90 °C and stirred 
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for 13 h after addition period. Polymer bound triphenylphosphine (75 mg) was added and stirred 
for 8 h. The crude residue was purified by silica gel flash column chromatography (gradient of 
20-30% EtOAc in hexanes) to afford the title compound (14 mg, 22%) as a sticky residue. 
Data for 1.128. 
1H NMR (400 MHz, CDCl3) 
5.97 (s, 1 H), 4.18-4.10 (m, 4 H), 2.95-2.88 (m, 4 H), 2.59-2.53 (m, 2 H), 2.39-
2.33 (m, 2 H), 2.31-2.26 (m, 2 H), 1.87 (s, 3 H), 1.23 (t, J = 7.2 Hz, 6 H) ppm; 
Impurities visible at 4.20, 1.29, 0.87 ppm. 
13C NMR (150 MHz, CDCl3) 
204.9, 173.5, 171.7, 138.0, 133.0, 132.0, 61.7, 57.2, 41.7, 31.5, 31.4, 29.7, 28.1, 
24.6, 14.2 ppm; 
HRMS  (FTMS + p ESI) 
[M + H]+ calcd for C18H25O5, 321.1697; found, 321.1702; 
IR  (thin film) 
  2980, 2930, 1729, 1687, 1566, 1446, 1247, 1188, 1082, 1031cm-1; 
TLC  Rf = 0.13 (20% EtOAc in hexanes) 
  Silica gel, UV visible, KMnO4  
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2.0  GUAIANOLIDE ANALOG SYNTHESIS VIA AN 
ALLYLBORATION/LACTONIZATION SEQUENCE AND THE APKR REACTION 
2.1 INTRODUCTION 
The Brummond group has successfully applied the allenic Pauson-Khand reaction 
(APKR) to the synthesis of oxygenated 6,12-guaianolide analogs trans-1.83 and cis-1.84.43 
Access to the guaianolide framework was achieved via an allylboration/lactonization sequence to 
afford lactones 1.82a and b, inspired by the work of Dennis Hall,58 followed by an APKR to 
access the 5,7,5-fused ring system (Scheme 39). Overall, this synthesis extended the scope of the 
APKR to the preparation of highly oxygenated substrates. Typically for the synthesis of 
guaianolides, the α-methylene-γ-butyrolactone is installed at the end of the synthesis due to its 
potential reactivity, however this moiety was well tolerated in the APKR and the subsequent silyl 
deprotection toward 1.83 and 1.84. This synthesis afforded racemic mixtures of the trans-lactone 
1.83 as a mixture of diastereomers with respect to the methoxy group at C8, and the cis-lactone 
1.84, as a single diastereomer. Through collaboration with the Harki lab at the University of 
Minnesota, these guaianolide analogs (trans-1.83 and cis-1.84) were tested for relative nuclear 
factor kappa B (NF-ĸB) inhibition and antiproliferative activity to cancerous cell lines.  
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Scheme 39. Previous synthesis of oxygenated guaianolide analogs 1.83 and 1.84. 
 
Figure 7. NF-ĸB inhibition of 1.83 and 1.84 benchmarked with parthenolide (PTL, 1.3). A) Compounds tested. B) 
NF-ĸB luciferase reporter assay in A549 cells induced with TNF-α (15 ng/mL) 30 min after molecular treatment. 
1.83 and 1.84 were dosed at 20, 10, and 1 µM. PTL (1.3) was dosed at 10, 1 µM. NI = noninduced, I = Induced. 
 
NF-ĸB is a transcription factor that regulates the gene expression of many physiological 
processes including acute phase inflammatory response.59 For more information on the NF-ĸB 
activity pathway, see Section 4.1. To evaluate the trans-1.83 and cis-1.84 for inhibition of 
induced NF-ĸB activity, the compounds were dosed at varying concentrations on A549 cells that 
had been activated by TNF-α (Figure 7). Activation of NF-ĸB signaling results in an increase of 
reporter luminescence; the presence of an NF-ĸB inhibitor will then diminish the reporter 
luminescence. Trans-1.83 and cis-1.84 were benchmarked against a known SL NF-ĸB inhibitor, 
parthenolide (PTL, 1.3). Trans-1.83 and cis-1.84 were shown to be equal inhibitors in the assay, 
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as both diminished induced NF-κB activity to non-induced levels at 20 µM treatment. The NF-
κB levels were also significantly diminished when 1.83 and 1.84 were dosed to cells at a 
concentration of 10 µM; with residual activity at 57 and 59%, respectively. PTL (1.3) was 
slightly more active at this concentration, inhibiting NF-κB to a 53% residual activity level.  
Inhibition of NF-κB pathway has also been described as a viable strategy for treating 
cancer, as upregulated NF-κB signaling has been shown to result in transcriptional activation of 
genes associated with all 6 hallmarks of cancer.10 In addition, other sesquiterpene lactones have 
been shown to display antiproliferative properties; these factors motivated the antiproliferative 
evaluation of these guaianolide analogs. Trans-1.83 and cis-1.84 were evaluated for growth 
inhibitory activity for an array of cancerous cell lines as well as one non-cancerous cell line 
(Vero). PTL was again used as a benchmark (Table 3).  Against DU-145 (human prostate cancer) 
cells, trans-1.83 and cis-1.84 showed similar antiproliferative activity compared to each other, 
but were less potent than PTL.  However, against HeLa (cervical cancer) and HL-60 (leukemia) 
cell lines, trans-1.83 was almost two times more active than cis-1.84 and PTL. Against U-87 MG 
(glioblastoma), trans-1.83 was less potent compared to both cis-1.84 and PTL. Cis-1.84 was 
shown to be the most potent of these three compounds toward NCI/ADR-RES cell lines, which 
model ovarian cancer as a result of over-expression of p-glycoprotein (p-gp) efflux pump. 
Toxicity towards healthy cells (Vero) of trans-1.83 and cis-1.84 was slightly lower than PTL, 
with all three compounds causing moderate levels of cell death. 
Table 3. Antiproliferative data of guaianolide analogs, trans-1.83 and cis-1.84, compared to parthenolide (PTL). 
Compound DU-145 HeLa HL-60 U-87 MG NCI/EDR-RES Vero 
trans-1.83 29.1 ± 4.7 20.3 ± 6.0 5.5 ± 0.4 27.1 ± 4.8 80.9 ± 24.0 32.2 ± 7.0 
cis-1.84 21.6 ± 1.9 39.7 ± 16.4 7.8 ± 2.3 9.8 ± 1.4 24.4 ± 1.0 30.1 ± 5.5 
PTL 8.9 ± 4.6 45.1 ± 3.7 9.3 ± 3.8 8.8 ± 2.1 57.6 ± 8.9 22.4 ± 1.5 
aCompounds were dosed to cells and incubated for 48 h. Cell viability was measured by Alamar Blue staining. Mean IC50 values 
± SD (µM) are shown. 
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Given the potent NF-κB inhibition and antiproliferative properties of 1.83 and 1.84, we 
were motivated to investigate the NF-κB mechanism of inhibition further. Having a greater 
understanding of how these molecules behave in vivo to inhibit NF-κB would help guide future 
synthetic endeavors toward additional guaianolide analogs with high therapeutic potential.  
However, in order to continue these biochemical investigations, the synthesis of 1.83 had to be 
repeated. Reproducibility for the formation of allylboronate 2.2a and the subsequent 
allylboration/ lactonization step has been challenging. Herein, I report my efforts to reproduce 
and optimize the synthesis of trans-guaianolide analog 1.83. We also set out to separate and 
characterize the two diastereomers of trans-1.83 in order to evaluate their corresponding 
biochemical properties. 
2.2 RESULTS AND DISCUSSION 
2.2.1 Synthesis of allenyl-ynoate 2.1a 
The first phase of the synthesis involves preparation of ynoate 2.1a in 7 synthetic steps 
from commercially available butyn-1,4-diol 2.3 (Scheme 40). Mono-protection of diol 2.3 with 
tert-butyldiphenylsilane has been previously achieved by reacting excess butyn-1,4-diol with 
imidazole and tert-butyl(chloro)diphenylsilane (TBDPSCl) in DCM (0.5 M with respect to 
TBDPSCl).60 When this procedure was attempted, the diol was not fully soluble in DCM, 
causing formation of the corresponding disilylated alkyne as the major product rather than 1.116. 
To overcome this issue, DMF was used as a co-solvent to completely solubilize diol 2.3 prior to 
addition of imidazole and TBDPSCl, which afforded 1.116 in 73% yield (Scheme 40).  
 52 
 
Scheme 40. Synthesis of allenyl-ynoate 2.1a from 2-butyne-1,4-diol (2.3) in 7 steps. 
The allenyl ester 2.4 was furnished from 1.116 via a Johnson-Claisen rearrangement 
reaction. The apparatus for this step included a 2-necked, round-bottomed flask equipped with a 
Dean-Stark trap, condenser, nitrogen inlet adapter and a septa in the side arm. The size of the 
Dean-Stark trap made a significant difference in the progression of the reaction. When a smaller 
trap was used (14/20 fittings, 2.0 mL collection volume) 2.4 was afforded in 76% yield, however 
when a larger trap was used (19/22 fittings, 10.0 mL collection volume), 2.4 was afforded in 
36% yield, and 63% of the starting material was recovered (97% yield based on recovered 
starting material). We presume that the larger Dean-Stark trap hindered efficient removal of 
ethanol, slowing the reaction progression.  
Next, ester 2.4 was transformed to Weinreb amide 2.5. Use of previously reported 
conditions (1.3 equiv N,O-dimethylhydroxylamine hydrochloride and 2.5 equiv of iso-propyl 
magnesium chloride) resulted in significant recovery of 2.4. Optimal yields were achieved when 
the ester 2.4 was reacted initially with 1.5 equiv N,O-dimethylhydroxylamine hydrochloride and 
2.5 equiv of iso-propyl magnesium chloride (2.0 M), with extra equivalents of these reagents 
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being added after 2 h (additional 0.7 equiv N,O-dimethylhydroxylamine hydrochloride and 1.2 
equiv iso-propyl magnesium chloride) which gave 2.5 in 67% yield. 
 Ethynylmagnesium bromide was added to amide 2.5 to form ketone 2.6. The reaction 
temperature was important for the success of this reaction. While the reaction was previously 
reported to occur cleanly at 0 °C, repetition of these conditions afforded 2.6 in only 35% yield 
along with a significant byproduct. Structural assignment of the byproduct was not obtained but 
1H NMR resonances were observed in the alkene region (~ 5.2 ppm).  Lowering the temperature 
to -10 °C improved the yield of 2.6 to 49% but the byproduct was still observed. By adding 
ethynylmagnesium bromide to a stirring solution of 2.5 at -78 °C and then allowing the reaction 
to warm slowly to rt and stirred for 2 h, 2.6 was afforded in 69% yield and the byproduct was not 
observed.61 It was later determined that 2.6 may be unstable to silica gel column 
chromatography, and the crude mixture should be taken on directly to the reduction step. 
Reduction of crude ketone 2.6 using lithium aluminum hydride (LAH) at -78 °C afforded alcohol 
2.7 in 71% yield over two steps from Weinreb amide 2.5. When the reduction was performed at a 
warmer temperature (0 °C), undesired desilylation of the protected alcohol was observed. 
 In turn, deprotonation of alcohol 2.7 with sodium hydride followed by reaction with 
iodomethane at 0 °C readily gave 2.8 in 77% yield. Finally, formation of ynoate 2.1a was 
accomplished in 69% yield by reacting the lithium acetylide of 2.8 with methyl chloroformate.  
2.2.2 Optimization of allylboronate formation 
The conversion of ynoate 2.1a to allylboronate 2.2a is accomplished by an aluminum 
hydride 1,4-conjugate addition to the ynoate using DIBAL-H and HMPA, followed by trapping 
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of the aluminium intermediate with pinacol chloromethylboronate (ClCH2BPin). This process 
can be done either with or without the use of catalytic copper iodide and methyl lithium.  
Mechanistically, when the CuI/MeLi catalyst is not used, the reaction of an ynoate 2.1 
with DIBAL-H and HMPA, affords an aluminum intermediate 2.9, which can undergo 
isomerization via an allenyl intermediate. HMPA acts as a ligand on the aluminate species to 
assist with the selective 1,4-addition.62 Trapping of the aluminum intermediates 2.9, with 
ClCH2BPin affords the E/Z mixture of the allylboronate 2.2 (Scheme 41).  
 
Scheme 41. Conjugate reduction of ynoate 2.1 to afford the Z and E isomers of 2.2. 
 While the mechanism for transformation of alkynoates to allylboronates catalyzed by 
CuI/MeLi has not been reported explicitly, the literature lends itself to suggest the following 
proposed mechanism for the transformation (Scheme 42). Equimolar amounts of CuI and MeLi 
combine to form the catalyst, methyl copper (CuMe), in solution.63 In contrast, when 2 equiv of 
MeLi are reacted with CuI, lithium dimethyl cuprate is generated, which is a source of a methyl 
anion. Formation of this cuprate should be avoided for the formation of the desired 
allylboronates.64 Reaction of CuMe with the DIBAL-H affords the aluminate species 2.10 which 
can undergo cis-1,4-addition to ynoate 2.1 to generate alkene aluminate 2.11 (which can also 
undergo isomerization as shown in Scheme 41). This reactive species is trapped by ClCH2BPin, 
to afford allylboronate 2.2 as well as a chlorine substituted aluminate species 2.12. Formation of 
chlorobis(iso-butyl) aluminum as a byproduct regenerates the CuMe catalyst. The CuMe catalyst 
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accelerates the overall process of this transformation due to the increased nucleophilicity of 
aluminate species 2.11 compared to the corresponding aluminum species 2.9, generated in the 
reaction without CuMe.  
 
Scheme 42. Proposed reaction pathway for the formation of allylboronate 2.2 using catalytic CuMe. 
The need for CuMe catalyst and the resulting alkene E/Z geometry ratios both seem to be 
substrate dependent for this transformation.  In 1993, Villieras reported the preparation of (2-
methoxycarbonyl)allylboronate 2.14a from ynoate 2.13a using DIBAL-H and HMPA (Scheme 
43).65 Later in 2007, the same group extended this transformation to ethyl ester 2.14b, for which 
they got a 95% yield. However, for the methyl propynoate 2.13c, with a methyl substituted 
alkyne, the CuI/MeLi catalyst was required to afford 2.14c (the reaction is slower without the 
catalyst), in a Z:E ratio of 1.9:1 (Scheme 43).66  
During the synthesis of 6,12-guaianolide, chinensiolide, Hall and coworkers used 
DIBAL-H and HMPA to form allylboronate 2.16 in 68% yield as 3.5:1 mixture of Z:E isomers 
(Scheme 43).58b Our group also synthesized 2.16 in our first report of the APKR to the 6,12-
guaianolide framework, however, the CuI/MeLi catalyst was required and a lower Z:E selectivity 
of 1.5:1 was observed (no yield was reported).42  
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Scheme 43. Previous syntheses of trisubstituted pinacol allylboronates from alkynoates. 
Previous members of the Brummond group tested the allylboronate synthesis on a series 
of model substrates with substitutions at the propargyl position because of instability of the 
protecting group (P) in the lactonization reaction. Alkynoates 2.17a-d formed the corresponding 
allylboronates 2.18a-d in high yields (95-90% yield) using DIBAL-H and HMPA; however, long 
reaction times were required. The ratio of Z/E alkene isomers varied based upon the substrate, 
but the Z isomer was always favored (Scheme 43).43 
The Hall group has also published reports on the synthesis of tetrasubstituted 
allylboronates from ynoates using organocopper reagents, optimized for selective cis-addition 
across the alkyne. For example, when 2-heptynoic acid methyl ester 2.19 was reacted with 2 
equiv of methyl lithium and copper bromide (to form Me2CuLi in situ), followed by HMPA (9 
equiv) and pinacol iodomethylboronate, 2.20 was afforded in 99% yield, with high selectivity for 
the Z isomer (Scheme 44). This degree of selectivity for the cis-addition has not yet been 
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observed for this formation of the trisubstituted allylboronates seen in Scheme 43.67 These 
tetrasubstituted allylboronates have been reacted with aldehydes for the synthesis of methylene 
lactones with a quaternary center. 
 
Scheme 44. Synthesis of tetrasubstituted allylboronate 2.20, with high selectivity for the Z isomer. 
Within our report for the synthesis of guaianolide analog 1.83, allene-containing 
allylboronate 2.2a was obtained using two protocols, either with or without the CuI/MeLi 
catalyst system (Table 4).68 When a pre-stirred mixture of HMPA (3 equiv) and DIBAL-H (1.6 
equiv) was reacted with ynoate 2.1a overnight, followed by stirring with pinacol 
chloromethylboronate for 48 h, 2.2a was obtained in 80% yield as a 2.2:1 mixture of  Z and E 
isomers. However, this alkene byproduct 2.21a was also obtained in 20% yield, resulting from 
protonation of the aluminum intermediate (Entry 1). Employing the CuI/MeLi catalyst system 
significantly improved the reaction rate and lowered alkene byproduct formation. However, the 
stereoselectivity of the reaction was lower (Z:E, 1.2:1, Entry 2). 
Table 4. Previously reported results for conversion of ynoate 2.1a to allylboronate 2.2a.43 
 
Entry Conditions (Step 1) Time (Step 2) Yield 2.2a, (Z:E) Yield 2.21a(Z:E) 
1 A: DIBAL-H (1.6 equiv), HMPA (3 equiv), 
0 °C, toluene, overnight 
 
48 h 80%, (2.2:1) 20%, (3:1) 
2 B: CuI (0.1 equiv), MeLi (0.1 equiv, 
DIBAL-H (1.5 equiv), HMPA (2 equiv), 
-30 °C, toluene/THF, 5 h 
Overnight 89%a (1.2:1) 11%, (2:1) 
aYield reported is the crude yield determined by NMR. 2.2a was purified and isolated in 78%.  
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Difficulties reproducing the preparation of allylboronate 2.2a have included recovery of 
2.1a, or large amounts of the unwanted alkene byproduct 2.21a. To determine which reaction 
component may be hindering the formation of 2.2a, we attempted simplified transformations 
(Table 5). First, conjugate reduction of allene-containing alkynoate 2.1a was achieved using 
excess HMPA and DIBAL-H without CuI and MeLi and without the addition of ClCH2BPin. 
Stirring of allenyl-ynoate 2.1a with HMPA (6 equiv) and DIBAL-H (3 equiv) for 5 h at 0 °C, 
successfully gave unsaturated ester 2.21a with a small amount of starting material remaining (10 
: 1 ratio of alkene 2.21a : ynoate 2.1a) (Entry 1). Next, ClCH2BPin was re-incorporated in 
attempts to form allylboronate 2.2a. Reacting ynoate 2.1a with HMPA (4 equiv) and DIBAL-H 
(2 equiv) for 3 h completely consumed allenyl-ynoate 2.1a; ClCH2BPin (1.5 equiv) was then 
added to trap the aluminum intermediate. After stirring overnight (16 h), allylboronate 2.2a and 
alkene 2.21a were afforded in a 1 : 7.8 ratio (Entry 2). Increasing the amount of ClCH2BPin to 
2.6 equiv showed an improved 1: 1.7 ratio of allylboronate 2.2a to alkene 2.21a after stirring for 
10 h. This reaction was allowed to continue stirring to see if the reaction was still progressing. 
However, after 41 hours, the ratio of allylboronate 2.2a: alkene 2.21a had lowered to 1: 2.6, 
suggesting allylboronate 2.2a was not stable to the reaction conditions over time (Entry 3). It was 
evident that the aluminum intermediate was not nucleophilic enough to react with ClCH2BPin 
efficiently. 
Due to the sensitive nature of the reaction, attempts to incorporate the CuI/MeLi catalyst 
were performed on propargyl-substituted model system 2.1b. Unfortunately, using the previously 
reported procedure and reagent equivalents resulted in complete recovery of alkynoate 2.1b 
(Entry 4). The reaction was again simplified by eliminating the addition of ClCH2BPin to isolate 
the conjugate reduction product 2.21b. Model ynoate 2.1b was reacted with CuI and MeLi (0.1 
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equiv each), distilled HMPA (2 equiv), and DIBAL-H (1.5 equiv), but no alkene 2.21b was 
obtained (Entry 5).  
Table 5. Reaction optimization for conversion of alkynoates 2.1 to allylboronates 2.2. 
R CO2Me
1. CuMe, DIBAL-H, 
HMPA, toluene -30 °C
2. ClCH2BPin 
-30 °C to rt
Ha
R CO2Me
H
R CO2Me
HBPin
+
2.1 2.2 2.21  
Entry Alkynoate (2.1) CuMe 
(Equiv) 
HMPA 
(Equiv) 
DIBAL 
(Equiv) 
Time 
A 
ClCH2BPin 
(equiv) 
Time 
B 
Product ratio 
(2.2:2.21:2.1) 
1 
 
 2.1a 
0 6 3a 5 h 0 --- N/A : 10 : 1 
2 2.1a 0 4 2a 3 h 1.5 16 h 1 : 7.8 : 0 
3 2.1a 0 4 2a 2 h 2.6 10 h 
41 h 
1 : 1.7: 0 
1 : 2.6 : 0 
4 
 
2.1b 
 
0.1 
 
2 
 
1.5a 
 
5 h 
 
1.2 
 
16 h 
 
0 : 0 : 1 
5 2.1b 0.1 2 1.5a 5 h 0 --- N/A : 0 : 1 
6  
2.1c 
0.1 2 1.5b 5 h 0 --- N/A : 1 : 4 
7 
 
2.1a 
 
0.1 
 
2 
 
1.5b 
 
5 h 
 
0 
 
 
--- 
 
Messy 
8  
2.1d 
0.1c 3 2b 5 h 2 16 h 1 : 1 : 0 
9 2.1d 0.1 3 2b 4 h 2c 16 h 1 : 0 : 0 
Reactions w/o CuI, MeLi were performed on a 0.034-0.041 mmol scale. Reactions w/ CuI and MeLi performed on a 0.23-0.32 
mmol scale. Time A: time after addition of ynoate, prior to addition of ClCH2BPin. Time B: time after addition of ClCH2BPin. 
Product ratios were determined by crude 1H NMR spectroscopy. aDIBAL-H in hexanes. bDIBAL-H in toluene, cNew bottle of 
halogen free MeLi. dFreshly distilled ClCH2BPin. 
 
Next, an alkynoate lacking substitution at the propargyl position, methyl 2-nonynoate 
(2.1c), was subjected to these conditions. Also, DIBAL-H as a solution in toluene, rather than 
hexanes, was employed. As a result, the corresponding α,β-unsaturated ester 2.21c was obtained 
in small amounts; (1:4 ratio of alkene 2.21c : ynoate 2.1c) (Entry 6). Reaction of allene-
containing ynoate 2.1a under these conditions resulted in a complicated mixture, evidenced by 
TLC analysis (Entry 7).  
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Next, in an effort to avoid inaccurate measuring of reagents for small-scale reactions, 
excess equivalents of CuI and MeLi were pre-stirred in THF and then the appropriate 0.1 equiv 
was transferred to the reaction flask. Also, the equivalents of HMPA (3 equiv) and DIBAL-H (2 
equiv) were increased. Using this method, methyl 2-octynoate (2.1d) was reacted with 
CuI/MeLi, HMPA, and DIBAL-H, followed by ClCH2BPin to afford allylboronate 2.2d (Z:E, 
3.6:1) and alkene 2.21d in a 1 : 1 mixture (Entry 8). The improved result of this experiment may 
also be attributed to the use of a new bottle of MeLi (1.0 M in THF). Next, employing freshly 
distilled ClCH2BPin in the reaction significantly improved reactivity, giving the allylboronate 
2.2d as the only product (Entry 9).  
Identification of the Z and E isomers of 2.2d were determined by comparing the chemical 
shift of the corresponding alkene signals (Ha). The signal representing Ha is seen at 5.93 ppm and 
6.74 ppm for the Z and E isomers respectively (Figure 8). Ha for the E isomer is further 
downfield because of closer proximity to the ester group.  
 
Figure 8. The Z-and E-isomers of allylboronate 2.2d. 
With the successful formation of model allylboronate 2.2d, we applied the optimized 
reaction conditions to the formation of 2.2a (Scheme 45). Careful observation of the appearance 
of the reaction was recorded for each step. CuI and MeLi (0.1 equiv each) were stirred at -30 °C, 
and the solution changed from pale white to dark yellow to brown over 30 min. HMPA (3 equiv) 
and DIBAL-H (2 equiv) were added resulting in a dark black solution. Ynoate 2.1a was added 
and stirred at -20 °C for 5 h, and the black color was maintained. After overnight stirring with 
freshly distilled pinacol chloromethylboronate (2 equiv) at rt, the solution had turned to a pale, 
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translucent green. Analysis of the crude residue by 1H NMR revealed allylboronate 2.2a as the 
only product. Purification of the crude material through a short silica plug afforded allylboronate 
2.2a in 78% yield as a 1.7:1 ratio of the Z and E isomers. Allylboronate 2.2a may be unstable 
towards silica gel because when purified by standard silica gel flash column chromatography, 
2.2a was obtained in only 22% yield. 
 
Scheme 45. Repeated synthesis of allylboronate 2.2a. 
In summary, many factors were critical to the successful formation of allylboronate 2.2a. 
The quality of reagents is of utmost importance; use of impure reagents can render the entire 
reaction unsuccessful. Therefore, for best practice, relatively new DIBAL-H and MeLi solutions 
should be employed. No-D NMR titration techniques can be used to ascertain the quality and 
accurate concentrations of these reagents prior to use.69 The HMPA should be distilled and 
stored over molecular sieves. The toluene solvent as well as the ClCH2BPin need to be freshly 
distilled. For a small scale reaction, a solution of CuI/MeLi can be prepared on a larger scale 
than required for the reaction, with the appropriate amount being transferred as a solution to the 
reaction flask.  
If a reaction does not go as expected, trouble shooting can be performed by methodically 
simplifying the reaction. Conjugate reduction of the ynoate, by quenching an aliquot of the 
reaction prior to addition of ClCH2BPin, confirms formation of aluminum intermediates. Also, 
performing the reaction both with and without the CuI/MeLi catalyst can help determine what 
reagent may be leading to poor results.  
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2.2.3 Completing the synthesis of guaianolide analog 1.83. 
The final synthetic steps to complete the synthesis of trans-guaianolide analog 1.83 
include the allylboration/lactonization, cyclocarbonylation, and deprotection of the silyl group. 
For the allylboration/lactonization step, Hall and coworkers have employed various acids to 
assist the allylic addition to aldehydes including boron trifluoride diethyl etherate, scandium 
triflate, and triflic acid.58a In previous efforts toward the synthesis of guaianolide 1.83, use of 
acidic reagents to accelerate the allylboration of phenylpropynal (2.22) resulted in decomposition 
of allylboronate 2.2a. Thermal heating in toluene at 50 °C was not sufficient for the reaction to 
proceed and increasing the temperature to 90 °C resulted in decomposition of 2.2a.65 
Interestingly, heating of allylboronate 2.2a and aldehyde 2.22 in chloroform for 7 days at 50 °C 
followed by stirring with PTSA overnight at rt gave trans-lactone 1.82a in 40% yield as a 
mixture of two diastereomers. The cis-hydroxy ester 2.23 was also obtained and required stirring 
with sodium hydride to afford the cis-lactone 1.82b in 14% yield as a single diastereomer 
(Scheme 46).43 
 
Scheme 46. Previously reported synthesis of trans- and cis-lactone 1.82a,b via allylboration followed by 
lactonization. 
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Our efforts to repeat this synthetic step gave similar results. The Z and E isomers of 
allylboronate 2.2a were inseparable and taken on to the lactonization step as a mixture. Stirring 
2.2a with phenylpropynal 2.22 in chloroform for 7 days followed by the addition of PTSA, 
which stirred for 14 h at room temperature, resulted in 3 major product spots as observed by 
TLC. The trans-lactone 1.82a (Rf = 0.33, 10% EtOAc in hexanes) was obtained as a 1.7:1 
mixture of diastereomers (pertaining to the methoxy group stereochemistry). The other two 
product spots pertained to the two cis-lactone 1.82b diastereomers, which were separable by 
TLC and column chromatography (Diastereomer 1: Rf = 0.25, Diastereomer 2: Rf = 0.19, 10% 
EtOAc in hexanes). However, Diastereomer 1 of cis-1.82b was contaminated with unreacted 
allylboronate 2.2a (E isomer). No evidence of the hydroxyl ester intermediate 2.23 was 
observed. Trans-1.82a and cis-1.82b were obtained in an overall 50% yield (trans:cis, 1.6:1) 
(Scheme 47).  
 
Scheme 47. Formation of trans- and cis-lactones 1.82a and 1.82a from allylboronate 2.2a. 
 Formation of the trans-1.82a and cis-1.82b and the corresponding product ratio can be 
understood using Zimmerman-Traxler transition states for the reaction between the allylboronate 
2.2a and phenylpropynal 2.22. Reaction of the Z isomer of 2.2a with 2.22 results in a trans-
hydroxyl ester via TS1, which is then cyclized to afford trans-lactone 1.82a.  In a similar 
fashion, the E isomer of 2.2a eventually affords the cis-lactone 1.82b via TS2 (Scheme 48). This 
also explains why trans-1.82a is the major product; the Z isomer is the major allylboronate 
isomer. In addition, when the reaction between 2.2a and 2.22 is monitored by 1H NMR 
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spectroscopy, the Z isomer reacts faster that the E isomer, which is often recovered in small 
amounts.  
 
Scheme 48.  Zimmerman-Traxler transition states for the reaction between allylboronate 2.2a and aldehyde 2.22. 
Next, trans-allene-yne 1.82a was successfully subjected to the APKR, using the 
optimized high dilution conditions described in Section 1.2.3, to afford trans-guaianolide analog 
2.24. Due to previous reports that 2.24 was unstable towards silica, the crude material was 
carried on without purification; subsequent deprotection using trimethylamine trihydrofluoride 
afforded guaianolide 1.83 in 64% yield over the two steps (Scheme 49). Because our previous 
report also obtained trans-1.83 in 64% over two steps, we can conclude that the high dilution 
conditions did not make a significant impact on the yield.  
 
Scheme 49. Completing the synthesis of trans-guaianolide analog 1.83. 
It was later determined that the silyl-protected guaianolide analog 2.24 could in fact be 
purified by chromatography without any evidence of decomposition. By employing the high 
 65 
dilution APKR conditions, guaianolide analog 2.24 was obtained in 79% yield. It should be 
noted that if trans-lactone 1.82a is obtained from the previous lactonization reaction as a mixture 
with unreacted allylboronate 2.2a, the mixture can be taken on to the APKR to afford 2.24a, 
which is more easily separable from impurities. One diastereomer of the cis-1.82b was also 
subjected to the high dilution conditions, which afforded cis-2.25 in 58% yield (Scheme 50). 
 
Scheme 50. Isolation of cyclocarbonylation adducts trans-2.24 and cis-2.25. 
2.2.4 Distinguishing stereochemistry of trans-and cis-α-methylene lactones  
The stereochemical identity of the guaianolide analogs trans-2.24, cis-2.25, and trans-
1.83 were confirmed using the coupling constant of Ha and comparing this to the X-ray crystal 
structure of 2.26a (Figure 9). Trans-guaianolide analog 2.26a was part of a series of guaianolide 
analogs synthesized in our group. All of the trans-analogs 2.26 had coupling constants for Ha 
ranging from 9.0 to 10.0 Hz. The cis-analogs 2.27 had coupling constants of 7.0-7.5 Hz. 
Similarly, the highly oxygenated trans-guaianolide analogs 2.24 and 1.83 (2 diastereomers of 
each) have Ha coupling constants from 9.2-10.5 Hz, while cis-2.25 has a coupling constant of 7.5 
Hz (Figure 9).  
Interestingly, for the allene-yne APKR precursors trans-1.82a and cis-1.82b, the coupling 
constant of Ha with Hb, is larger for the cis isomer than the trans isomer, which is opposite of the 
trend seen for the guaianolide analogs in Figure 9. The major and minor diastereomers of trans-
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1.82a had Jab values of 4.4 Hz and 3.2 Hz respectively, while the major and minor diastereomers 
of cis-1.82b had Jab values of 8.0 Hz and 7.0 Hz (Figure 10). This trend was also previously 
reported for α-methylene lactones trans- and cis-2.28, a synthetic precursor to the corresponding 
guaianolide analog 2.26. Trans-2.28a has a Ha coupling constant of 6.0 Hz, while the cis-isomer 
2.28b coupling constant for Ha is 8.4 Hz (Figure 10).42  
 
Figure 9. Comparison of coupling constants for 2.24, 1.83, and 2.25 with previously reported guaianolide analogs. 
 
Figure 10. Coupling constants for mono-cyclic trans- and cis-methylene lactones.  
The change in the coupling constant between Ha and Hb when comparing the mono-cyclic 
trans-α-methylene lactones (Figure 10) and the trans-α-methylene lactone of the fused 5,7,5-
tricyclic frameworks (Figure 9) can be understood by comparing the orientations of Ha and Hb 
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(Figure 11).  Trans-1.82a and trans-1.83 were drawn in Chem3D 15.0 and MM2 minimization 
calculations were performed to show a low energy conformer of the structures. For these 
conformers, the Ha, Hb dihedral angle was observed. Mono-cyclic lactone 1.82a had a dihedral 
angle of 114.8 ° for Ha and Hb. However, the fused ring system 1.83 requires the alkyl 
substituents of the lactone ring to be in a more planar configuration, resulting in a larger dihedral 
angle for Ha and Hb, estimated to be 147.7°. This larger dihedral angle is responsible the larger 
coupling constant observed for the fused trans-methylene lactones. Trans-2.28a also had a 
dihedral angle for Ha and Hb of 114.4 ° and was shown in Figure 11 rather than allene-yne 1.82a 
for ease of visualization.  
 
Figure 11. 3D-representations of trans-2.28a and trans-1.83 (Chem3D) with highlighted Ha, Hb dihedral angle. 
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2.2.5 Assignment of 1.83 diastereomers using NMR calculations 
The described synthesis provides trans-guaianolide analog 1.83 as a mixture of 
diastereomers with respect to the methoxy group at C8 of the guaianolide framework. Biological 
evaluations previously described for trans-1.83 (NF-ĸB inhibition and antiproliferative activity) 
are representative of this diastereomeric mixture. However, we were interested to know if the 
diastereomers had equal or differing biological properties. Slight separation of the 1.83 
diastereomers is observed by TLC. We assigned the faster moving (Rf = 0.41, 100% EtOAc), 
major spot as Diastereomer A, and the slower moving (Rf = 0.34, 100% EtOAc), minor spot as 
Diastereomer B. Column chromatography was insufficient for complete separation. However, 
HPLC purification afforded the separated isomers. The following method was used: 100% 
EtOAc for 20 min followed by a gradient increase to 5% EtOH in EtOAc over 5 min, which was 
then maintained until completion. Diastereomer A eluted at 14.004 min while Diastereomer B 
eluted at 17.009 min. The major diastereomer (Diastereomer A) was determined to be 8βH-1.83a 
isomer while the minor diastereomer (Diastereomer B) was the 8αH-1.83b isomer by comparing 
computational and experimental 1H NMR data for the two isomers (Figure 12). 
 
Figure 12. Structure of 8βH-1.83a and 8αH-1.83b. 
The two diastereomers have distinct 1H NMR spectra, particularly for the α-methylene 
protons H13 and H13’, and the proton α to the oxygen of the lactone ring (H6). These signals all 
appear between 6.5 and 5.0 ppm (Figure 13). Computational methods have been utilized to 
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assign closely related chemical structures by comparing predicted chemical shifts with 
experiment.70  
 
Figure 13. 1H NMR spectra for 1.83a,b from 6.7-3.7 ppm. 
The two possible isomers were drawn in Spartan. 8βH-1.83a has a trans relationship for 
H6 and H7 of the lactone ring, as well as a trans relationship between H7 and H8. 8αH-1.83b also 
has a trans-lactone, but H7 and H8 have a cis-relationship. The lowest energy conformations of 
each were determined using molecular mechanics (MMFF) calculations. Then, 1H NMR 
chemical shifts were predicted using EDF2/6-31 methods. Spartan assigned the predicted 
chemical shifts to the corresponding hydrogen atoms. 
Next, COSY and HSQC NMR spectra were obtained for each diastereomer, which 
assisted the assignment of the 1H NMR signals to the corresponding protons for each structure. 
For complete signal assignments, see Figure 12 and Table 6. Due to complicated splitting 
patterns of each diastereomer, the COSY and HSQC spectra were key in determining the identity 
of a few protons. The signals of protons H2 and H2’ were confirmed because the only COSY 
correlations were with each other, and the HSQC confirmed that these two signals were on the 
 70 
same carbon. This was also the case for protons H14 and H14’, however, these protons were 
shifted further down field (~4.2 ppm) indicating their proximity to the hydroxyl group. COSY 
correlations were particularly useful for the assignment of H7, H9, and H9’. Even though H9 and 
H9’ have significantly different chemical shifts (~3.2 and 2.5 ppm for both diastereomers), COSY 
correlations with only H8 and each other lead to their assignment. HSQC also confirmed that H9 
and H9’ were on the same carbon. H7 has a similar chemical shift to H9 (~3.1 ppm), however H7 
has COSY correlations with H8, H6, H13, and H13’ for both diastereomers.   
Table 6. Experimental 1H NMR spectral data of 8βH-1.83a and 8αH-1.83b compared to calculated chemical shifts 
(corrected).  
Diastereomer A (8βH-1.83a)  Diastereomer B (8αH-1.83b) 
H Exp δ (ppm) Calc δ (ppm)  H Exp δ (ppm) Calc δ (ppm) 
 
Ph 
 
7.40-7.32 (m, 3 H),  
7.27-7.24 (m, 2 H) 
 
7.73, 7.69, 
7.26, 7.26, 
7.25 
 
  
Ph 
 
7.45-7.32 (m, 3 H),  
7.30-7.26 (m, 2 H) 
 
7.66, 7.32, 
7.28, 7.28, 
7.26 
13 
13’ 
6.25 (d, J = 3.5 Hz, 1 H) 
5.85 (d, J = 3.0 Hz, 1 H) 
6.23 
5.78 
 
 13 
13’ 
6.36 (d, J = 3.6 Hz, 1 H) 
5.52 (d, J = 3.2 Hz, 1 H) 
6.35 
5.36 
6 5.39 (d, J = 10.5 Hz, 1 H) 5.37 
 
 6 5.78 (d, J = 9.2 Hz, 1 H) 5.83 
14, 
14’ 
4.31 (d, J = 12.5 Hz, 1H), 
4.19 (d, J = 12.5 Hz, 1 H) 
 
4.28, 4.12  14, 
14’ 
4.34-4.26 (m, 2 H) 4.39, 4.31 
8 3.86 (ddd, J = 8.0, 4.0, 2.5 
Hz, 1 H) 
 
3.59  8 4.14-4.07 (m, 1 H) 4.09 
OMe 3.54 (s, 3 H) 
 
3.54  OMe 3.45 (s, 3 H) 3.39 
2, 2' 3.29 (d, J = 21.0 Hz, 1 H), 
 3.17 (d, J = 21.0 Hz, 1 H) 
 
2.92, 2.54  2, 2’ 3.28-3.15 (m, 2 H) 
 
2.89, 2.51 
7 3.18-3.13 (m, 1 H) 
 
3.04  7 3.37-3.31 (m, 1H) 3.22 
9,9’ 3.16-3.12 (m, 1 H) 
2.56 (dd, J = 15.8, 2.5 Hz, 1H) 
 
3.12, 2.28  9, 9’ 3.27 (dd, J = 15.2, 6.8 Hz, 1H) 
2.53 (dd, J = 15.2, 8.4 Hz, 1H) 
3.28, 2.24 
OH 1.73 (bs, 1 H) 0.27  OH 1.26 (t, J = 7.2 Hz, 1 H) 0.27 
 
Using proton assignments determined by analyzing the 1H, COSY, HSQC NMR spectra, 
experimental chemical shifts were compared to the chemical shifts that Spartan had generated for 
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each corresponding hydrogen (Table 6, entries are listed in order of decreasing experimental 
chemical shift for both diastereomers). Comparison of the experimental and calculated chemical 
shifts of protons H13, H13’, and H6 were instrumental in making this conclusion. In 8αH-1.83b, 
H6 is shifted further down field that H13’ at 5.83 ppm; whereas H6 appears at 5.37 ppm for 8βH-
1.83a. The predicted chemical shifts were also quite accurate, with errors of less than 0.1 ppm 
for protons H13, H13’, and H6.  
2.3 CONCLUSIONS 
In conclusion, the synthesis of racemic trans-guaianolide analog 1.83 was successfully 
reproduced. The synthesis was performed in three phases; 1) synthesis of ynoate 2.1a from 2-
butyn-1,4-diol in 7 steps, 2) generation of the allylboronate 2.2a, and 3) allylboronation/ 
lactonization followed by the APKR to generate the 5,7,5-fused ring system.  
The synthesis of ynoate 2.1a was achieved with minimal modifications to the previously 
published protocols. Some minor changes were required related to reaction temperatures, 
especially for conversion of the Weinreb aide 2.5 to ketone 2.6.  This segment of the guaianolide 
synthesis showcases the robust nature of the allene functional group. In synthetic endeavors, 
allenes are generally made directly prior to being utilized for unique functionalization. However, 
in this sequence, the allene was formed during an early synthetic step, and carried through many 
reaction steps, showing compatibility with a variety of reagents. 
Conversion of ynoate 2.1a to allylboronate 2.2a was the most difficult step to reproduce. 
The experimental conditions used to successfully achieve formation of allylboronate 2.2a were 
similar to that previously reported. The equivalents of DIBAL-H and HMPA were increased to 2 
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and 3 equiv respectively (previously 1.5 and 2 equiv). Also, for small scale reactions, the 
CuI/MeLi catalyst was made in excess as a solution, and then the required amount was 
transferred to the reaction flask. However, we found that the quality and nature of many reagents 
affected the success of the reaction. Use of model systems, quenching of aluminate 
intermediates, and performing a non-CuMe catalyzed variant of the reaction all contributed to the 
trouble shooting, and eventual success of the reaction. 
Finally, the ring-forming lactonization and APKR reactions were readily reproduced. The 
allylboration/lactonization reaction between allylboronate 2.2a and phenylpropynal 2.22 
successfully afforded both trans-allene-yne 1.82a and cis-allene-yne 1.82b. While the yield of 
trans-1.82a was comparable to the previous report, improvements were observed for the 
formation of cis-1.82b. The hydroxyester intermediate 2.23 was not observed, and lactonization 
of both cis-diastereomers were achieved directly from the reaction. Both cis- and trans- lactones 
are found in guaianolide natural products, so having a synthesis that can afford both, with ease of 
separation, is advantageous. Use of the dropwise addition conditions for the APKR did not 
significantly improve the yield of trans-guaianolide 1.83. Silyl protected guaianolides trans-2.24 
and cis-2.25 were found to be stable to column chromatography despite previous reports of 
instability. 
One major improvement made to this synthesis was the separation and relative 
stereochemical assignments of the two trans-1.83 diastereomers, 8βH-1.83a and 8αH-1.83b. 
Separation was achieved by HPLC. NMR methods were used alongside computational 
predictions, obtained using Spartan software, to assign the corresponding structures. We plan to 
evaluate the separated diastereomers for relative NF-ĸB inhibition and compare to the previous 
data obtained using a mixture of the compounds (See Section 4.2).  
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2.4 EXPERIMENTALS 
2.4.1 General Methods 
All commercially available compounds were used as received unless otherwise noted. 
Dichloromethane (DCM), diethyl ether (Et2O), and tetrahydrofuran (THF) were purified by 
passing through alumina using a solvent purification system. Deuterated chloroform (CDCl3) 
was stored over 4 Å molecular sieves. Toluene was freshly distilled from CaH2. Acetonitrile was 
distilled and stored over 4 Å molecular sieves. HMPA was distilled from CaH2 under vacuum 
pressure. Pinacol chloromethylboronate (ClCH2BPin) was distilled at 14 mmHg. Carbon 
monoxide gas was purchased from Matheson gas (Grade: Matheson 99.99%). Purification of the 
compounds via manual flash column chromatography was performed using silica gel (40-63 μm 
particle size, 60 Å pore size) purchased from Sorbent Technologies. TLC analyses were 
performed on Silicycle SiliaPlate G silica gel glass plates (250 μm thickness) and visualized by 
UV irradiation (at 254 nm) and KMnO4 stain. 1H NMR and 13C NMR spectra were recorded on 
Bruker Avance 300 MHz, 400 MHz, 500 MHz, or 600 MHz. Spectra were referenced to residual 
chloroform (7.26 ppm, 1H; 77.16 ppm, 13C). Chemical shifts are reported in ppm, multiplicities 
are indicated by s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quartet), p (pentet), and 
m (multiplet). Coupling constants, J, are reported in hertz (Hz). All NMR spectra were obtained 
at room temperature.  IR spectra were obtained using a Nicolet Avatar E.S.P. 360 (NaCl plate) 
FT-IR. ESI mass spectrometry was performed on a Waters Q-TOF Ultima API, Micromass UK 
Limited. Separation of 8βH-1.83a and 8αH-1.83b was performed on a Varian Prostar HPLC 
chomatograph using a Varian Dynamax Microsorb 100-5 Si column. 
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2.4.2 Synthesis of ynoate 2.1a. 
4-((tert-Butyldiphenylsilyl)oxy)but-2-yn-1-ol (1.116). A 15 mL, round-
bottomed flask, equipped with a stir bar, septum, and nitrogen inlet needle was charged with 
DCM (5 mL), 2-butyn-1,4-diol 2.3 (0.132 g, 1.54 mmol, 2 equiv), and DMF (1 mL). Imidazole 
(0.063 g, 0.920 mmol, 1.2 equiv) was added followed by tert-butyl(chloro)diphenylsilane (0.211 
g, 0.770 mmol, 1 equiv) and the reaction stirred for 3 h at rt. The reaction was diluted with water 
(3 mL) and DCM (3 mL). The contents were transferred to a separatory funnel. The organic layer 
was separated and the aqueous layer was extracted with DCM (2 x 6 mL). The combined organic 
layers were dried over MgSO4, filtered, and concentrated via reduced pressure rotary 
evaporation. The crude residue was purified by silica gel flash column chromatography (gradient 
of 10-20% EtOAc in hexanes) to afford 250 mg of 1.116 in 73% yield as an oil. The 
characterization data obtained matches previously reported data.60 
• Performing the reaction on 40.6 mmol scale afforded 8.76 g of 1.116 (66% yield). 
Data for 1.116. 
1H NMR (300 MHz, CDCl3) 
7.73-7.68 (m, 4H), 7.48-7.37 (m, 6H), 4.37 (t, J = 1.8 Hz, 2H), 4.20 (dt, J = 6.3, 
1.8 Hz, 2H), 1.29 (t, J = 6.3 Hz, 1H), 1.06 (s, 9H) ppm; 
TLC  Rf = 0.38 (20% EtOAc in hexanes) 
 Silica gel, UV visible 
Ethyl 3-(((tert-butyldiphenylsilyl)oxy)methyl)penta-3,4-dienoate (2.4). A 
100 mL, 2-necked, round-bottomed flask, equipped with a stir bar, a Dean-
Stark trap topped with a condenser and nitrogen inlet adapter, and a septum in the side arm was 
charged with 1.116 (7.31 g, 22.5 mmol, 1 equiv) and triethyl orthoacetate (12.7 mL, 69.1 mmol, 
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3 equiv). The flask was placed in a pre-heated oil bath (130 °C) and propionic acid (0.3 mL, 4.0 
mmol, 0.18 equiv) was added. Additional propionic acid was added after 1.5 h and after 3.5 h 
(0.2 mL each time, 2.7 mmol, 0.12 equiv). After 5 h, an additional 0.1 mL of propionic acid (1.3 
mmol, 0.06 equiv) was added. The reaction stirred for a total of 6 h. The oil bath was removed 
and the reaction cooled to rt. The reaction was diluted with diethyl ether (20 mL). 1M HCl (40 
mL) was added and contents were transferred to a separatory funnel. The aqueous layer was 
separated and extracted with diethyl ether (3 x 15 mL). The combined organics were washed 
with saturated NaHCO3 (40 mL) and brine (40 mL), dried over MgSO4, filtered, and 
concentrated using reduced pressure rotary evaporation. The crude residue was purified by silica 
gel flash column chromatography (gradient of 10-20% EtOAc in hexanes) to afford 2.4 6.74g, 
76%) as a pale yellow oil. The characterization data obtained matches previously reported data.43 
Data for 2.4. 
1H NMR (300 MHz, CDCl3) 
7.69-7.65 (m, 4H), 7.45-7.33 (m, 6H), 4.75 (quintet, J = 2.4 Hz, 2H), 4.27 (t, J = 
2.4 Hz, 2H), 4.12 (q, J = 7.2 Hz, 2H), 3.12 (t, J = 2.4 Hz, 2H), 1.23 (t, J = 7.2 Hz, 
3H), 1.05 (s, 9H) ppm; 
TLC  Rf = 0.47 (10% EtOAc in hexanes) 
  Silica gel, UV visible, KMnO4 stain 
3-(((tert-Butyldiphenylsilyl)oxy)methyl)-N-methoxy-N-methylpenta-
3,4-dienamide (2.5). A 200 mL, single-necked, round-bottomed flask, 
equipped with a stir bar, septum, and nitrogen inlet needle was charged with THF (68 mL), ester 
2.4 (3.12 g, 7.91 mmol, 1 equiv), and N,O-dimethylhydroxylamine hydrochloride (1.16 g, 11.9 
mmol, 1.5 equiv). The resulting slurry was cooled to -20 °C on a cryo-cool and ethanol bath. 
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Isopropylmagnesium chloride (9.89 mL of a 2.0 M solution in THF, 19.8 mmol, 2.5 equiv) was 
added over 5 min via syringe. The reaction stirred for 1 h at -20 °C and 2 h at -10 °C. A 
significant amount of 2.4 remained, as evidenced by TLC, so additional N,O-
dimethylhydroxylamine hydrochloride (600 mg, 6.15 mmol) and isopropylmagnesium chloride 
(5.0 mL, 10.0 mmol) were added. The reaction stirred for 2.5 h at -10 °C, until the reaction was 
complete. The reaction was quenched with saturated NH4Cl solution (75 mL) and the contents 
were transferred to a separatory funnel. The aqueous layer was extracted with diethyl ether (3 x 
50 mL). The combined organics were dried over MgSO4, filtered, and concentrated under 
reduced pressure rotary evaporation. The crude residue was purified by silica gel flash column 
chromatography (gradient of 10-30% EtOAc in hexanes) to afford 2.17 g of 2.5 in 67% yield as a 
pale yellow oil. The characterization data obtained matches previously reported data.43 
Data for 2.5. 
1H NMR (300 MHz, CDCl3) 
7.70-7.64 (m, 4H), 7.42-7.33 (m, 6H), 4.75 (quintet, J = 2.6 Hz, 2H), 4.29 (t, J = 
2.4 Hz, 2H), 3.67 (s, 3H), 3.26 (b s, 2H), 3.18 (s, 3H), 1.05 (s, 9H) ppm; 
TLC  Rf = 0.32 (20% EtOAc in hexanes) 
  Silica gel, UV visible 
5-(((tert-Butyldiphenylsilyl)oxy)methyl)hepta-5,6-dien-1-yn-3-one 2.6. A 
flame-dried, 250 mL, round-bottomed flask, equipped with a stir bar and 
septum was charged with amide 2.5 (3.17 g, 7.7 mmol, 1 equiv), dissolved in THF (77 mL). The 
flask was cooled to -78 °C in a dry ice and acetone bath. Ethynylmagnesium bromide (46.4 mL 
of a 0.5 M solution in THF, 23.2 mmol, 3 equiv) was added over 5 min via syringe. The reaction 
stirred for 30 min. The dry ice bath was removed and the solution was allowed to warm slowly to 
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rt. After 1 h of stirring, the reaction was complete as evidenced by TLC. The reaction was 
quenched with saturated NH4Cl (100 mL), and the flask contents were transferred to a separatory 
funnel. The organic layer was separated and the aqueous layer was extracted with diethyl ether (3 
x 60 mL). The combined organics were dried over MgSO4, filtered, and concentrated to afford 
2.92 g of crude 2.6 (quantitative). The NMR showed contamination with THF, but the crude 
material was taken onto the next step without further purification. The characterization data 
obtained matches previously reported data.43 
Data for 2.6. 
1H NMR (300 MHz, CDCl3) 
7.70-7.64 (m, 4H), 7.46-7.32 (m, 6H), 4.79 (t, J = 2.4 Hz, 2H), 4.23 (t, J = 2.4 Hz, 
2H), 3.35 (t, J = 2.4 Hz, 2H), 3.19 (s, 1H), 1.05 (s, 9H) ppm;    
TLC  Rf = 0.34 (10% Et2O in hexanes) 
 Silica gel, UV visible 
5-(((tert-Butyldiphenylsilyl)oxy)methyl)hepta-5,6-dien-1-yn-3-ol 2.7. A 
flame-dried, 250 mL, round-bottomed flask equipped with a stir bar and 
septum, pierced with a nitrogen inlet needle was charged with Et2O (31 mL) and LAH (8.47 mL 
of a 1.0 M solution in Et2O, 8.47 mmol, 1.1 equiv). The flask was cooled to -78 °C on a dry ice 
and acetone bath. Ketone 2.6 was dissolved in Et2O (20 mL) and was added over 5 minutes via 
syringe. The reaction stirred for 25 min until complete, as evidenced by TLC. The dry ice bath 
was removed and the reaction was quenched slowly with water as the solution warmed to rt. The 
solution was diluted with Et2O (60 mL) and water (60 mL). The flask contents were transferred 
to a separatory funnel. The organic layer was separated and the aqueous layer was extracted with 
Et2O (3 x 40 mL). The combined organics were dried over MgSO4, filtered, and concentrated. 
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The crude material was purified by silica gel flash column chromatography (gradient of 20-30% 
Et2O in hexanes) to afford 2.04 g of 2.7 in 71% yield (over 2 steps from 2.5). The 
characterization data obtained matches previously reported data.43 
Data for 2.7. 
1H NMR (300 MHz, CDCl3) 
7.73-7.67 (m, 4H), 7.48-7.36 (m, 6H), 4.74 (quintet, J = 2.1 Hz, 2H), 4.60-4.53 
(m, 1H), 4.25-4.14 (m, 2H), 3.14 (d, J = 5.7 Hz. 1H), 2.62-2.45 (m, 2H), 2.44 (d, 
J =2.1 Hz, 1H), 1.06 (s, 9H) ppm;  
Impurities observed at 1.55, 1.27, 0.96, 0.88 ppm. 
TLC  Rf = 0.38 (20% EtOAc in hexanes) 
 Silica gel, UV visible 
tert-Butyl((4-methoxy-2-vinylidenehex-5-yn-1-yl)oxy)diphenylsilane 2.8. 
A flame-dried, 25 mL, round-bottomed flask equipped with a stir bar, 
septum, and nitrogen inlet needle was charged with THF (9 mL) and sodium hydride (53.5 mg of 
a 60% dispersion in mineral oil, 1.34 mmol, 1.2 equiv). The suspension was cooled to 0 °C on an 
ice bath. Alcohol 2.7 (375 mg, 0.996 mmol, 1 equiv) was dissolved in THF (2 mL) and added to 
the reaction. The solution stirred for 15 min prior to addition of iodomethane (0.14 mL, 2.23 
mmol, 2 equiv). The reaction was allowed to warm to rt and stirred for 3.5 h until complete, as 
evidenced by TLC. The solution was quenched with saturated NH4Cl (20 mL) and transferred to 
a separatory funnel. The organic layer was separated and the aqueous layer was extracted with 
Et2O (3 x 20 mL). The combined organics were dried over MgSO4, filtered, and concentrated. 
The crude material was purified by silica gel flash column chromatography (gradient of 2-10% 
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EtOAc in hexanes) to afford 300 mg of 2.8 in 77% yield. The characterization data obtained 
matches previously reported data.43 
Data for 2.8. 
1H NMR (300 MHz, CDCl3) 
7.71-7.64 (m, 4H), 7.45-7.34 (m, 6H), 4.78-4.69 (m, 2H), 4.21 (app s, 2 H), 4.08 
(dt, J = 6.8, 1.6 Hz, 1H), 3.38 (s, 3H), 2.57-2.41 (m, 2H), 2.41 (d, J = 1.6 Hz, 1H), 
1.05 (s, 9H) ppm;  
TLC  Rf = 0.46 (10% Et2O in hexanes) 
 Silica gel, UV visible 
Methyl 6-(((tert-butyldiphenylsilyl)oxy)methyl)-4-methoxyocta-
6,7-dien-2-ynoate 2.1a. A flame-dried, 25 mL, round-bottomed flask 
equipped with a stir bar, septum, and nitrogen inlet needle was charged with alkyne 2.8 (315 mg, 
0.806 mmol, 1 equiv) dissolved in THF (4 mL). The reaction was cooled to -78 °C on a dry ice 
and acetone bath. n-Butyl lithium (0.61 mL of a 1.6 M soln in hexanes, 0.967 mmol, 1.2 equiv) 
was added dropwise via syringe. The reaction stirred for 1 h while the ice bath was warmed 
slowly to -35 °C by the addition of acetone to the dry ice bath. Methyl chloroformate (0.12 mL, 
1.61 mmol, 2 equiv), dissolved in THF (2 mL), was added and solution stirred for 15 min. The 
reaction was quenched with saturated NH4Cl and diluted with Et2O. The flask contents were 
transferred to a separatory funnel and the organic layer was separated. The aqueous layer was 
extracted with Et2O (3 x 10 mL). The combined organics were dried over MgSO4, filtered, and 
concentrated. The crude residue was purified by silica gel flash column chromatography 
(gradient of 5-10% EtOAc in hexanes) to afford 244 mg of 2.1a in 69% yield as a pale yellow 
oil. The characterization data obtained matches previously reported data.43 
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Data for 2.1a. 
1H NMR (300 MHz, CDCl3) 
7.71-7.64 (m, 4H), 7.44-7.32 (m, 6H), 4.78 (quintet, J = 2.7 Hz, 2H), 4.21 (t, J = 
7.2 Hz, 1H), 4.20 (t, J = 2.7 Hz, 1H), 3.78 (s, 3H), 3.39 (s, 3H), 2.56-2.49 (m, 
2H), 1.05 (s, 9H) ppm; 
TLC  Rf = 0.27 (10% Et2O in hexanes) 
 (Silica gel, UV visible) 
2.4.3 Optimization of Allylboronate formation   (Experiments for Table 5) 
Reaction of 2.1a with HMPA and DIBAL-H (Entry 1) 
 
A flame-dried, 5 mL, round-bottomed flask, equipped with a stir bar and septum pierced 
with a nitrogen inlet needle was charged with toluene (0.3 mL) and cooled to 0 °C on an ice and 
water bath. HMPA (36 µL, 0.21 mmol, 6 equiv) and DIBAL-H (0.10 mL of a 1.0 M solution in 
toluene, 0.10 mmol, 3 equiv) were added sequentially and stirred for 30 min. Alkynoate 2.1a (15 
mg, 0.034 mmol, 1 equiv), dissolved in toluene (0.2 mL), was added to the reaction in one 
portion via syringe and stirred for 5 h. A small aliquot was removed from the reaction, diluted 
with diethyl ether (2 mL) and washed with 1 M HCl, saturated NaHCO3, and brine (2 mL each), 
dried over MgSO4, filtered and concentrated. Crude 1H NMR revealed a 10:1 mixture of alkene 
2.21a and ynoate 2.1a. Alkene 2.21a, although previously reported, was not previously 
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characterized.43 Characterization was obtained from a sample obtained by a previous group 
member; the sample had a 6.1: 1, Z:E isomeric ratio. 
Data for 2.21a. 
1H NMR (400 MHz, CDCl3)  
7.71-7.65 (m, 4 H), 7.44-7.34 (m, 6 H), 6.82 (dd, J = 15.6, 6.4 Hz, 1 H)*, 6.08 
(dd, J = 11.6, 8.6 Hz, 1 H), 5.98 (dd, J = 15.6, 1.2 Hz, 1 H)*, 5.90 (dd, J = 11.6, 
1.2 Hz, 1 H), 4.99-4.92 (m, 1 H), 4.73-4.69 (m, 2 H), 4.20 (t, J = 2.8, 2 H), 3.75 
(s, 3 H)*, 3.69 (s, 3 H), 3.27 (s, 3 H), 2.37 (ddt, J = 14.8, 7.2, 2.8 Hz, 1 H), 2.27 
(ddt, J = 14.8, 5.2, 2.8 Hz, 1 H), 1.05 (s, 9H)*, 1.04 (s, 9 H) ppm; 
*discernable signal for E-2.21a 
13C NMR (100 MHz, CDCl3) 
206.7, 166.3, 150.4, 135.8, 129.7, 127.8, 127.7, 121.6, 99.7, 75.4, 64.9, 57.1, 51.5, 
34.4, 27.0, 19.5 ppm; 
IR  (thin film) 
  2931, 2858, 1961, 1725, 1429, 1196, 1109, 824, 703 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
 [M + H]+ calcd for C27H35O4Si, 451.2299; found, 451.2280;  
TLC   Rf = 0.65 (20% EtOAc in hexanes) 
  Silica gel, UV visible 
Reaction of 2.1a with HMPA, DIBAL-H, ClCH2BPin (Entries 2, 3). 
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Entry 2: A flame-dried, 10 mL, round-bottomed flask, equipped with a stir bar and 
septum pierced with a nitrogen inlet needle was charged with toluene (0.4 mL) and cooled to 0 
°C on an ice and water bath. HMPA (29 µL, 0.17 mmol, 4 equiv) and DIBAL-H (0.14 mL of a 
0.6 M solution in toluene, 0.082 mmol, 2 equiv) were added sequentially and stirred for 1 h. 
Alkynoate 2.1a (18 mg, 0.041 mmol, 1 equiv), dissolved in toluene (0.3 mL), was added to the 
reaction in one portion via syringe and stirred for 3 h. ClCH2BPin (11 mg, 0.062 mmol, 1.5 
equiv), dissolved in toluene (0.2 mL), was added and stirred overnight at rt. The reaction was 
quenched with addition of 1 M HCl (3 mL) and diluted with Et2O. The organics were washed 
with 1 M HCl, saturated NaHCO3, and brine (3 mL each), dried over MgSO4, filtered and 
concentrated. The crude residue was purified by silica gel flash column chromatography (10% 
EtOAc in hexanes) to afford 6 mg of alkene 2.21a (33% yield) and 1 mg allylboronate 2.2a (4% 
yield) (a 7.8 : 1 molar ratio). 
• When 2.6 equiv of ClCH2BPin were used, a crude 1H NMR taken 10 h after the boronate 
addition revealed a 1.7:1 ratio of alkene 2.21a: boronate 2.2a. Stirring was continued; at 
41 h, crude 1H NMR showed a 2.6:1 ratio of alkene 2.21a: boronate 2.2a (Entry 3). 
Data for 2.2a, see below. 
Attempted reaction of ynoate 2.1b (Table 5, Entries 4, 5).  
 
Entry 4: A flame-dried, 15 mL, round-bottomed flask equipped with a stir bar and septum 
was charged with THF (0.7 mL), and copper iodide (4 mg, 0.023 mmol, 0.1 equiv). The flask 
was cooled to -30 °C (dry ice and acetonitrile bath). Methyl lithium (14 µL of a 1.6 M solution in 
diethyl ether, 0.023 mmol, 0.1 equiv) was added and the solution stirred for 30 min. Toluene (1.6 
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mL) was added followed by sequential addition of HMPA (80 µL, 0.46 mmol, 2 equiv) and 
DIBAL-H (0.34 mL of a 1.0 M solution in hexanes, 0.34 mmol, 1.5 equiv). The reaction was 
stirred for 2 h. Alkynoate 2.1b (100 mg, 0.23 mmol, 1 equiv) was dissolved in toluene (1.1 mL) 
and added to the reaction in a single portion via syringe. The reaction stirred for 5 h. ClCH2BPin 
(48 mg, 0.27 mmol, 1.2 equiv) was added and the reaction stirred overnight at rt. No change in 
the reaction was observed by TLC. The reaction was diluted with Et2O (5 mL), quenched with 1 
M HCl (5 mL). The organic layer was separated and washed with 1 M HCl (2 x 5 mL), saturated 
NaHCO3 (5 mL), and brine (5 mL), dried over Na2SO4, filtered, and concentrated. The crude 1H 
NMR showed ynoate 2.1b with signals consistent with literature values.68  
Entry 5: Follows same procedure as described for entry 4 with THF (0.35 mL), copper 
iodide (2 mg, 0.012 mmol, 0.1 equiv), methyl lithium (8 µL of a 1.6 M solution in diethyl ether, 
0.012 mmol, 0.1 equiv), toluene (0.8 mL), distilled HMPA (40 µL, 0.23 mmol, 2 equiv), 
DIBAL-H (0.17 mL of a 1.0 M solution in toluene, 0.17 mmol, 1.5 equiv), ynoate 2.1b (50 mg, 
0.12 mmol, 1 equiv) dissolved in toluene (0.5 mL). After addition of ynoate 2.1b, no reaction 
had occurred after 5 h of stirring. ClCH2BPin was not added to this experiment. 1H NMR of the 
crude residue showed ynoate 2.1b68 and no alkene 2.21b.   
Attempted 1,4-reduction of ynoate 2.1c (Table 5, Entry 6).  
 
A flame-dried, 15 mL, round-bottomed flask equipped with a stir bar and septum was 
charged with THF (0.9 mL), and copper iodide (6 mg, 0.030 mmol, 0.1 equiv). The flask was 
cooled to -30 °C (cryocool and ethanol bath). Methyl lithium (19 µL of a 1.6 M solution in Et2O, 
0.030 mmol, 0.1 equiv) was added and the solution stirred for 30 min. Toluene (2.0 mL) was 
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added followed by sequential addition of HMPA (0.10 mL, 0.59 mmol, 2 equiv) and DIBAL-H 
(0.34 mL of a 1.0 M solution in hexanes, 0.45 mmol, 1.5 equiv). The reaction was stirred for 2 h. 
Alkynoate 2.1c (50 mg, 0.30 mmol, 1 equiv) was dissolved in toluene (1.4 mL) and added to the 
reaction in a single portion via syringe. The reaction stirred at -20 °C for 5 h. An aliquot was 
taken from the reaction and concentrated. Crude NMR of this residue showed a 4:1 mixture of 
ynoate 2.1c: alkene 2.21c. Presence of alkene 2.21c was determined by 1H NMR signals at 6.3 
and 5.8 ppm, which is consistent with literature values of this compound.71  
• Allenyl-ynoate 2.1a was subjected to the same procedure which resulted in a complicated 
mixture as determined by TLC analysis (Entry 7). 
Reaction of methyl 2-octynoate 2.1d (Table 5, Entries 8, 9).  
 
A flame-dried, 10 mL, round-bottomed flask, equipped with a stir bar and septum was 
charged with THF (3.6 mL), and copper iodide (24 mg, 0.13 mmol, 0.4 equiv). The flask was 
cooled to -30 °C (cryocool and ethanol bath). Methyl lithium (80 µL of a 1.6 M solution in 
diethyl ether, 0.013 mmol, 0.4 equiv) was added and the solution stirred for 30 min. In a 
separate, 10 mL flask, toluene (1.3 mL) was cooled to -30 °C. 0.9 mL of the stirring CuMe 
solution (0.032 mmol, 0.1 equiv) was added followed by sequential addition of HMPA (0.17 mL, 
0.97 mmol, 3 equiv) and DIBAL-H (1.28 mL of a 0.6 M solution in toluene, 0.64 mmol, 2 
equiv). The reaction was stirred for 1 h. Alkynoate 2.1d (50 mg, 0.32 mmol, 1 equiv) was 
dissolved in toluene (0.4 mL) an added to the reaction in a single portion via syringe. The 
reaction stirred at -20 °C for 5 h until the ynoate was consumed, as evidenced by crude 1H NMR 
spectroscopy. ClCH2BPin (113 mg, 0.64 mmol, 2 equiv), dissolved in toluene (0.2 mL), was 
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added and stirred overnight. The reaction was quenched by 1 M HCl and diluted with diethyl 
ether. The organic layer was washed with 1 M HCl, saturated NaHCO3, and brine, dried over 
MgSO4, filtered, and concentrated. Analysis by crude 1H NMR revealed a 1 : 1 mixture of alkene 
2.21d (signals observed matched literature values)72 and allylboronate 2.2d (3.6:1, Z:E isomeric 
ratio). The crude mixture was purified by silica gel flash column chromatography (gradient of 
10-20% diethyl ether in hexanes) to afford 7 mg of the Z-2.2d and 9 mg of the Z- and E-isomers 
of allylboronate 2.2d (1.4: 1 isomeric ratio) (35% yield overall).  
• With freshly distilled ClCH2BPin, the crude 1H NMR showed 2.2d as the only product; 
no alkene 2.21d was observed. 
Data for 2.2d. 
1H NMR  Z-isomer only: (600 MHz, CDCl3) 5.93 (t, J = 7.2 Hz, 1H), 3.70 (s, 3H), 2.48 (q, 
J = 7.2 Hz, 2H), 1.83 (s, 2H), 1.44-1.37 (m, 2H), 1.34-1.24 (m, 4H), 1.23 (s, 
12H), 0.88 (t, J = 7.2 Hz, 3H) ppm; 
Z- and E-isomer: (400 MHz, CDCl3)  6.74 (t, J = 7.4 Hz, 1H)*, 5.93 (t, J = 7.4 
Hz, 1H)**, 3.71 (s, 3H)*, 3.70 (s, 3H)**, 2.48 (q, J = 7.4 Hz, 2H)**, 2.14 (q, J = 
7.4 Hz, 2H)*, 1.85 (s, 2H)*, 1.83 (s, 2H)**, 1.44-1.37 (m, 2H), 1.34-1.25 (m, 
4H), 1.232 (s, 12H)**, 1.228 (s, 12H)*, 0.88 (m, 3 H) ppm; 
*E isomer, **Z isomer 
Impurities observed at 7.03, 3.65, 1.58 ppm. 
13C NMR Z-isomer (150 MHz, CDCl3) 
168.5, 143.9, 127.8, 83.4, 51.2, 31.7, 29.8, 29.3, 27.4, 24.9, 22.7, 14.2 ppm; 
HRMS  (FTMS + p ESI Full ms) 
 [M + H]+ calcd for C16H30O4B, 297.2232; found, 297.2235; 
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IR  (thin film) 
  2927, 2858, 1723, 1435, 1354, 1324, 1201, 1147 cm-1; 
TLC  Rf = 0.45 (20% diethyl ether in hexanes) 
  Silica gel, UV visible, KMnO4  
Allylboronate 2.2a. To a flame-dried, single-necked, round-bottomed 
flask, equipped with a stir bar and septum pierced with a nitrogen inlet 
needle, was added THF (1.2 mL) and copper iodide (8 mg, 0.040 mmol, 0.1 equiv) to form an 
off-white slurry. The flask was cooled to -30 °C using a cryocool/ethanol bath. Methyl lithium 
(0.025 mL of a 1.6 M solution in Et2O, 0.040 mmol, 0.1 equiv) was added and the solution 
turned dark brown. The solution was stirred for 40 min. Toluene (1.7 mL) was added followed 
successively by HMPA (0.21 mL, 1.19 mmol, 3 equiv) and DIBAL-H (0.80 mL of a 1.0 M 
solution in toluene) and the black solution stirred for 2 h. Alkynoate 2.1a (174 mg, 0.40 mmol, 1 
equiv) was dissolved in toluene (0.5 mL) and added to the reaction all at once via syringe. The 
temperature was warmed to -20 °C stirred for 3 h until all of the ynoate 2.1a had been consumed, 
determined by crude 1H NMR spectroscopy (shows formation of alkene 2.21a). Freshly distilled 
ClCH2BPin (141 mg, 0.80 mmol, 2 equiv), dissolved in toluene (0.4 mL), was added and stirred 
overnight at rt. Over this time, the reaction solution went from black to translucent pale green. 
The reaction was quenched by the addition of 1 M HCl (10 mL). The mixture was transferred to 
a separatory funnel and diluted with Et2O (10 mL). The organic layer was separated and the 
aqueous layer was extracted with Et2O (2 x 10 mL). The combined organics were washed with 1 
M HCl (12 mL), saturated NaHCO3 (12 mL), and brine (12 mL), dried over MgSO4, filtered, and 
concentrated using reduced pressure rotary evaporation. The crude material was purified by 
elution through a small silica column using 20% diethyl ether in hexanes to afford the title 
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compound 2.2 (183 mg, 78%) as a 1.6:1, Z:E isomeric ratio and as a colorless oil. The isomers 
were inseparable and taken on to the next step as a mixture. The characterization for the mixture 
is reported and the data matches previously reported data.43 
Data for 2.2a. 
1H NMR (400 MHz, CDCl3)  
7.71-7.66 (m, 4H), 7.43-7.32 (m, 6H), 6.53 (d, J = 9.2 Hz, 1H)*, 5.74 (d, J = 8.8 
Hz, 1H)**, 4.74-4.69 (m, 2H), 4.72-4.63 (m, 1H)**, 4.23-4.17 (m, 2H), 4.16-4.05 
(m, 1H)*, 3.73 (s, 3H)*, 3.66 (s, 3H)**, 3.25 (s, 3H)**, 3.23 (s, 3H)*, 2.40-2.20 
(m, 2H), 1.92-1.82 (m, 2H), 1.21 (s, 12H)**, 1.20 (s, 12H)*, 1.04 (s, 9H) ppm; 
 *E isomer, **Z isomer 
TLC  Rf = 0.48 (20% EtOAc in hexanes) 
 Silica gel, UV visible 
2.4.4 Completing the synthesis of trans-guaianolide 1.83. 
Trans-lactone 1.82a and cis-lactone 1.82b. A 2-
5 mL Biotage microwave irradiation vial, 
equipped with a stir bar, was charged with 
chloroform (3.7 mL), allylboronate 2.2a (222 mg 
of a 1.7:1 mixture of Z:E isomers, 0.376 mmol, 1 equiv), and phenylpropynal (108 mg, 0.827 
mmol, 2.2 equiv). The vial was sealed with a septum, pierced with a N2 inlet needle, and flushed 
with N2. The vial was lowered into an oil bath (50 °C) and stirred for 7 d. Disappearance of 
allylboronate 2.2a was monitored my 1H NMR spectroscopy. p-Toluene sulfonic acid 
monohydrate (7 mg, 0.038 mmol, 0.1 equiv) was added and the reaction stirred for 16 h at rt. The 
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reaction was quenched by the addition of saturated NaHCO3 (8 mL) and diluted with DCM (6 
mL). The organic layer was separated and the aqueous layer was extracted with DCM (2 x 10 
mL). The combined organics were dried over MgSO4, filtered, and concentrated. The crude 
residue was purified by silica gel flash column chromatography (10% Et2O in hexanes) to 
provide 61 mg of trans-lactone 1.82a as a 1.5:1 ratio of diastereomers, 13 mg of cis-lactone 
1.82b (Diastereomer 1) contaminated with recovered allylboronate 2.2a (E isomer), and 35 mg 
cis-lactone 1.82b (Diastereomer 2) in an overall 50% yield. The characterization data obtained 
for trans-1.82a  and cis-1.82b (Diastereomer 2) matches previously reported data.43  
Data for trans-1.82a  
1H NMR (400 MHz, CDCl3)  
7.69-7.62 (m, 5H), 7.46-7.28 (m, 10H), 6.38 (d, J = 2.4 Hz, 1H)*, 6.35 (d, J = 2.4 
Hz, 1H)**,  5.73 (d, J = 2.0 Hz, 1H)*, 5.66 (d, J = 2.0 Hz, 1H)**, 5.38 (d, J = 4.4 
Hz, 1H)**, 5.20 (d, J = 3.2 Hz, 1H)*, 4.79-4.75 (m, 2H), 4.23-4.19 (m, 2H), 3.62-
3.56 (m, 1H), 3.49-3.46 (m, 1H)*, 3.42-3.38 (m, 1H)**, 3.36 (s, 3H)*, 3.33 (s, 
3H)**, 2.51-2.43 (m, 1H)**, 2.42-2.32 (m, 1H)*, 2.31-2.21 (m, 1H), 1.06 (s, 
9H)*, 1.05 (s, 9H)** ppm; 
* Major diastereomer, ** minor diastereomer. 
Impurities observed at 1.54, 1.43, 1.25, and 1.20 ppm. 
TLC   Rf = 0.33 (10% EtOAc in hexanes) 
Silica gel, UV visible 
Data for cis-1.82b, Diastereomer 1 
1H NMR (500 MHz, CDCl3) 
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7.70-7.62 (m, 5H), 7.43-7.30 (m, 10H), 6.34 (d, J = 1.5 Hz, 1H), 5.73 (d, J = 1.5 
Hz, 1H), 5.39 (d, J = 7.0 Hz, 1H), 4.79-4.72 (m, 2H), 4.22-4.16 (m, 2H), 4.01 (dt, 
J = 9.5, 4.0 Hz, 1H), 3.37 (s, 3H), 3.26-3.22 (m, 1H), 2.53-2.47 (m, 1H), 2.40-
2.31 (m, 1H), 1.04 (s, 9H) ppm; 
Signals for E-2.2a observed at 6.53, 4.62, 3.73, 3.23 ppm. 
13C NMR (125 MHz, CDCl3) 
206.8, 186.7, 141.6, 135.7, 134.8, 133.4, 131.9, 129.9, 129.3, 128.6, 127.9, 127.8, 
124.2, 99.5, 83.6, 83.1, 79.3, 70.5, 64.9, 57.0, 45.9, 28.1, 27.0, 19.4 ppm; 
IR  (thin film) 
3070, 2932, 2858, 1962, 1774, 1721, 1428, 1360, 1265, 1110, 703 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
  [M + H]+ calculated for C36H39O4Si, 563.2612; found, 563.2589; 
TLC   Rf = 0.25 (10% EtOAc in hexanes) 
Silica gel, UV visible 
Data for cis-1.82b, Diastereomer 2 
1H NMR (600 MHz, CDCl3) 
7.68-7.61 (m, 5H), 7.43-7.28 (m, 10H), 6.37 (d, J = 2.1 Hz, 1H), 5.78 (d, J = 2.1 
Hz, 1H), 5.48 (d, J = 8.4 Hz, 1H), 4.77-4.72 (m, 1H), 4.69-4.63 (m, 1H), 4.22-
4.11 (m, 2H), 3.93-3.87 (m, 1H), 3.54-3.48 (m, 1H), 3.38 (s, 3H), 2.61-2.55 (m, 
1H), 2.16-2.08 (m, 1 H), 1.02 (s, 9 H) ppm; 
13C NMR (150 MHz, CDCl3) 
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206.1, 169.4, 135.8, 135.7, 133.7, 132.1, 129.82, 129.77, 129.30, 128.5, 127.8, 
125.2, 121.7, 100.8, 90.1, 82.4, 80.0, 77.7, 69.5, 65.0, 57.3, 44.4, 30.5, 26.9, 19.4 
ppm; 
TLC   Rf = 0.19 (10% EtOAc in hexanes) 
Silica gel, UV visible 
Trans-guaianolide analog 2.24. Followed general procedure 1A 
(Section 1.4.3), using [Rh(CO)2Cl]2 (2 mg, 0.0057 mmol, 0.05 equiv) in 
toluene (8.5 mL), trans-lactone allene-yne 1.82a (64 mg, 0.114 mmol, 1 
equiv) dissolved in toluene (2.9 mL), and triphenylphosphine polymer bound (65 mg). The 
residue was purified by silica gel flash column chromatography (gradient of 30-40% EtOAc in 
hexanes) to yield the title compound (53 mg, 79%) as a colorless oil. The characterization data 
obtained matches previously reported data.43 
Data for 2.24. 
1H NMR (400 MHz, CDCl3) 
7.73-7.64 (m, 4H), 7.48-7.32 (m, 9H), 7.27-7.21 (m, 2H), 6.35 (d, J = 3.6 Hz, 
1H)**, 6.23 (d, J = 3.6 Hz, 1H)*, 5.85 (d, J = 2.8 Hz, 1H)*, 5.71 (d, J = 9.6 Hz, 
1H)**, 5.48 (d, J = 3.2 Hz, 1H)**, 5.32 (d, J = 10.4 Hz, 1H)*, 4.33 (d, J = 13.2 
Hz, 1H)*, 4.31 (d, J = 12.4 Hz, 1H)**, 4.27 (d, J = 12.8 Hz, 1H)**, 4.23 (d, J = 
13.2 Hz, 1H)*, 4.01-3.94 (m, 1H)**, 3.86-3.82 (m, 1H)*, 3.424 (s, 3H)*, 3.418 (s, 
3H)**, 3.39-3.31 (m, 1H), 3.17-3.07 (m, 1H), 2.86 (d, J = 20.8 Hz, 1H)*, 2.83 (d, 
J = 20.8 Hz, 1H)**, 2.76 (d, J = 20.4 Hz, 1H)**, 2.73 (d, J = 21.2 Hz, 1H)*, 2.45-
2.37 (m, 1H), 1.11 (s, 9H)**, 1.10 (s, 9H)* ppm; 
*Major diastereomer, ** Minor diastereomer 
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TLC  Rf = 0.18 (20% EtOAc in hexanes) 
Silica gel, UV visible. 
Cis-guaianolide analog 2.25. Followed general procedure 1A (Section 
1.4.3), using [Rh(CO)2Cl]2 (3 mg, 0.0083 mmol, 0.05 equiv) in toluene 
(12.0 mL), cis-lactone allene-yne 1.82b (93 mg, 0.11 mmol, 1 equiv) 
dissolved in toluene (4.5 mL). Cooled reaction solution was filtered through a celite plug, rinsed 
with Et2O and concentrated using reduced pressure rotary evaporation. The residue was purified 
by silica gel flash column chromatography (gradient of 20-40 % EtOAc in hexanes) to yield the 
title compound (56 mg, 58%) as a colorless oil. The characterization data obtained matches 
previously reported data.43 
Data for 2.25. 
1H NMR (300 MHz, CDCl3) 
7.70-7.63 (m, 4H), 7.49-7.38 (m, 9H), 7.29-7.22 (m, 2H), 6.51 (bs, 1H), 5.93 (bs, 
1H), 5.58 (d, J = 7.5 Hz, 1H), 4.28 (d, J = 12.6 Hz, 1H), 4.18 (d, J = 12.0 Hz, 1H), 
3.77-3.70 (m, 1H), 3.59 (dd, J = 9.8, 5.0 Hz, 1H), 3.44 (s, 3H), 2.96 (d, J = 18.3 
Hz, 1H), 2.91 (d, J = 20.4 Hz, 1H), 2.80 (d, J = 20.4 Hz, 1H), 2.41-2.29 (m, 1H), 
1.07 (s, 9H) ppm; 
TLC  Rf = 0.39 (30% EtOAc in hexanes) 
Silica gel, UV visible. 
Trans-guaianolide analog 1.83. A flame-dried, 10 
mL, round-bottomed flask, equipped with a stir bar and 
septum pierced with a nitrogen inlet needle, was 
charged with acetonitrile (1.0 mL) and crude silyl 
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protected trans-guaianolide 2.24 (0.076 mmol of 2.3:1 mixture of diastereomers, 1 equiv). 
Triethylamine trihydrofluoride was added and the flask was lowered into a pre-heated oil bath 
(60 °C) and stirred overnight. The oil bath was removed and the solution cooled to rt. The 
solution was diluted with Et2O and water (5 mL each). The organic layer was separated and the 
aqueous was extracted with Et2O (2 x 10 mL). The combined organics were washed with 
saturated NaHCO3 (2 x 6 mL), dried over MgSO4, filtered, and concentrated. The crude material 
was purified by silica gel flash column chromatography (100% EtOAc) to afford 17 mg of the 
title compounds as 2.3:1 mixture of diastereomers (64% over two steps). The 1H NMR spectra 
obtained of the diastereomer mixture was consistent with that previously reported.43 The 
diastereomers were separated for by HPLC utilizing the following eluent method with a flow rate 
of 4 mL/min: 100% EtOAc for 20 min, gradient increase from 100% EtOAc to 5% methanol in 
EtOAc for 5 min, followed by constant 5% methanol in EtOAc for 5 min. 8βH-1.83a had a 
retention time of 14.0 min and 8αH-1.83b had a retention time of 17.0 min. Each diastereomer 
was analyzed by 1H, 13C, COSY, and HSQC NMR spectroscopy. 
Data for Diastereomer A: 8βH-1.83a 
HPLC  14.004 min retention time 
1H NMR (500 MHz, CDCl3) 
7.40-7.32 (m, 3H), 7.27-7.24 (m, 2H), 6.25 (d, J = 3.5 Hz, 1H), 5.85 (d, J = 3.0 
Hz, 1H), 5.39 (d, J = 10.5 Hz, 1H), 4.31 (d, J = 12.5 Hz, 1H), 4.19 (d, J = 12.5 
Hz, 1H), 3.86 (ddd, J = 8.0, 4.0, 2.5 Hz, 1H), 3.54 (s, 3H), 3.29 (d, J = 21.0 Hz, 
1H), 3.17 (d, J = 21.0 Hz, 1H), 3.18-3.13 (m, 1H), 3.16-3.12 (m, 1H), 2.56 (dd, J 
= 15.8, 2.5 Hz, 1H), 1.73 (bs, 1H) ppm; 
13C NMR (125 MHz, CDCl3) 
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201.4, 167.8, 161.6, 143.3, 137.2, 133.9, 133.0, 130.7, 130.0, 128.8, 127.8, 122.1, 
81.7, 75.8, 65.3, 56.9, 50.0, 39.5, 30.6 ppm; 
TLC  Rf = 0.41 (100% ethyl acetate) 
Silica gel, UV visible. 
Data for Diastereomer B: 8αH-1.83b. 
HPLC  17.006 min retention time 
1H NMR (400 MHz, CDCl3) 
7.45-7.32 (m, 3H), 7.30-7.26 (m, 2H), 6.36 (d, J = 3.6 Hz, 1H), 5.78 (d, J = 9.2 
Hz, 1H), 5.52 (d, J = 3.2 Hz, 1H), 4.34-4.26 (m, 2H), 4.14-4.07 (m, 1H), 3.45 (s, 
3H), 3.37-3.31 (m, 1H), 3.27 (dd, J = 15.2, 6.8 Hz, 1H), 3.28-3.15 (m, 2H), 2.53 
(dd, J = 15.2, 8.4 Hz, 1H), 1.26 (t, J = 7.2 Hz, 1H) ppm; 
13C NMR  (150 MHz, CDCl3) 
201.3, 168.4. 162.2, 144.1, 134.2, 133.7, 132.2, 130.8, 130.0, 128.9, 127.9, 123.0, 
74.9, 74.0, 65.6, 57.5, 49.8, 39.9, 33.9 ppm; 
TLC  Rf = 0.34 (100% ethyl acetate) 
Silica gel, UV visible. 
2.4.5 Computational Methods 
Predicted 1H NMR chemical shift calculations were performed using Spartan 10 software 
for windows.70c The structure was drawn in the drawing window, and lowest energy conformers 
were determined by performing conformer distribution calculations using molecular mechanics 
and MMFF. For 8βH-1.83a, this generated 37 possible conformers and the lowest energy 
conformer was ~79 kcal/mol. For 8αH-1.83b, 43 possible conformers were generated and the 
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lowest energy conformer was ~81 kcal/mol. Using the lowest energy conformers, 1H NMR 
chemical shift calculations were performed using EDF2/6-31G* (subset of equilibrium geometry 
and density functional theory) functionals in a vacuum. Corrected chemical shifts were displaced 
as atom labels (shown by clicking Model>Configure>Chem Shift), these values were recorded. 
Table 7. Calculated chemical shifts for 8βH-1.83a and 8αH-1.83b. 
8βH-1.83a 
O
O
O
O
H6 H10
H15
H3
H5
H14
H1
OH8
H4
H19
H2
H13
H9
H7
H16
H12
H17
H20
H18
H11
 
 8αH-1.83b 
O
O
O
O
H6
H15
H10
H14 H
16
H1
OH8
H4
H19
H7
H9
H2
H13
H5
H3
H12
H17
H20
H18
H11
 
Calculated ppm Spartan Assignment  Calculated ppm Spartan Assignment 
7.728 20  7.662 11 
7.69 11  7.315 12 
7.263 17  7.279 17 
7.263 18  7.276 20 
7.249 12  7.259 18 
6.226 5  6.354 5 
5.784 3  5.831 1 
5.369 1  5.355 3 
4.275 7  4.389 7 
4.117 9  4.312 9 
3.588 16  4.089 16 
3.544 6, 10, 15  3.393 6, 10, 15 
3.119 2  3.284 2 
3.038 14  3.220 14 
2.915 4  2.890 4 
2.543 19  2.505 19 
2.278 13  2.237 13 
0.272 8  0.272 8 
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3.0  INSTALLATION OF ALKYNE LIGATION HANDLES VIA THE NICHOLAS 
REACTION 
This chapter is based upon results described in “Alkyne Ligation Handles: Propargylation of 
Hydroxyl, Sulfhydryl, Amino, and Carboxyl Groups via the Nicholas Reaction,” by Sarah M. 
Wells, John C. Widen, Daniel A. Harki, and Kay M. Brummond, submitted for publication 
7/16/2016. 
3.1 INTRODUCTION 
One factor contributing to the slow realization of guaianolides as therapeutics is the 
presence of covalent modifiers and limited understanding of their biological mechanism of 
action. Despite prevalent bioactivity, covalent modifiers have been criticized for their 
irreversible interactions with protein targets and poor selectivity. For progress to be made for this 
class of molecules, their protein targets and mechanism of action must be understood. Towards 
this end, we sought to synthesize activity based protein profiling (ABPP) probes for the 
guaianolide NF-ĸB inhibitors synthesized in our group to determine their protein targets. 
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3.1.1 Activity Based Protein Profiling for Protein Target Identification 
Natural products (NPs) are distinguished classes of organic molecules and provide 
inspiration for a large portion of pharmaceuticals.1 For NPs and derivatives there-of to be 
approved for therapeutic use, a complete understanding of their molecular targets and 
mechanism of action should be understood.73 This is particularly true for covalent modifiers, 
often criticized for irreversibly and indiscriminately modifying proteins.  
ABPP has been established as a fundamental technique for characterizing specific protein 
activity within a complex proteome, popular for its ability to examine proteins in vivo without 
disturbing natural function.74 The method depends on the development of activity based probes 
(ABPs) capable of selective covalent interaction with active enzymes and analytical detection ex 
post facto. These probes contain three essential parts; 1) a binding group that enables protein 
selectivity presumably through non-covalent binding interactions, 2) the reactive group (or 
warhead) that covalently binds to active proteins, and 3) a reporter group, or detectable agent that 
is used for analytical characterization. While ABPP has been a powerful tool for understanding 
the functional characteristics of individual proteins in native proteomes, the method has also 
been applied to identifying specific protein targets and mechanism of action for NPs and other 
drug candidates.73b, 75 
 ABPs for target identification studies are derivatives of the active small molecules, 
which are modified to contain an analytical tag, or reporter group. ABPP exploits the reactive 
groups of the covalent modifiers, which serve as the war head and form covalent linkages with 
nucleophilic amino acids near the protein binding pocket. Once the interaction between the 
bioactive molecule and the proteome have been established, analytical methods, such as gel 
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electrophoresis, fluorescence detection, and mass spectrometry are employed to characterize the 
interactions (Figure 14).  
 
Figure 14. Overview of activity-based protein profiling (ABPP). Reprinted from MDPI Open Access: Martell, J.; 
Weerapana, E. Molecules, 2014, 19, 1378-1393. 76 
 
3.1.2 Probe design for target identification of bioactive small molecules. 
Probe design for target identification experiments involves the installation of the reporter 
group onto the bioactive molecule. Two main considerations for tag installation are the size and 
position of the tag; minimizing perturbation of the parent molecule’s natural biological activity is 
a major concern.77 Some of the most common tags include biotin 3.1, which is commonly 
detected by western blot analysis and avidin enrichment prior to mass spectroscopy, and 
rhodamine 3.2, a fluorophore detectable by in-gel fluorescence (Figure 15).  These analytical 
tags allow for direct evaluation of the protein target(s), but their size has led to major 
disadvantages such as perturbation of protein-probe interactions, decreased cell permeability, and 
destruction of native biological conditions (Figure 16A). 
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Figure 15. Popular reporter groups for ABPP. 
The advances and popularity of biorthogonal chemistry, or “Click chemistry,” have 
allowed for an alternative, two-step probe, where bioactives are modified to contain smaller, less 
obstructive ligation handles, or “pre-tags”.77 After forming their respective covalent linkages 
with active proteins in the cell, these ligation handles can be elaborated with a fluorophore or 
enrichment tag containing the complementary bioorthoganal functionality (Figure 16B). The 
“pre-tag” probe also allows for the utilization of numerous reporter groups and characterization 
methods while employing a single synthetic probe.74b 
= Reporter group= reactive group
 
Figure 16. Advantages of a two-step ABP with an alkyne ligation handle. A) Bulky reporter groups interfere with 
warhead-protein binding. B) Alkyne ligation handle can be modified for analytical interpretation after covalent 
binding of reactive group with target protein. Reprinted by permission from John Wiley & Sons, Inc.: Lehmann, J.; 
Wright, M. H.; Sieber, S. A. Chem. Eur. J. 2016, 22, 4666-4678. © 2016 WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. 
3.1.3 Bioorthogonal reactions and the value of alkyne ligation handles 
An ideal bioorthogonal reaction involves rapid coupling of two precursors without the 
formation of byproducts, and can be done under physiological conditions.78 The coupling 
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precursors must also be biologically inert. The development of new bioorthogonal reactions has 
become a prevalent research area; some of the most popular reactions used for ABPP are shown 
in Scheme 51. First, Bertozzi and coworkers developed a “traceless” Staudinger reaction. The 
classical Staudinger reaction occurs between a trialkyl phosphine and an azide to form an aza-
ylide, which in the presence of water, readily undergoes hydrolysis affording the corresponding 
amine and phosphine oxide.79 Bertozzi’s modified reaction utilizes an electrophilic trap, 
incorporated into the phosphine component (3.3), which allows rearrangement of the aza-ylide 
3.5 to form a stable amide linkage 3.6. (Scheme 51A).80 Many methodologies utilize Diels-Alder 
chemistry for the coupling of two substrates; one example is the reaction between a tetrazene 
(3.8) and either a trans-cyclooctene (3.7) or cyclopropene (Scheme 51B).81 The Huisgen copper 
catalyzed [3+2] cycloaddition of an alkyne (3.11) and azide (3.12) to form 1,2,3-triazoles (3.13), 
also called the click reaction, was revisited by Sharpless in 2002 (Scheme 51C).82  
 
Scheme 51. Selected bioorthogonal reactions. 
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The copper-catalyzed [3+2] click reaction has arguably become the most prominently 
used bioorthogonal reaction with over 5848 papers including 927 reviews citing the 2002 report 
by Sharpless.82 Many advancements have allowed the Huisgen cycloaddition, often criticized for 
corresponding cell toxicity of the copper/ascorbate catalyst, to be applied to numerous biological 
applications. Water-soluble, accelerating tris(triazolylmethyl)amine ligands have been shown to 
intercept harmful oxygenative species generated by the catalyst system. This protocol allows an 
accelerated reaction which minimizes both the concentration of the catalyst and time required to 
perform the click-based labeling, resulting in increased cell viability.83 Also, a variation that 
exploits the reactivity of strained cyclooctynes does not require a copper catalyst.84 Utility of the 
click reaction for biochemical applications also stems from the nature of the click reaction 
precursors, the azide and alkyne. These functional groups are rarely found in biological systems, 
minimizing potential side reactions, and they are small in size, which minimizes their effect on 
the activity or physical characteristics of the parent molecule. For ABPP specifically, it has 
become most common to incorporate the alkyne moiety on the small molecule probe, while the 
azide is installed on the analytical tag.77, 85   As a result, synthetic methodology for incorporation 
of an alkynyl group in small molecules is valuable. 
3.1.4 Traditional methods for installation of alkyne handles  
Typically, late-stage incorporation of an alkyne handle has been achieved by either 
alkylation or acylation of an existing amino, hydroxyl, or carboxyl group where the installed 
alkyl or acyl group contained an alkyne. Alkylation is most commonly achieved by 
propargylation of an alcohol via the base-mediated Williamson ether synthesis with propargyl 
bromide. For example, the synthesis of Src-directed probe 3.16 included the propargylation of 
 101 
3.14 using sodium hydroxide and propargyl bromide (Scheme 52).86 A series of hydroxyl and 
amino protecting groups were required to avoid over-propargylation. Alternatively, a hydroxyl 
group can be converted to a propargyl amine by conversion to a mesylate followed by reaction 
with propargyl amine; this method was used for the synthesis of Fmk probe 3.18 (Scheme 53).  
 
Scheme 52. Synthesis of Src-directed alkyne probe 3.16 via base mediated propargylation. 
 
Scheme 53. Propargylation of Fmk 3.17. 
Acylation is commonly performed by incorporating a hexynoic carbonyl onto an amino 
or hydroxyl group. This transformation can also be accomplished under basic conditions, where 
a hydroxyl group reacts with hexynoyl chloride.87 Carbodiimide coupling reactions offer neutral 
alternatives for acylation; an activated carbodiimide facilitates coupling between hexynoic acid 
and either an alcohol or amine (Scheme 54). Showdomycin 3.19 was modified using 
diisopropylcarbodiimide (DIC) and 1-hydroxybenzotriazole (HOBT) with hexynoic acid to 
selectively acylate the primary alcohol, affording showdomycin probe 3.20.88 Mitsunobu 
reaction conditions are typically employed for the acylation of secondary alcohols.77 
 102 
Modification of the secondary amino group of 3.21 gave the duocarmycin probe 3.22 under 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) coupling conditions.89  Alternatively, 
propargyl amine can be coupled with an available carboxylic acid for the formation of amide 
linkages. This strategy is used in the synthesis of 3.24, which was made as part of a series of 
acivicin probes.90  
 
Scheme 54. Synthesis of alkyne probes 3.20, 3.22, and 3.24 using amide coupling reactions. 
In 2013, the Romo and Cravatt groups applied C-H amination of allylic and benzylic 
hydrogens, previously developed by DuBois,91  to the incorporation of alkyne ligation handles 
onto natural products for biochemical studies.92 Amination using sulfonamide derivatives is 
achieved using Rh2(esp)2 and oxidant (PhI(O2CtBu)2) reagent system. One example described 
therein was the amination of Eupalmerin acetate (EuPA, 3.25) to afford 3.26 in 28% yield 
(Scheme 55). An advantage of this method is that it functionalizes the natural product at a 
previously “unfunctionalized” position to avoid rendering the probe inactive. However, low 
 103 
yields, arising from poor site selectivity, and the complex nature of the installed alkynyl group 
are potential concerns. 
 
Scheme 55. Synthesis of EuPAyne 3.26 via Rh(I) catalyzed C-H amination. 
Alternatively, examples of early-stage incorporation of an alkyne functionality have been 
reported. The synthesis of Orlistat probes, such as 3.28, simply replaced a –CH2CH3 group at the 
end of a long alkane chain of Orlistat (3.27), with a –CCH group (Figure 17).68 This modification 
minimizes change in both physical and biological properties of Orlistat but requires a second 
total synthesis, where the alkyne group is incorporated in the starting material.  
 
Figure 17. Orlistat 3.27 and Orlistat probe 3.28, synthesized using early-alkyne incorporation. 
Despite these available methods for alkyne incorporation, synthesis of alkyne probes for 
functionally dense bioactive molecules is still challenging. For example, we envisioned that an 
alkyne probe derivative of trans-guaianolide analog 1.83 could be readily obtained by 
propargylation of the allylic alcohol using the Williamson ether synthesis. However, the base-
sensitive nature of 1.83 was revealed upon stirring with sodium hydride; complete 
decomposition was observed by TLC within 1 h. Also, attempts to deprotect the hydroxyl group 
at the C8 position, for subsequent functionalization of the corresponding secondary alcohol, were 
unsuccessful. Our collaborator, Dan Harki, also expressed setbacks for the synthesis of an alkyne 
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probe for NP melampomagnolide B (MelB, 3.29, Figure 18). MelB is base-sensitive and could 
not be propargylated under classical conditions. Also, attempted oxidations of the allylic alcohol 
were unsuccessful. A biotinylated derivative of MelB has been achieved via an ester linkage, 
however the stability of esters in vivo is still a concern. Consequently, non-basic conditions for 
propargylation of these functionally dense molecules were needed.  
 
Figure 18. Base-sensitive sesquiterpene-lactone analogs. 
3.1.5 The Nicholas reaction: an acid mediated propargylation reaction  
The Nicholas reaction provides propargyl synthons via an acid mediated reaction. 
Dicobalt hexacarbonyl complexed propargyl alcohol 3.30a (Co2(CO)6-propargyl alcohol) 
derivatives react in the presence of either a Lewis or protic acid to yield a cobalt stabilized 
propargylic carbocation 3.31. Trapping of this intermediate with a nucleophile affords the 
corresponding cobalt-complexed alkyne 3.32 species (Scheme 56).93 Even primary propargyl 
alcohols, which result in pseudo-primary carbocations, can be employed in the Nicholas reaction 
due to the stabilization that the adjacent cobalt provides.94 Oxidative decomplexation of the 
cobalt complex 3.32 affords the corresponding alkyne 3.33. To our knowledge, the Nicholas 
reaction has not been applied to the synthesis of biochemical probes.93c  
The click reaction works most efficiently when the alkynyl group has no substituents 
other than the connecting methylene unit (R-CH2-CCH). Therefore, the Nicholas reaction offers 
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advantages over other acid mediated methods for preparing propargyl ethers. For example, metal 
triflates, such as Al(OTf)3, are effective Lewis acid catalysts for preparing propargyl ethers from 
2° and 3° propargyl alcohols. However, primary alcohols are not tolerated due to cationic 
instability.95  
 
Scheme 56. Synthesis of propargyl derivatives via Nicholas reaction followed by oxidative decomplexation. 
A variety of nucleophiles have been used in the Nicholas reaction. Nucleophiles for the 
formation of a carbon-carbon bond include enol derivatives, allyl metals, electron-rich alkenes, 
aryl groups.93b Nucleophilic heteroatoms have also been employed; predominantly hydroxyl 
groups, used for the formation of both cyclic and acyclic propargyl ethers.  
Typically, the standard protocol for preparing ethers via an intermolecular Nicholas 
reaction requires use of the nucleophilic hydroxyl group in excess compared to the Co2(CO)6-
alkyne. For example, unsymmetrical ether 3.36, a precursor for a ring-closing metathesis 
reaction, was made in 76% yield by reacting 1 equiv of cobalt complex 3.34 with 5 equiv of 
alcohol 3.35 and BF3•OEt2 (Scheme 57);96 a molar equivalencies ratio that limits a competing 
homodimerization of the Co2(CO)6-propargyl alcohol. 97  
 
Scheme 57. Synthesis of unsymmetrical ether 3.36 via the Nicholas reaction. 
We expected that the Nicholas reaction could be applied to the synthesis of biologically 
relevant alkyne probes. However, employing the nucleophilic bioactive molecule in excess 
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would be uneconomical. Therefore, we set out to determine reaction conditions where the high-
value, nucleophilic species (bioactive compound) could be employed as the limiting reagent. 
3.2 RESULTS AND DISCUSSION 
3.2.1 Preparation of alcohol 3.40 as a model system. 
In order optimize Nicholas reaction conditions for use of high-value, nucleophilic species 
as the limiting reagent, molecularly complex alcohol model 3.40 was prepared in 3 steps from 
allylboronate 3.37, previously synthesized in our group (Scheme 58).98 Addition of allylboronate 
3.37 (2.8:1 mixture of Z:E alkene isomers) to phenylpropynal 2.22 followed by lactonization 
gave a 2.4:1 ratio of the trans- and cis-lactone 3.38 in 85% yield. The stereochemical 
identification of the trans-and cis-1.38 isomers was confirmed using the coupling of proton Ha 
with comparison to an X-ray crystal structure of α-methylene-γ-butyrolactone 2.26a, as 
discussed in Section 2.2.4.42  Trans-3.38a has a Jab of 5.2 Hz, while cis-3.38b has a coupling 
constant of 8.0 Hz. These Jab values compare favorably to the trans- and cis- isomers of 2.28 
published previously, which have coupling constants for Ha of 6.0 Hz and 8.4 Hz respectively 
(Figure 19).42 
 Trans-3.38a was taken on; the acetal protecting group was removed to afford ketone 
3.39 in 77% yield. Reaction of 3.39 with sodium borohydride reduced both the ketone and 
methylene group, producing 3.40 in 76% yield (Scheme 58). Alcohol 3.40 was obtained as a 1: 1 
ratio of two diastereomers; the methylene group was reduced diastereoselectively while 
reduction of the ketone resulted in two stereoisomers.99 The relative geometry of the lactone ring 
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was determined by examining the 1H NMR spectra; Hc appears at 2.34 ppm as a doublet of 
quartets with the corresponding coupling constants of 10.8 and 6.6 Hz. The 10.8 Hz coupling 
constant between Hc and Hb, as well as the 9.0 Hz coupling between Hb and Ha indicates a 
trans,trans-relationship for the tri-substituted butyrolactone ring, which prefers an envelope 
conformation with the alkyl groups in the equatorial positions and hydrogens in the axial 
positions.100  
 
Scheme 58. Synthesis of molecularly complex model system 3.40. 
 
Figure 19. Comparison of coupling constants of 3.38 with previously synthesized 2.28. 
3.2.2 Optimization of the Nicholas reaction conditions 
The Nicholas reaction requires a dicobalt hexacarbonyl complexed alkyne with an 
adjacent oxygen leaving group. Co2(CO)6-propargyl alcohol 3.30a was prepared by stirring 
propargyl alcohol with Co2(CO)8 in DCM until bubbles (presumed to be evolution of CO gas) 
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were no longer observed. This procedure afforded complex 3.30a in quantitative yield. 3.30a is 
stable to air and moisture and was purified by silica gel chromatography (Scheme 59).  
 
Scheme 59. Cobalt complexation of propargyl alcohol to afford 3.30a. 
 With alcohol 3.40 and complex 3.30a in hand, optimization for propargylation of 
molecularly complex compounds via the Nicholas reaction began.  Alcohol 3.40 was used as the 
limiting reagent in all experiments. Initially, we examined the effects of various equivalencies of 
complex 3.30a and the Lewis acid, BF3•OEt2, while the order of reagent addition remained 
constant. Due to the multiple Lewis base coordination sites of alcohol 3.40 that could potentially 
compete for the Lewis acid, we predicted that the addition of the Co2(CO)6-propargyl alcohol 
3.30a to a stirring solution of BF3•OEt2, prior to the addition of 3.40, would allow efficient 
formation of the propargylic cation. In turn, complex 3.30a (2 equiv) and alcohol 3.40 (1 equiv) 
were added sequentially to a stirring solution of BF3•OEt2 (2.5 equiv) at 0 °C in DCM which 
afforded Co2(CO)6-propargyl ether 3.42 in 47% yield (Table 8, Entry 1). Increasing the 
equivalents of the BF3•OEt2 and complex 3.30a decreased the yield of 3.42 to 36% (Entry 2). 
Adding alcohol 3.40 dropwise also resulted in decreased yields of 3.42 (28%, Entry 3).  
These low yields led to examination of the reagent addition order. Inverting the addition 
of Co2(CO)6-propargyl alcohol 3.30a and alcohol 3.40 to the BF3•OEt2 solution did not have a 
significant effect on the yield of 3.42 (44%, Entry 4 compared to 47%, Entry 1). Next, alcohol 
3.40 and BF3•OEt2 were added sequentially to a solution of Co2(CO)6-propargyl alcohol 3.30a in 
DCM, an addition order more commonly seen in previous Nicholas reaction reports. Reacting 
3.40, 3.30a and BF3•OEt2 in molar equivalencies of 1:2:2.5 afforded Co2(CO)6-propargyl ether 
3.42 in 55% yield (Entry 5). Again, increasing equivalencies of alcohol 3.40 and the Lewis acid 
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decreased yield of 3.42 (22%, Entry 6). Despite the stability of 3.30a to air and moisture, it was 
reasoned that generation of the cobalt complex in situ from propargyl alcohol and dicobalt 
octacarbonyl may be advantageous. Stirring of propargyl alcohol (2 equiv) and Co2(CO)8 (2 
equiv) in DCM, followed by addition of alcohol 3.40 and BF3•OEt2 gave the highest yield of 
3.42 (60%, Entry 7). This protocol was used in subsequent experiments.  
Table 8. Optimization of the Nicholas reaction with alcohol 3.40. 
 
Entry Equiv  
(3.40:3.30a:BF3•OEt2) 
Order of 
Addition 
Temp (°C) Time (h) Yield  
1 1:2:2.5 LA, 3.30, 3.40 0 4.5 47% 
2 1:3:5 LA, 3.30, 3.40 0 4 36% 
3 1:2:2.5 LA, 3.30, 3.40a 0 4 28% 
4 1:2:2.5 LA, 3.40, 3.30 0 4.5 44% 
5 1:2:2.5 3.30, 3.40, LA 0 4  55% 
6 1:3:5 3.30, 3.40, LA 0 5  22% 
7 1:2:2.5 3.30, 3.40, LAb 0 3.5 60% 
8 1:2:2.5 3.30, 3.40, LA -40 3.5 23% 
9 1:2:2.5 3.30, 3.40, LA -10 3.5 38% 
LA: Lewis Acid, aAlcohol 3.40 was added dropwise over 5 min.b3.30a was generated in situ from 
propargyl alcohol and dicobalt octacarbonyl. 
 
 
Efforts were made to increase mass balance and decrease material on the baseline of the 
TLC by lowering the reaction temperature. The reaction was performed at -40 ºC and -10 ºC, 
which afforded 3.42 in 23% and 38% yield, respectively (Entries 8, 9). Both of these 
experiments were quenched after 3.5 h because degradation of the product was observed over 
time by TLC. Further experiments showed that extended reaction times resulted in lower yields 
suggesting that 3.42 may not be stable in the reaction media. 
All experiments also afforded byproduct 3.43 resulting from homodimerization of excess 
3.30a (Figure 20).101 Formation of this byproduct is the reason the nucleophilic species has 
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traditionally been used in high excess compared to the cobalt complex. However, byproduct 3.43 
is non-polar and easily separable from 3.42 using column chromatography.  
 
Figure 20. Homodimerization of 3.30a results in byproduct 3.43. 
Decomplexation of Co2(CO)6-alkynes can be accomplished using an oxidant such as 
CAN. Stirring 3.42 with CAN for 10 minutes afforded 3.44 in 97% yield without the need for 
purification (Scheme 60). NMO was also employed as an oxidant but resulted in decomposition 
of 3.42.102 Evidence of cobalt decomplexation can be easily observed by comparison of the 1H 
and 13C NMR spectra for the cobalt complex and resulting alkyne. For the cobalt-complexed 
alkyne 3.42, the hydrogen on the terminus of the alkyne is observed at 6.01 ppm. The 
corresponding proton of 3.44 is shifted up-field to 2.39 ppm when the alkyne is decomplexed. 
Also, the carbonyl ligands bound to cobalt can be observed at 199.8 ppm in the 13C NMR 
spectrum for the complexed alkyne 3.42; this signal disappears upon decomplexation.  
 
Scheme 60. Decomplexation of 3.42 to afford propargyl ether 3.44. 
3.2.3 Testing the scope and limitations of the Nicholas reaction conditions on amino acid 
derived nucleophiles 
Next, we sought to establish the generality of these efficient Nicholas reaction conditions 
for the propargylation of a range of heteroatomic nucleophiles. Amino acids residues were 
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chosen for these experiments due to the wide variety of functionality available in a single 
compound class. In addition, alkyne-containing amino acid residues have been used in many 
click-chemistry applications.78b Alkynyl groups are most commonly installed onto amino acid 
residues by alkylating a heteroatom containing side chain using basic conditions, or by 
transforming the C-terminus carboxylic acid into an alkyne via Corey-Fuchs or Seyferth-Gilbert 
protocols.103 Therefore, the Nicholas reaction would provide a viable alternative for the synthesis 
of these unnatural alkynylated residues.   
N,O-protected amino acid derivatives were employed to examine reactions with the 
heteroatomic side chains. Continuing our investigation of aliphatic alcohols, N-Boc and N-Fmoc 
serine methyl esters 3.45a,b were subjected to the Nicholas reaction by our collaborator, John 
Widen (Table 9).  Stirring of N-Boc-ʟ-serine methyl ester (3.45a) with Co2(CO)6-propargyl 
alcohol (generated in situ) and BF3•OEt2 resulted in only a 20% yield of Co2(CO)6-propargyl 
ether 3.46a (Entry 1). Further analysis revealed that the majority of Co2(CO)6-propargyl alcohol 
had been consumed, presumably due to the competing homodimerization, and 76% of serine 
3.45a was recovered. Subjecting N-Fmoc-ʟ-serine ethyl ester (3.45b) gave a similar result, where 
Co2(CO)6-propargyl ether 3.46b was obtained in 29% yield and 63% of 3.46b was recovered 
(Entry 4). It was clear that the cobalt complexed propargylium ion was reacting faster with 
excess Co2(CO)6-propargyl alcohol 3.30a than with the hydroxyl group of serine.  
Through our weekly collaboration discussions, we decided to try alternative sources of 
the propargylium ion that would not undergo homodimerization. Many substituted oxygens have 
been employed in the Nicholas reaction as leaving groups, including but not limited to esters 
(Ac, Bz, Piv, MS, and Tf) as well as cyclic and non-cyclic ethers (Me, Bn, and TBS).93b We 
chose to test the dicobalt hexacarbonyl complexes of propargyl acetate (3.30b) and methyl 
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propargyl ether (3.30c) in the reactions with the serine derivatives 3.45a,b. Both reactions of 
Co2(CO)6-propargyl acetate 3.30b with 3.45a and 3.45b in the presence of BF3•OEt2 successfully 
afforded the Co2(CO)6-propargyl ethers 3.46a and 3.46b in 29% and 23% yield respectively, 
similar to the results obtained when Co2(CO)6-propargyl alcohol 3.30a was employed (Entries 2 
and 5). However, using Co2(CO)6-methyl propargyl ether 3.30c as the precursor for the 
propargylium cation resulted in significant improvements; 3.46a was afforded in 97% yield, a 5-
fold increase compared to the use of propargyl alcohol (Entry 3), while 3.46b was afforded in 
54% yield, representing a 2-fold increase in yield (Entry 6). By eliminating the possible 
homodimerization reaction of the propargylium ion, the hydroxyl group of the serine derivatives 
became the prominent nucleophilic species. Oxidative decomplexation of 3.46a,b with CAN 
readily gave propargyl ethers 3.47a and 3.47b, both in 90% yield (Scheme 61). 
Table 9. Propargylation of N-protected serine methyl esters 3.45a,b. 
 
Entry R R’ Yield 3.46 (%) 
1 Boc (3.45a) H (3.30a) 20 
2 Boc Ac (3.30b) 29 
3 Boc Me (3.30c) 97 
4 Fmoc (3.45b) H 29 
5 Fmoc  Ac 23 
6 Fmoc  Me 54 
  
 
Scheme 61. Oxidative decomplexation to afford alkynyl serine derivatives 3.47a,b. 
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Next, the Nicholas reaction conditions were applied to the propargylation of cysteine 
residues. While thiols have been used previously in the Nicholas reaction, examples have been 
limited, with most reports pertaining to the synthesis of sulfur containing macrocycles.104 
Cysteine residues have never been employed in the Nicholas reaction. Towards this end, N-
protected cysteine ethyl esters 3.49a,b were prepared (Scheme 62). N-Acetyl-ʟ-cysteine ethyl 
ester 3.49a was obtained in 33% yield, from ʟ-cysteine ethyl ester hydrochloride 3.48 using N,N-
diisopropylethylamine (DIEA) and acetyl chloride. This procedure has been previously used for 
the synthesis of N-acetyl-ʟ-cysteine methyl ester.105 N-Fmoc-ʟ-cysteine ethyl ester 3.49b was 
also prepared from 3.48 in 66% yield using DIEA and Fmoc-OSu.  
 
Scheme 62. Synthesis of N-protected cysteine ethyl esters 3.49a,b. 
These cysteine derivatives were first subjected to the Nicholas reaction with Co2(CO)6-
propargyl alcohol 3.30a. In the presence of 3.30a (generated in situ) and BF3•OEt2, N-acetyl-ʟ-
cysteine ethyl ester 3.49a readily afforded Co2(CO)6-propargyl thioether 3.50a in 86% yield 
(Table 10, Entry 1). N-Fmoc-ʟ-cysteine ethyl ester 3.49b afforded cysteine derivative 3.50b in 
71% yield (Entry 2). A comparison was made between the use of propargyl alcohol complex 
3.30a and methyl propargyl ether complex 3.30c for the synthesis of the Fmoc-cysteine example 
3.50b. Reacting 3.49b with complex 3.30c, formed in situ, gave a moderate yield of 58% for 
formation of 3.50b (Entry 3). Alternatively, when Co2(CO)6-methyl propargyl ether complex 
3.30c was prepared prior to the reaction, 3.50b was afforded in 67% yield (Entry 4). Overall, we 
concluded that for the cysteine examples, methyl propargyl ether complex 3.30c gives 
comparable results to the use of propargyl alcohol complex 3.30a. The increased nucleophilicity 
 114 
of the sulfhydryl group compared to the hydroxyl groups likely minimizes the competing 
homodimerization of 3.30a.  
Table 10. Propargylation of cysteine derivatives 3.49. 
 
Entry R R’ Time Yield 3.50 (%) 
1 Ac (3.49a) H 2 h 86 
2 Fmoc (3.49b) H 45 min 71 
3 Fmoc Me 2 h 58 
4 Fmoc Mea 2 h 67 
aCo2(CO)6-methyl propargyl ether was prepared prior to the reaction. 
 
Both Co2(CO)6-alkynes 3.50a and 3.50b underwent oxidative decomplexation with CAN 
which gave propargyl thioethers 3.51a and 3.51b in 83% and 92% respectively (Scheme 63). 
The reactions were clean, with no evidence of byproducts. We were concerned that the sulfur 
atoms may undergo oxidation in the presence of CAN to afford sulfoxides, however, this was not 
observed. The chemical shift for the α-hydrogens to the sulfur atom (Ha) were at about 3.1 ppm 
for all four compounds 3.50a,b and 3.51a,b. We would have expected the chemical shift of Ha to 
move downfield if the sulfur had been oxidized. Mass spec data obtained for 3.51a and 3.51b 
also confirmed the structures. 
 
Scheme 63. Oxidative decomplexation for the formation of alkynyl cysteine derivatives 3.51a,b. 
Phenolic nucleophiles were then examined by employing tyrosine amino acid derivatives. 
Only one example exists where a phenol was used as a nucleophile in a Nicholas reaction; during 
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the synthesis of unsymmetrical ethers, Co2(CO)6-hex-5-en-2-yn-1-ol (3.52) was reacted with 
BF3•OEt2 in the presence of phenol (3.53), followed by a cobalt decomplexation with CAN to 
afford the ether 3.54  in 60% yield.97  
 
Scheme 64. Previous example of a phenolic nucleophile in the Nicholas reaction. 
To evaluate the phenolic side chains of tyrosine in the Nicholas reaction, N-Boc- and N-
Fmoc-ʟ-tyrosine methyl esters 3.55a,b were employed. When our collaborator, John Widen, 
subjected N-Boc-ʟ-tyrosine methyl ester 3.55a to the Nicholas reaction conditions using 
Co2(CO)6-propargyl alcohol 3.30a, the desired product 3.56a was obtained consistently in 45% 
yield (Table 11, Entry 1). 3.55a was recovered in 22% while complex 3.30a was fully consumed, 
due to homodimerization. A byproduct was also been observed during the reaction, but was not 
isolated. When I repeated this reaction, I also observed two major products by TLC. The desired 
product 3.56a was obtained in 32% yield but the byproduct appeared to be unstable and was only 
obtained in trace amounts. After careful NMR analysis, we determined this byproduct to be 3.57 
(Figure 21), presumably resulting from an electrophilic aromatic substitution process.  
A key 1H NMR signal that led to the structure assignment was a new aromatic singlet at 
6.95 ppm (Ha). Also, the integration of the aromatic protons totaled three.  In addition, the 
signals at 6.07 and 4.10 ppm correspond to the presence of the Co2(CO)6-alkyne (Hd, Hh). The 
remaining proton assignments were made by comparison to literature values for 3.55a.106 Based 
on these assignments, the signal at 4.75 ppm represents phenolic proton (Hf); the presence of this 
signal also supports the proposed structure of 3.57. The regiochemistry of the propargyl 
substitution on the aryl ring was confirmed by comparing the aromatic region in the 1H NMR 
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spectrum of 3.57 to the 1H NMR spectra of 3,4-xylenol and 2,4-xylenol. For these trisubstituted 
aromatic rings, aromatic protons ortho to the hydroxyl group are observed at about 6.6 ppm 
while meta protons are observed at about 6.9 ppm. Both byproduct 3.57 and 2,4-xylenol had two 
aromatic signals at ~6.9 ppm and one aromatic signal at ~6.6 ppm. Also, substitution of 3.55a at 
the ortho position in relation to the hydroxyl group is expected when considering electrophilic 
aromatic substitution cationic intermediates. 
Table 11. Propargylation of N-protected tyrosine methyl esters 3.55a,b 
 
Entry R R’ Yield 3.56 (%) Time Observations 
 
1 
 
Boc (3.55a) 
 
H 
 
45 
 
1 h 
3.55a recovered in 22% Unstable 
byproduct 3.57 observed by TLC 
(Figure 21) 
 
2 
 
Boc  
 
Me 
 
23 
 
3 h 
 
Partial decomposition  
 
3 
 
Fmoc (3.55b) 
 
H 
 
6 
 
1 h 
 
3.55b recovered in 89% 
 
4 
 
Fmoc 
 
Me 
 
73 
 
1 h 
 
--- 
 
 
Figure 21. 1H NMR analysis of electrophilic aromatic substitution byproduct 3.57. 
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To avoid homodimerization of Co2(CO)6-propargyl alcohol 3.30a, Co2(CO)6-methyl 
propargyl ether 3.30c was employed. However, this did not result in an improved yield for the 
formation of Co2(CO)6-propargyl N-Boc-tyrosine 3.56a, which was isolated in 23% yield (Table 
11, Entry 2). We believe that the Boc protecting group was unstable under the extended reaction 
time required; a significant amount of baseline material was observed after the reaction. 
BF3•OEt2 has been reported as a viable deprotecting agent for Boc groups.107 
 However, for the conversion of N-Fmoc-ʟ-tyrosine methyl ester 3.55b to the 
corresponding Co2(CO)6-propargyl phenyl ether 3.56b, the precursor for the propargylium ion 
made a significant difference. When propargyl alcohol complex 3.30a was used, 3.56b was 
isolated in 6% yield and 89% of 3.55b was recovered (Entry 3). Alternatively, the reaction with 
methyl propargyl ether complex 3.30c afforded 3.56b in 73% yield (Entry 4). Evidence of a 
byproduct, presumably formed via electrophilic aromatic substitution, was also observed by TLC 
during these reactions with 3.55b, but was not isolated. The decomplexed propargyl phenyl ether 
derivative of tyrosine 3.58a and 3.58b were successfully obtained from the corresponding cobalt 
complexes in 75% and 81% respectively (Scheme 65).  
 
Scheme 65. Oxidative decomplexation of tyrosine derivatives 3.56a,b. 
In addition to the side chain hydroxyl and sulfhydryl groups, we examined the reactivity 
unprotected carboxyl and amino functionality of amino acids with the cobalt complexed 
propargylium ions. N-benzoyl-ᴅ-phenylalanine (3.59) was used to establish the reactivity of the 
carboxyl group as a nucleophile in the Nicholas reaction. To date, only two reports of using a 
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carboxylic acid in a Nicholas reaction have been reported. In the process of studying the use of 
chiral auxiliaries in the Nicholas reaction, Martin and coworkers transformed propargyl alcohols 
to propargyl acetates by employing acetic acid as the nucleophilic species.108 The Shea group has 
exploited this reactivity of carboxylic acids for the synthesis of macrocyclic diolides.109 Amino 
acids have never been used in the Nicholas reaction for the synthesis of propargylic esters. N-
benzoyl-ᴅ-phenylalanine 3.59 was reacted with complex 3.30a (generated in situ) and BF3•OEt2 
to afford the Co2(CO)6-propargylic ester 3.60 in 60% yield. Decomplexation of 3.60 with ceric 
ammonium nitrate generated propargyl ester 3.61 in 90% yield (Scheme 66).  
 
Scheme 66. Use of a carboxylic acid in the Nicholas reaction for formation of propargylic ester 3.61. 
Next, a serine derivative, N-benzyloxycarbonyl-ʟ-serine (3.62), containing an unprotected 
carboxylic acid was examined to determine if the cobalt-complexed propargylic cation reacted 
more readily with the aliphatic alcohol or the carboxylic acid.  Bis-propargylated serine 3.63 was 
obtained as the major product in 42% yield, resulting from alkylation of both the hydroxyl and 
the carboxyl groups. Co2(CO)6-complexed propargyl ester 3.64 was also isolated in 9% yield, 
suggesting that the carboxylic acid is more reactive than the aliphatic alcohol. When Co2(CO)6-
diyne 3.63 was reacted with excess CAN, diyne 3.66 was obtained in 94% yield (Scheme 67). 
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Scheme 67.  Result of employing N-Cbz-L-serine 3.62 in the Nicholas Reaction. 
 
Figure 22. 1H NMR analysis of Nicholas reaction products 3.63 and 3.64. 
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Structural assignment of byproduct 3.64 was determined by comparison of its 1H NMR 
spectrum with that of Co2(CO)6-diyne 3.63 (Figure 22). For both 3.63 and 3.64, the AB doublets 
at ~5.1 ppm were assigned to belong to He of the Cbz group by comparison to the N-Cbz-ʟ-serine 
3.62. For diyne 3.63, the singlet at 6.07 (Ha) and doublets at 5.37 and 5.24 ppm (Hd) represent 
the propargyl ester group, shifted downfield compared to the propargyl ether signals Hb and Hg 
(singlet at 6.00 ppm and signal at 4.63 ppm respectively). Analysis of the byproduct 3.64 
spectrum revealed propargyl signals represented by a singlet at 6.08 ppm (Ha) and doublets at 
5.43 and 5.33 ppm (Hd) consistent with the propargyl ester signals of 3.63. 
Next, amino groups were subjected to the Nicholas reaction conditions. When ʟ-proline 
methyl ester (3.67) was reacted with Co2(CO)6-propargyl alcohol 3.30a and BF3•OEt2,  
Co2(CO)6-propargyl amine 3.68 was not obtained. TLC analysis showed that upon addition of 
the Lewis acid, ʟ-proline methyl ester 3.67 was no longer present, but no product were observed 
(Table 12, Entry 1). We concluded that BF3•OEt2 immediately coordinates with the amine, 
preventing formation of 3.68. Next, Co2(CO)6-methyl propargyl ether 3.30c was employed and 
stirred with BF3•OEt2 for 30 minutes, prior to addition of proline derivative 3.67, however this 
experiment also resulted in no formation of 3.68 (Entry 2).  
For some previous Nicholas reaction reports where an amino group was used as the 
nucleophile in the Nicholas reaction, formation and isolation of the propargylium ion as a salt 
was achieved prior to the reaction by reacting the corresponding propargyl alcohol derivative 
with a protic acid, such as tetrafluoroboric acid (HBF4).110 We predicted that if Co2(CO)6-methyl 
propargyl ether 3.30c was reacted with HBF4, tetrafluoroborate salt 3.30d could be formed in 
situ without homodimerization, thereby allowing an efficient reaction with proline 3.67 to afford 
the desired product 3.68 (Scheme 68, desired result). To test this hypothesis, 3.30c was stirred 
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with HBF4 until consumed (30 min) followed by addition of proline 3.67 (Table 12, Entry 3). As 
a result, the 3.68 was not observed and 3.30c was regenerated (Scheme 68, observed result). 
Table 12. Propargylation of ʟ-proline methyl ester 3.67. 
 
Entry 3.30 (equiv) Acid (equiv) Comment Yield 
1 
 
3.30a, R = CH2OH (2 equiv) BF3·OEt2 (2.5 equiv) --- 0% 
2 3.30c, R = CH2OMe (1.5 equiv) BF3· OEt2 (1.5 equiv) 3.30c and BF3· OEt2 stirred for 
30 min before addition of 3.67 
 
 
0% 
3 3.30c, R = CH2OMe (1.5 equiv) HBF4/OEt2 (1.5 equiv) 3.30b and HBF4 stirred for 30 
min before addition of 3.67 
 
 
0% 
4 3.30d, R = CH2+(-BF4) (1.5 equiv) --- 3.30d used 14 h after isolation 
 
31% 
5 3.30d, R = CH2+(-BF4) (1.3 equiv) --- 3.30d  used 14 h after isolation 
 
46% 
6 3.30d, R = CH2+(-BF4) (1.3 equiv) --- 3.30d  had been stored in glove 
box for 2 weeks 
19% 
 
 
Scheme 68. Desired result compared to actual result for Entry 3 of Table 12. 
In turn, we decided to isolate the tetrafluoroborate propargylium salt 3.30d. An Organic 
Syntheses procedure for this transformation reacts Co2(CO)6-propargyl alcohol 3.30a with HBF4 
in propionic anhydride.111 However, in our hands, use of propionic anhydride as the solvent did 
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not afford salt 3.30d; precipitation was never observed. As a result we decided to use diethyl 
ether as the solvent for this transformation because 3.30a is soluble in ether, while the salt 3.30d 
is not. Co2(CO)6-propargyl alcohol 3.30a was reacted with HBF4 in diethyl ether at -10 °C. 
Precipitation of 3.30d was observed and removal from the ethereal solution was obtained using a 
Schlenk filtration apparatus. 3.30d is sensitive to air and water and therefore was both isolated 
(57% yield) and stored in a nitrogen filled glove box (Scheme 69).  
 
Scheme 69.  Synthesis of propargylium cation tetrafluoroborate salt 3.30d. 
ʟ-Proline methyl ester 3.67 was reacted with 1.5 equiv of 3.30d in DCM at 0°C to 
successfully afford Co2(CO)6-propargyl amine 3.68 in 31% yield after 1.5 h (Table 12, Entry 4). 
Reducing the amount of 3.30d to 1.3 equiv increased the yield of 3.68 to 46% (Entry 5). For both 
of these reactions, salt 3.30d was used within 14 h of isolation. Over time, the salt changes from 
a deep red color to a darker maroon/brown color. When salt 3.30d was reacted with proline 3.67 
after being stored in the glove box for 2 weeks, the yield of 3.68 suffered (19%, Entry 6). This 
revealed that 3.30d is unstable, even when stored under nitrogen.  
With 3.68 in hand, decomplexation to obtain the proline derived propargyl amine 3.69 
was attempted. Unfortunately, 3.69 was determined to be unstable (Scheme 70). When 3.38 was 
reacted with 4 equiv of CAN, 3.68 and 3.69 were obtained as a mixture. Increasing the amount 
of CAN to 5 equivalents resulted in complete decomposition. By reacting 3.68 with 4 equiv of 
CAN for 1 h, and then an additional 0.5 equiv of CAN for 20 min, 3.69 was obtained in 68% 
yield and was characterized by NMR spectroscopy, HRMS, and TLC analysis before undergoing 
non-specific decomposition. Attempts to repeat this result were unsuccessful. Additional 
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oxidizing agents were examined. Stirring of 3.68 in the presence of trimethylamine oxide112 
resulted in decomposition while iron(III) nitrate nonahydrate was unreactive, resulting in 
recovery of 3.68.113 
 
Scheme 70. Decomplexation of proline derivative 3.68. 
Next, ʟ-phenylalanine methyl ester (3.70) was subjected to the Nicholas reaction, 
allowing us to ascertain the reactivity of primary amino groups as nucleophiles.  Reaction of 3.70 
with tetrafluoroborate salt 3.30d in DCM at 0 °C fo 1.5 h afforded 3.71 in 59% yield, resulting 
from dipropargylation of the primary amino group. Decomplexation in the presence of CAN (8 
equiv) gave the dipropargyl amine 3.72 in 56% yield (Scheme 71).  
 
Scheme 71. Reaction of ʟ-phenylalanine methyl ester (3.70) with 3.30d followed by decomplexation. 
 
To effect mono-propargylation of primary amines, we increased the steric bulk of the 
tetrafluoroborate propargylium cation. The Co2(CO)6-2-methyl-3-butyn-2-ol was prepared in 
92% yield from 3.73. In turn, Co2(CO)6-2-methyl-3-butyn-2-ol was stirred with HBF4 in diethyl 
ether to afford tetrafluoroborate salt 3.74 in 36% yield (Scheme 72). Addition of ʟ-phenylalanine 
methyl ester 3.70 to 3.74 afforded the corresponding Co2(CO)6-alkyne in 23% yield. No 
evidence of the dipropragylation product was observed. Decomplexation afforded alkyne 3.75 in 
64% yield. Next, one of the most effective nucleophiles tested, N-Fmoc-ʟ-cysteine ethyl ester 
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3.49b was reacted with 3.74 to determine its relative reactivity compared to the use of complex 
3.30a and BF3•OEt2. Co2(CO)6-alkyne 3.76 was obtained in 55% yield; a moderate yield 
compared to the 71% yield of 3.50b without the gem-dimethyl groups obtained when using 
Co2(CO)6-propargyl alcohol 3.30a and BF3•OEt2 (Table 10, Entry 2). Cobalt decomplexation 
afforded 3.77 in 46% yield.   
 
Scheme 72. Synthesis of 3.74 and its application to the formation of 3.75 and 3.77. 
3.2.4 The synthesis of sesquiterpene lactone alkyne probes 
Finally, we used the optimized Nicholas reaction conditions for propargylation of high-
value substrates to synthesize alkyne probes of sesquiterpene analogs. trans-Guaianolide analog 
1.83, which is unstable to basic conditions, was reacted with Co2(CO)6-propargyl alcohol 3.30a, 
formed in situ, and BF3•OEt2, to afford Co2(CO)6-alkyne derivative 3.78 in 46% yield (Scheme 
73). Employing complex 3.30a isolated prior to the reaction gave a lower yield of 30% for 3.78. 
Due to the limited quantities of 1.83 available, attempts to synthesize 3.78 using Co2(CO)6-
methyl propargyl ether 3.30c were not carried out, however, this protocol may improve yields. 
3.78 was decomplexed using CAN to afford the guaianolide analog alkyne probe 3.79 in 
quantitative yield. 
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Scheme 73. Synthesis of guaianolide analog alkyne probe 3.79. 
Next, the synthesis of MelB alkyne probe derivative 3.81 was pursued (Table 13). First, 
MelB 3.29 was reacted Co2(CO)6-proparyl alcohol 3.30a, formed in situ, and BF3•OEt2. 3.80 
formed immediately, as determined by TLC. However, Mel B 3.29 was not fully consumed so 
the reaction stirred for 45 min. Over this time, decomposition of Co2(CO)6-alkyne 3.80 was 
observed and isolated in only 20 % yield (Entry 1). Due to the observed product degradation, the 
reaction was repeated but only allowed to stir for 10 min, which doubled the isolated yield of 
3.80 to 41% (Entry 2). Methyl propargyl ether complex 3.30c was next employed in place of 
propargyl alcohol complex 3.30a. When this reaction was allowed to stir for 1.5 h, 3.80 was 
obtained in 21% yield (Entry 3). Significant degradation had been observed (by TLC) after 40 
minutes during this reaction; therefore, the reaction was repeated but stirred for only 40 min 
which afforded 3.80 in 39% yield. For this example, use of propargyl alcohol and methyl 
propargyl ether gave comparable results.  
Table 13. Synthesis of MelB cobalt complexed alkyne probe 3.80. 
 
Entry R (3.30) Time Yield (%) 
1 H (3.30a) 45 min 20 
2 H  10 min 41 
3 Me (3.30c) 1.5 h 21 
4 Me  40 min 39 
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Oxidative decomplexation of Co2(CO)6-alkyne 3.80 was the final step towards synthesis 
of a MelB alkyne probe. Reaction of 3.80 with ceric ammonium nitrate in acetone cleanly 
afforded 3.81 in 94% yield (Scheme 74). 
 
Scheme 74. Oxidative decomplexation of 3.80 to afford propargylated Mel B 3.81. 
3.3 CONCLUSIONS 
In conclusion, the Nicholas reaction offers an acid-mediated propargylation strategy for 
the preparation of biologically relevant alkyne probes. Conditions were optimized to allow high-
value small molecules to be employed as the limiting reagent compared to the cobalt complexed 
propargyl synthons and Lewis acid. A variety of heteroatom nucleophiles can be propargylated 
using this method, including hydroxyl, sulfhydryl, amino, and carboxyl groups. The 
corresponding alkynyl derivatives were obtained after oxidative decomplexation using ceric 
ammonium nitrate. 
Multiple cobalt complexed propargylium ion precursors were compared for various 
nucleophilic species. Dicobalt hexacarbonyl complexed propargyl alcohol is the preferred 
precursor for highly reactive nucleophilic species due to its low cost and volatility compared to 
methyl propargyl ether. However, for less nucleophilic heteroatoms, use of dicobalt 
hexacarbonyl complexed methyl propargyl ether avoids the competing homodimerization of the 
propargyl synthon, allowing the desired nucleophilic species to react selectively. Finally, 
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propargylium tetrafluoroborate salts allow proparylation of amino groups. Primary amino groups 
can be selectively mono- or di-propargylated depending on the steric nature of the propargylium 
salt. 
This alternative, non-basic, propargylation protocol was compatible with a wide range of 
functionality. Both ethyl and methyl carboxyl protecting groups were tolerated but not directly 
compared. Carboxybenzyl, fluorenylmethoxycarbonyl, acetyl, and benzoxy amino protecting 
groups were well tolerated with some variability in yields observed when various protecting 
groups were used on the same parent amino acid. tert-Buyloxycarbonyl protecting group was 
tolerated when employed on a serine derivative, however, when used on a tyrosine derivative, 
evidence of protecting group instability was observed, resulting in low yields of the Nicholas 
reaction product. The Lewis acid being used, borontrifluoride diethyl etherate has been shown to 
be an effective deprotecting agent for Boc groups.107 Functionally dense natural product analogs 
containing reactive covalent modifiers such as α-methylene-γ-butyrolactones and epoxides were 
also tolerated, allowing the synthesis of potential biological probes. 
3.4 EXPERIMENTALS 
3.4.1 General Methods 
All commercially available compounds were used as received unless otherwise noted. 
Dichloromethane (DCM), diethyl ether (Et2O), and tetrahydrofuran (THF) were purified by 
passing through alumina using a solvent purification system. Deuterated chloroform (CDCl3) 
was stored over 4 Å molecular sieves. Boron trifluoride diethyl etherate (BF3•OEt2) was or 
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redistilled under a nitrogen atmosphere. Dicobalt octacarbonyl (Co2(CO)8) was used as 
purchased and was stored at -20 ºC and opened only in a nitrogen filled glove box. Purification 
of compounds by manual flash column chromatography was performed using silica gel (40-63 
μm particle size, 60 Å pore size) purchased from Sorbent Technologies. TLC analyses were 
performed on Silicycle SiliaPlate G silica gel glass plates (250 μm thickness) and visualized by 
UV irradiation (at 254 nm) and KMnO4 stain. 1H NMR and 13C NMR spectra were recorded on 
Bruker Avance 300 MHz, 400 MHz, 500 MHz, or 600 MHz. Spectra were referenced to residual 
chloroform with or without 0.05% v/v TMS (7.26 ppm, 1H; 77.16 ppm, 13C). Chemical shifts are 
reported in ppm, multiplicities are indicated by s (singlet), bs (broad singlet), d (doublet), t 
(triplet), q (quartet), p (pentet), and m (multiplet). Coupling constants, J, are reported in hertz 
(Hz). All NMR spectra were obtained at room temperature.  IR spectra were obtained using a 
Nicolet Avatar E.S.P. 360 (NaCl plate) FT-IR. ESI mass spectrometry was performed on a 
Waters Q-TOF Ultima API, Micromass UK Limited. 
The synthesis of the following compounds were completed by John Widen, from the 
Harki group at the University of Minnesota (Figure 23). Characterization for these compounds 
are included in the manuscript “Alkyne Ligation Handles: Propargylation of Hydroxyl, 
Sulfhydryl, Amino, and Carboxyl Groups via the Nicholas Reaction,” by Sarah M. Wells, John 
C. Widen, Daniel A. Harki, and Kay M. Brummond, submitted for publication 7/16/2016. 
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Figure 23. Compounds synthesized and characterized by collaborator John Widen. 
3.4.2 General Procedures  
 
General Procedure 3A: Coordination of alkyne to cobalt carbonyl complex. A 
single-necked, round-bottomed flask, equipped with a stir bar and a septum, was charged with 
Co2(CO)8 (1 equiv) in a N2 filled glove box. The flask was transferred out of the glove box and 
the septum was pierced with a nitrogen inlet needle.  The flask was charged with DCM, followed 
by the alkyne (1 equiv), dissolved in DCM. The reaction stirred for 2 h, until evolution of CO 
gas, visible by small bubbles, was no longer observed. The contents were loaded directly onto a 
silica gel column for purification by flash column chromatography to afford the dicobalt 
hexacarbonyl complexed alkyne (Co2(CO)6-alkyne). 
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General Procedure 3B: Formation of tetra fluoroborate salts. A flame-dried 100 mL 
Schlenck flask equipped with a stir bar and septum was charged with either Co2(CO)6-propargyl 
alcohol 3.30a or Co2(CO)6-2-methyl-3-butyn-2-ol (3.S1), dissolved in Et2O. The flask was 
cooled to -10 °C on an ice/acetone bath. Tetrafluoroboric acid (54% by weight soln in Et2O, 1.5 
equiv) was added dropwise and the solution stirred for 2 h. Formation of a dark red precipitate 
was observed. The reaction was diluted with Et2O. The septum was replaced with a Schlenk 
filtration apparatus. The apparatus was inverted and partial vacuum was applied to separate the 
solid from the Et2O solution within the apparatus. The ether filtrate was removed via syringe and 
the crystals were dried under vacuum. The apparatus was transferred to the nitrogen filled glove 
box, where the crystals were isolated and stored.  
General Procedure 3C: Nicholas Reaction Procedures 
 
General Procedure 3C.1: Use of pre-made Co2(CO)6-alkyne.  A single-necked, round-
bottomed flask equipped with a stir bar and a septum pierced with a needle was charged with 
DCM (0.05 M), Co2(CO)6-propargyl alcohol 3.30a or Co2(CO)6-methyl propargyl ether 3.30c (2 
equiv), and the nucleophilic species (1 equiv). The solution was cooled in an ice bath to 0 °C. 
BF3•OEt2 (2.5 equiv) was added dropwise and the reaction stirred until the nucleophile was fully 
consumed, or the reaction was no longer progressing, as determined by TLC. The reaction was 
quenched by the addition of saturated NaHCO3. The mixture was transferred to a separatory 
funnel, the layers were separated and the aqueous layer was extracted with DCM (3x). The 
combined organics were dried over MgSO4, filtered, and concentrated under reduced pressure. 
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The crude residue was purified by silica gel flash column chromatography to afford the 
Co2(CO)6-alkyne. 
 
General Procedure 3C.2: In situ formation of dicobalt hexacarbonyl complexed 
alkyne. A single necked, round-bottomed flask, equipped with a stir bar and a septum was 
charged with Co2(CO)8 (2 equiv) in a N2 filled glove box. The flask was transferred out of the 
glovebox and the septum was pierced with a nitrogen inlet needle. Either propargyl alcohol or 
methyl propargyl ether (2 equiv), dissolved in DCM, was added and the reaction stirred for 1.5 h 
until evolution of CO gas was no longer observed. The solution was cooled to 0 °C in an ice 
bath. The nucleophilic species (1 equiv) was dissolved in DCM (0.05 M overall) and added to 
the flask via syringe, followed by the dropwise addition of BF3•OEt2 (2.5 equiv). The reaction 
stirred until the nucleophilic species was fully consumed, or the reaction was no longer 
progressing, as determined by TLC. The reaction was quenched by addition of saturated 
NaHCO3. The mixture was transferred to a separatory funnel, the layers were separated, and the 
aqueous layer was extracted with DCM (3x). The combined organic layers were dried over 
MgSO4, filtered, and concentrated under reduced pressure rotary evaporation. The crude residue 
was purified by silica gel flash column chromatography to afford the Co2(CO)6-alkyne. 
 
General Procedure 3C.3: Reaction of Tetrafluoroborate salts with nucleophiles. A 
single-necked, round-bottomed flask, equipped with a stir bar and a septum was charged with the 
propargylium tetrafluoroborate salt (1.3 equiv) in a N2 filled glove box. The flask was transferred 
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out of the glove box and the septa was pierced with a N2 inlet needle. The flask was cooled to 0 
°C in an ice and water bath. DCM was added followed by the amino nucleophile (1 equiv) 
dissolved in DCM (0.05 M overall). The reaction stirred for 2 h or until complete as determined 
by TLC. The reaction was quenched by the addition of saturated NaHCO3. The mixture was 
transferred to a separatory funnel; the layers were separated and the aqueous layer was extracted 
with DCM (3x). The combined organics were dried over MgSO4, filtered, and concentrated 
under reduced pressure rotary evaporation. The crude residue was purified by silica gel flash 
column chromatography to afford the Co2(CO)6-alkyne. 
 
General Procedure 3D: Oxidative Decomplexation of Co2(CO)6-alkynes. A single-
necked, round-bottomed flask, equipped with a stir bar and a septum pierced with a N2 inlet 
needle was charged with the Co2(CO)6-alkyne (1 equiv), dissolved in acetone (0.01 M).  The 
solution was cooled in an ice bath to 0° C. Ceric ammonium nitrate (CAN, 5 equiv) was added to 
the flask in a single portion. The reaction stirred until complete as evidenced by TLC. The 
reaction was diluted with distilled water and Et2O. The mixture was transferred to a separatory 
funnel. The layers were separated and the aqueous layer was extracted with Et2O (3x). The 
combined organics were dried over MgSO4, filtered, and concentrated under reduced pressure 
rotary evaporation. If necessary, the residue was purified by silica gel flash column 
chromatography to afford the alkyne. 
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3.4.3 Experimental procedures with compound characterization data 
Trans and cis-4-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)-
3-methylene-5-(phenylethynyl) dihydrofuran-2(3H)-
one (3.38a,b). A 2 mL vial equipped with a stir bar and 
cap pierced with a nitrogen inlet needle was charged with a solution of Z/E (2.8: 1) allylboronate 
3.37 (43 mg, 0.13 mmol, 1 equiv) in toluene (0.7 mL) followed by a solution of 3-
phenylpropioaldehyde (33 mg, 0.25 mmol, 2 equiv) in toluene (0.3 mL). The vial was lowered 
into a preheated oil bath (70 °C) and stirred for 6 d. The solution was cooled to RT and quenched 
by a 9:1 by volume solution of saturated ammonium chloride and ammonium hydroxide (7 mL). 
The contents were transferred to a separatory funnel and extracted with EtOAc (3 x 8 mL). The 
combined organics were dried over MgSO4, gravity filtered, and concentrated using reduced 
pressure rotary evaporation. The crude material was purified by silica gel flash column 
chromatography (gradient of 10-20% ethyl acetate in hexanes) to afford 18 mg of trans-lactone 
3.38a, 9 mg of a mixture of trans- and cis-lactones 3.38a,b (1 : 1.3), and 6 mg of a mixture of 
trans- and cis-lactones 3.38a,b (1 : 3.0) in an overall 85% yield, as clear oils. Cis- and trans-
configurations were determined by comparison to previous literature, where an X-ray was 
obtained for a trans-lactone compound.42 
Data for 3.38a,b 
1H NMR Trans-3.38a (400 MHz, CDCl3): 7.45-7.36 (m, 2H), 7.35-7.31 (m, 3H), 6.35 (d, J 
= 2.4 Hz, 1H), 5.69 (d, J = 2.4 Hz, 1H), 4.98 (d, J = 5.2 Hz, 1H), 4.00-3.91 (m, 
4H), 3.20-3.19 (m, 1H), 1.90-1.79 (m, 4H), 1.34 (s, 3H) ppm; 
Cis-3.38b (500 MHz, CDCl3): 7.46-7.44 (m, 2H), 7.35-7.32 (m, 3H), 6.33 (d, J = 
3.0 Hz, 1H), 5.65 (d, J = 3.0 Hz, 1H), 5.48 (d, J = 8.0 Hz, 1H), 3.96-3.90 (m, 4H), 
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3.24-3.17 (m, 1H), 2.01-1.94 (m, 2H), 1.92-1.83 (m, 1H), 1.81-1.76 (m, 1H), 1.34 
(s, 3H) ppm; 
Impurities seen at 1.55, 1.25, 0.88 ppm. 
13C NMR Trans-3.38a (100 MHz, CDCl3): 169.4, 137.7, 132.0 (2C), 129.3, 128.5 (2C), 
123.3, 121.7, 109.5, 88.0, 85.2, 72.5, 65.0, 64.9, 47.0, 35.8, 27.5, 24.1 ppm; 
Cis-3.38b (125 MHz, CDCl3): 169.7, 137.7, 132.0 (2C), 129.3, 128.5 (2C), 122.5, 
121.7, 109.7, 89.9, 82.3, 71.6, 64.9, 64.8, 43.3, 36.1, 24.5, 23.9 ppm; 
Impurities seen at 104.5, 22.8, 14.3 ppm. 
IR  (thin film) 
2981, 2930, 2884, 2233, 1771, 1491, 1444, 1264, 1132, 1064, 759, 692 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C19H21O4, 313.1434; found, 313.1433; 
TLC  Trans-3.38a: Rf = 0.25 (30% ethyl acetate in hexanes) 
 Cis-3.38b: Rf = 0.18 (30% ethyl acetate in hexanes) 
 Silica gel, UV 
Trans-3-methylene-4-(3-oxobutyl)-5-(phenylethynyl)dihydrofuran-2(3H)-
one (3.39). A 2 mL vial equipped with stir bar and cap pierced with a nitrogen 
inlet needle was charged with pyridinium p-toluenesulfonate (7 mg, 0.029 
mmol, 0.5 equiv), followed by dioxolane trans-S2a (18 mg, 0.058 mmol, 1 equiv) dissolved in 
acetone (1 mL). The vial was lowered into a preheated oil bath (60 ºC) and stirred for 15 h. 
When the reaction was complete, as evidenced by TLC, the oil bath was removed and the vial 
cooled to RT. The reaction was diluted with EtOAc (4 mL). The contents were transferred to a 
separatory funnel, and washed with water (2 x 6 mL) followed by brine (6 mL). The organics 
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were dried over MgSO4, gravity filtered, and concentrated under reduced pressure rotary 
evaporation. The crude residue was purified by silica gel flash column chromatography (20% 
EtOAc in hexanes) to afford 12 mg of 3.39 in 77% yield as a colorless oil. 
Data for 3.39  
1H NMR (400 MHz, CDCl3) 
7.45-7.42 (m, 2H), 7.40-7.31 (m, 3H), 6.36 (d, J = 2.8 Hz, 1H), 5.69 (d, J = 2.4 
Hz, 1H), 4.94 (d, J = 5.6 Hz, 1H), 3.24-3.19 (m, 1H), 2.74-2.64 (m, 2H), 2.17 (s, 
3H), 2.16-2.07 (m, 1H), 1.94-1.84 (m, 1H) ppm; 
13C NMR (100 MHz, CDCl3) 
207.0, 169.1, 137.4, 132.0 (2C), 129.4, 128.6 (2C), 123.3, 121.5, 88.3, 85.0, 72.4, 
46.2, 39.7, 30.3, 26.3 ppm; 
IR  (thin film) 
2921, 2852, 2233, 1769, 1714, 1491, 1444, 1408, 1364, 1268, 1130, 985, 759, 691 
cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C17H17O3, 269.1172; found, 296.1168; 
TLC   Rf = 0.22 (30% EtOAc in hexanes) 
Silica gel, UV 
4-(3-Hydroxybutyl)-3-methyl-5-(phenylethynyl)dihydrofuran-2(3H)-one 
(3.40). A 10 mL, single-necked, round-bottomed flask equipped with a stir bar 
and a septum pierced with a needle was charged with ketone 3.39 (52 mg, 0.19 
mmol, 1 equiv), dissolved in methanol (2.5 mL). The solution was cooled in an ice bath to 0 °C. 
Sodium borohydride (11 mg, 0.29 mmol, 1.5 equiv) was added in a single portion and the 
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reaction was stirred at 0 °C for 2 h, until complete as evidenced by TLC. The ice bath was 
removed and the reaction was quenched by adding 5% AcOH in water solution (6 mL). The 
reaction contents were transferred to a separatory funnel; the aqueous layer was separated and 
extracted with Et2O (3 x 8 mL). The combined organic layers were washed with saturated 
NaHCO3 (10 mL) and brine (10 mL), dried over MgSO4, gravity filtered, and concentrated using 
reduced pressure rotary evaporation. The crude material was purified by silica gel flash column 
chromatography (gradient of 30-40% EtOAc in hexanes) to afford 41 mg of alcohol 3.40 (76% 
yield) as a colorless oil. The product was obtained as a 1:1 mixture of diastereomers that were 
inseparable by column chromatography. 
Data for 3.40  
1H NMR (600 MHz, CDCl3) 
7.47-7.42 (m, 2H), 7.38-7.30 (m, 3H), 4.82 (d, J = 9.0 Hz, 1H), 3.90-3.83 (m, 
1H), 2.34 (dq, J = 10.8, 6.6 Hz, 1 H), 2.33-2.24 (m, 1H), 1.92-1.85 (m, 0.5H)*, 
1.81-1.58 (m, 3.5 H), 1.35 (d, J = 6.6 Hz, 1.5H), 1.34 (d, J = 6.6 Hz, 1.5H)*, 1.24 
(d, J = 7.2 Hz, 1.5H), 1.23 (d, J = 7.2 Hz, 1.5H)* ppm 
Trace impurities are observed at 6.4, 5.7, 5.0, 4.7, 3.0, 2.1 ppm. 
13C NMR (100 MHz, CDCl3) 
177.8, 131.9 (2C), 129.2, 128.6 (2C), 121.8, 88.0, 85.00, 84.97*, 73.02, 73.01*, 
68.1, 67.8*, 51.0, 50.8*, 41.3, 36.6, 36.4*, 28.3, 28.1*, 24.0, 23.9*, 14.6, 14.5* 
ppm; 
* Discernable signal for 1 of 2 diastereomers 
IR  (thin film) 
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3430, 3059, 2969, 2934, 2360, 2232, 1780, 1491, 1456, 1331, 1166, 992, 759, 692 
cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C17H21O3, 273.1485; found, 273.1468; 
TLC   Rf = 0.24 (40% EtOAc in hexanes) 
Silica gel, UV, potassium permanganate 
Dicobalt hexacarbonyl complexed propargyl alcohol 3.30a.94 Followed 
general procedure 3A: Co2(CO)8 (793 mg, 2.3 mmol, 1.3 equiv), DCM (1.5 mL), propargyl 
alcohol (0.10 mL, 1.8 mmol, 1 equiv), dissolved in DCM (2.5 mL). The reaction was stirred for 2 
h. The silica gel flash column chromatography was run with a gradient of 10-20% EtOAc in 
hexanes to afford 615 mg of Co2(CO)6-propargyl alcohol 3.30a in quantitative yield, as a dark 
red solid.  
Data for 3.30a 
MP  48-52 °C 
1H NMR (300 MHz, CDCl3) 
 6.08 (s, 1H), 4.81 (d, J = 6.0 Hz, 2H), 1.79 (t, J = 6.0 Hz, 1H) ppm; 
TLC  Rf = 0.28 (10% EtOAc in hexanes) 
Silica gel, visible (red) 
Dicobalt hexacarbonyl complexed 2-methyl-3-butyn-2-ol (3.S1).94 Followed 
general procedure 3A: Co2(CO)8 (1.37 g, 4.0 mmol, 1.0 equiv), DCM (15 mL), 2-methyl-3-
butyn-2-ol (344 mg, 4.0 mmol, 1 equiv), dissolved in DCM (5 mL). The reaction was stirred for 
2 h. The silica gel flash column chromatography was run with a gradient of 10-30% EtOAc in 
hexanes to afford 1.36 g of Co2(CO)6-2-methyl-3-butyn-2-ol 3.S1 in 92% yield, as a red solid.  
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Data for 3.S1  
MP  37.9-40.1 °C 
1H NMR (300 MHz, CDCl3) 
 6.03 (s, 1H), 1.71 (s, 1H), 1.59 (s, 6H) ppm; 
 Impurities observed at 1.54, 1.27, 0.88 ppm 
TLC  Rf = 0.26 (20% diethyl ether in hexanes) 
Silica gel, visible (red) 
Dicobalt hexacarbonyl complexed methyl propargyl ether 3.30c. Followed 
general procedure 3A: Co2(CO)8 (195 mg, 0.57 mmol, 1 equiv), DCM (1.5 mL), methyl 
propargyl (40 mg, 0.57 mmol, 1 equiv), dissolved in DCM (3.0 mL). The reaction was stirred for 
1.5 h. The silica gel flash column chromatography was run with a gradient of 0-2.5% Et2O in 
hexanes to afford 94 mg of 3.30c in 45% yield, as a dark red oil. Drying under high vacuum was 
not performed due to volatility. 
Data for 3.30c  
1H NMR (300 MHz, CDCl3) 
  6.06 (s, 1H), 4.60 (s, 2H), 3.49 (s, 3H) ppm; 
TLC  Rf = 0.59 (10% Et2O in hexanes) 
Silica gel, visible (red) 
α-(Ethynyl)dicobalt hexacarbonyl carbonium tetrafluoroborate salt 
3.30d.94 Follows General procedure 3B: Co2(CO)6-propargyl alcohol (500 
mg, 1.46 mmol, 1 equiv), Et2O (5 mL), HBF4 (356 mg of a 54% by weight soln in Et2O, 2.19 
mmol, 1.5 equiv). The reaction was diluted with Et2O (20 mL) prior to filtration and drying 
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which afforded 601 mg of salt 3.30d in 60% yield as a red solid. Due to sensitivity to water and 
air, the salt was stored in the glove box and used within 24 h of isolation for 
best results.  
α-(Dimethylethynyl)dicobalt hexacarbonyl carbonium tetrafluoroborate 
salt 3.74.94 Follows General procedure 3B: Co2(CO)6-2-methyl-3-butyn-2-ol 3.S1 (774 mg, 2.09 
mmol, 1 equiv), Et2O (10 mL), HBF4 (509 mg of a 54% by weight in Et2O, 3.14 mmol, 1.5 
equiv). The reaction was diluted with Et2O (10 mL) prior to filtration and drying which afforded 
558 mg of salt 3.74 in 61% yield as a red solid. Due to sensitivity to water and air, the salt was 
stored in the glove box and used within 24 h of isolation for best results. 
Dicobalt hexacarbonyl complexed 3-methyl-5-(phenylethynyl)-4-(3-
(prop-2-yn-1-yloxy)butyl)dihydrofuran-2(3H)-one (3.42). Method A: 
Follows general procedure 3C.1: Co2(CO)6-propargyl alcohol complex 
3.30a (25 mg, 0.073 mmol, 2 equiv), alcohol 3.40 (10 mg, 0.037 mmol, 1 equiv), DCM (0.75 
mL), and BF3•OEt2 (11.6 µL, 0.93 mmol, 2.5 equiv) The reaction stirred for 4 h. The crude 
residue was purified by silica gel flash column chromatography (gradient of 5-10% EtOAc in 
hexanes) to afford 12 mg of 3.42 in 55% yield as a dark red/brown oil. Method B: Follows 
general procedure 3C.2: propargyl alcohol (3.7 µL, 0.064 mmol, 2.2 equiv), DCM (0.36 mL), 
Co2(CO)8 (20 mg, 0.058 mmol, 2 equiv), alcohol 3.40 (8 mg, 0.029 mmol, 1 equiv), dissolved in 
DCM (0.25 mL), and BF3•OEt2 (9.1 µL, 0.073 mmol, 2.5 equiv). The reaction stirred for 3.5 h. 
The crude residue was purified by silica gel flash column chromatography (gradient of 5-10% 
EtOAc in hexanes) to afford 10 mg of 3.42 in 60% yield as a dark red/brown oil. The product 
was a 1:1 mixture of diastereomers that were inseparable by column chromotography. 
Data for 3.42 
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1H NMR (500 MHz, CDCl3) 
7.46-7.44 (m, 2H), 7.37-7.33 (m, 3H), 6.01 (d, J = 4.5 Hz, 1H), 4.79 (d, J = 9.0 
Hz, 1H), 4.69 (dd, J = 13.0, 4.5 Hz, 1 H), 4.51 (d, J = 13.0, 1H), 3.71-3.64 (m, 
1H), 2.34-2.19 (m, 2H), 1.95-1.87 (m, 0.5H)*, 1.80-1.61 (m, 3.5H), 1.33 (d, J = 
6.8 Hz, 1.5H), 1.32 (d, J = 6.8 Hz, 1.5H)*, 1.24 (d, J = 6.3 Hz, 1.5H), 1.23 (d, J = 
6.3 Hz, 1.5H)* ppm; 
* Discernable signal for one of two diastereomers 
13C NMR (125 MHz, CDCl3) 
199.8 (6C), 177.9, 131.9 (2C), 129.2, 128.5 (2C), 121.9, 92.7, 87.9, 85.1, 75.2, 
75.0*, 73.1, 71.3, 68.6, 51.2, 51.0*, 41.3, 34.5, 34.3*, 27.8, 27.5*, 19.3, 14.6, 
14.4* ppm; 
IR  (thin film) 
2971, 2934, 2094, 2052, 2022, 1784, 1491, 1456, 1377, 1327, 1164, 1086, 992, 
758, 691 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+Na]+ calcd for C26H22O9Co2Na, 618.9820; found, 618.9807; 
TLC   Rf = 0.47 (20% ethyl acetate in hexanes) 
Silica gel, visible, UV 
3-Methyl-5-(phenylethynyl)-4-(3-(prop-2-yn-1-
yloxy)butyl)dihydrofuran-2(3H)-one (3.44).  Follows general 
procedure 3D: cobalt complex 3.42 (15 mg, 0.025 mmol, 1 equiv), 
acetone (3.0 mL), and CAN (69 mg, 0.13 mmol, 5 equiv) The reaction stirred for 30 min. The 
crude residue was purified by silica gel flash column chromatography (15% EtOAc in hexanes) 
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to afford 8 mg of alkyne 9 in 97% yield as a clear oil. The product was a 1:1 mixture of 
diastereomers that were inseparable by column chromatography. 
Data for 9  
1H NMR (400 MHz, CDCl3) 
7.46-7.43 (m, 2H), 7.36-7.33 (m, 3H), 4.83 (d, J = 8.8 Hz, 1H), 4.22 (dd, J = 15.6, 
2.4 Hz, 0.5 H), 4.21 (dd, J = 15.6, 2.4 Hz, 0.5 H)*, 4.122 (dd, J = 15.6, 2.4 Hz, 
0.5H), 4.115 (dd, J = 15.6, 2.4 Hz, 0.5H)*, 3.74-3.66 (m, 1H), 2.394 (t, J = 2.4 
Hz, 0.5H), 2.387 (t, J = 2.4 Hz, 0.5H)*, 2.33-2.31 (m, 2H), 1.92-1.83 (m, 0.5H)*, 
1.77-1.67 (m 3.5H), 1.35 (d, J = 6.8 Hz, 1.5H), 1.34 (d, J = 6.8 Hz, 1.5H)*, 1.19 
(d, J = 6.0 Hz, 1.5H), 1.17 (d, J = 6.0 Hz, 1.5H)* ppm; 
13C NMR (100 MHz, CDCl3) 
177.9, 131.93 (2C), 131.91 (2C)*, 129.2, 128.6 (2C), 121.8, 87.9, 85.0, 80.4, 74.1, 
73.7, 73.1, 55.8, 55.7*, 51.0, 50.6*, 41.3, 34.2, 19.2, 14.7, 14.5* ppm; 
* Discernable signal for one of two diastereomers 
IR  (thin film) 
 3291, 2924, 2853, 2232, 1780, 1491, 1457, 1166, 1076, 992, 759, 692 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C20H23O3, 311.1642; found, 311.1631; 
TLC  Rf = 0.50 (30% ethyl acetate in hexanes) 
Silica gel, UV active 
 N-acetyl-ʟ-cysteine ethyl ester (3.49a). Prepared in an analogous manner to that 
reported for synthesis of N-acetyl-ʟ-cysteine methyl ester.105 To a flame-dried, 
single-necked, 50 mL, round-bottomed flask, equipped with a stir bar and septum pierced with a 
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N2 inlet needle was added acetonitrile (25 mL) and ʟ-cysteine ethyl ester hydrochloride (3.48, 
500 mg, 2.70 mmol, 1.1 equiv). The flask was cooled to 0 °C on an ice/water bath. DIEA (0.43 
mL, 2.45 mmol, 1 equiv) was added, followed by acetyl chloride (0.17 mL, 2.45 mmol, 1 equiv) 
and the reaction was stirred for 30 min.  The reaction was quenched by addition of saturated 
NH4Cl (20 mL). The mixture was transferred to a separatory funnel and the aqueous was 
extracted with EtOAc (3 x 20 mL). The combined organics were washed with saturated NaHCO3 
(15 mL) and brine (15 mL), dried over sodium sulfate, filtered, and concentrated using reduced 
pressure rotary evaporation. The crude NMR showed a small amount of disulfide byproduct. The 
crude residue was purified by silica gel flash column chromatography (60% EtOAc in hexanes) 
to afford the title compound (153 mg, 33%). Characterization data matches that previously 
reported.114 
Data for 3.49a.  
1H NMR (400 MHz, CDCl3) 
6.35 (bs, 1H), 4.87 (ddd, J = 7.6, 4.0, 4.0 Hz, 1H), 4.32-4.19 (m, 2H), 3.03, (dd, J 
= 8.8, 4.0 Hz, 2H), 2.09-2.04 (m, 1H), 2.07 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H) ppm; 
Dicobalt octacarbonyl complexed N-acetyl-S-(prop-2-yn-1-yl)cysteine 
ethyl ester (3.50a). Followed general procedure 3C.2: Co2(CO)8 (107 mg, 
0.31 mmol), propargyl alcohol (18 mg, 0.314 mmol) dissolved in DCM (1.5 mL), N-acetyl-ʟ-
cysteine ethyl ester (3.49a)105, 114 (30 mg, 0.16 mmol) in DCM (1.5 mL), and BF3•OEt2 (49 µL, 
0.39 mmol). The reaction was stirred for 2 h. The crude residue was purified by silica gel flash 
column chromatography (gradient of 10-30% EtOAc in hexanes) to yield 70 mg of 13c in 86% 
yield, as a red oil.  
Data for 3.50a  
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1H NMR (300 MHz, CDCl3) 
6.31 (d, J = 4.5 Hz, 1H), 6.14 (s, 1H), 4.87-4.85 (m, 1H), 4.25-4.23 (m, 2H), 4.02-
3.91 (m, 2H), 3.19 (dd, J = 13.5, 4.4 Hz, 1H), 3.06 (dd, J = 13.8, 4.7 Hz, 1H), 
2.03 (s, 3H), 1.30 (t, J = 6.9 Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
 199.5 (6 C), 170.8, 170.0, 92.0, 73.4, 62.2, 52.2, 36.8, 34.7, 23.3, 14.3 ppm; 
IR  (thin film) 
 3295, 2984, 2093, 2052, 2020, 1742, 1655, 1543, 1374, 1208, 1032 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+Na]+ calcd for C16H15O9NCo2NaS, 537.9024; found, 537.9035; 
TLC  Rf = 0.55 (50% ethyl acetate in hexanes) 
Silica gel, visible, UV 
N-acetyl-S-(prop-2-yn-1-yl)cysteine ethyl ester (3.51a). Followed general 
procedure 3D: Co2(CO)6-alkyne 3.50a (23 mg, 0.045 mmol), acetone (4.0 mL), 
and CAN (99 mg, 0.18 mmol). The reaction was complete after 10 min of stirring. The work-up 
afforded 9 mg of alkyne 3.51a in 83% yield as a colorless oil. Further purification was not 
performed. 
Data for 3.51a  
1H NMR (500 MHz, CDCl3) 
6.42 (bs, 1H), 4.86 (dt, J = 7.5, 5.0 Hz, 1H), 4.25 (q, J = 7.0 Hz, 2H), 3.31 (dd, J 
= 17.0, 2.5 Hz, 1H), 3.25-3.21 (m, 2H), 3.14 (dd, J = 14.3, 5.3 Hz, 1H), 2.30 (t, J 
= 2.5 Hz, 1H), 2.08 (s, 3H), 1.31 (t, J = 7.0 Hz, 3H) ppm; 
13C NMR (125 MHz, CDCl3) 
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  170.9, 170.3, 79.4, 72.1, 62.2, 51.9, 33.9, 23.3, 20.0, 14.3 ppm; 
 Impurity present at 29.8 ppm 
IR  (thin film) 
  3287, 2919, 2850, 2361, 1739, 1660, 1539, 1374, 1213, 1028 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C10H16O3NS, 230.0845; found, 230.0846; 
TLC  Rf = 0.23 (50% ethyl acetate in hexanes) 
Silica gel, potassium permanganate 
N-Fluorenylmoethyloxycarbonyl-ʟ-cysteine ethyl ester (3.49b). A flame-
dried, 15 mL, single-necked, round-bottomed flask equipped with a stir bar and 
a septum, pierced with an inlet needle was charged with ʟ-cysteine ethyl ester hydrochloride salt 
(100 mg, 0.54 mmol, 1.1 equiv) and acetonitrile (2 mL). The solution was cooled in an ice bath 
to 0 °C. N,N-Diisopropylethylamine (35 µL, 0.49 mmol, 1 equiv) was added to the solution 
followed by N-(9-Fluorenyl-methoxycarbonyloxy) succinimide (FMoc-OSu) (165 mg, 0.49 
mmol, 1 equiv). The reaction was slowly warmed to rt and stirred overnight (14 h). The solution 
was quenched by addition of saturated NH4Cl. The flask contents were transferred to a 
separatory funnel; the aqueous layer was separated and extracted with ethyl acetate (3 x 10 mL). 
The combined organics were washed with saturated NaHCO3 (15 mL) and brine (15 mL), dried 
over MgSO4, gravity filtered, and concentrated under reduced pressure rotary evaporation. The 
crude material was purified by silica gel flash column chromatography (gradient of 10-20% 
EtOAc in hexanes) to afford 120 mg of 3.49b in 66% yield as a white solid. 
Data for 3.49b 
MP  119-121 °C 
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1H NMR (400 MHz, CDCl3) 
7.77 (d, J = 7.6 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.41 (t, J = 7.4 Hz, 2H), 7.34 
(app tt, J = 7.4, 1.4 Hz, 2H), 5.69 (d, J = 7.2 Hz, 1H), 4.66-4.63 (m, 1H), 4.47-
4.40 (m, 2H), 4.30-4.23 (m, 3H), 3.03-3.00 (m, 2H), 1.36 (t, J = 8.8 Hz, 1H), 1.31 
(t, J = 7.2 Hz, 3H)  ppm; 
13C NMR (100 MHz, CDCl3) 
170.1, 155.8, 144.0, 143.8, 141.49, 141.46, 127.9 (2 C), 127.2 (2 C), 125.24, 
125.19, 120.18, 120.16, 67.2, 62.2, 55.3, 47.3, 27.3, 14.4 ppm; 
IR  (thin film) 
 3337, 3065, 2981, 1723, 1513, 1450, 1339, 1204, 1035, 759, 741 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C20H22O4NS, 372.1264; found, 372.1267; 
TLC  Rf = 0.28 (20% ethyl acetate in hexanes) 
Silica gel, UV 
Dicobalt hexacarbonyl complexed N-(((9H-fluoren-9-
yl)methoxy)carbonyl)-S-(prop-2-yn-1-yl)-ʟ-cysteine ethyl ester 
(3.50b). Method A: Followed general procedure 3C.2: (55 mg, 0.16 mmol), propargyl alcohol (9 
mg, 0.16 mmol), DCM (1.1 mL), N-Fmoc-ʟ-cysteine ethyl ester (3.49b) (30.0 mg, 0.081 mmol) 
dissolved in DCM (0.6 mL), and BF3•OEt2 (25 Co2(CO)8 µL, 0.20 mmol). The reaction was 
stirred for 45 min. The crude residue was purified by silica gel flash column chromatography 
(gradient of 5-20% EtOAc in hexanes) to afford 40 mg of 3.50b in 71% yield, as a red oil. 
Method B: Followed general procedure 3C.1: Co2(CO)6-methyl propargyl ether 3.30c (45 mg, 
0.13 mmol), DCM (0.6 mL), N-Fmoc-ʟ-cysteine ethyl ester (3.49b) (24 mg, 0.063 mmol) 
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dissolved in dichloromethane (0.6 mL), and boron trifluoride diethyl etherate (20 µL, 0.156 
mmol). The reaction was stirred for 2 h. The crude residue was purified by silica gel flash 
column chromatography (gradient of 10-20% diethyl ether in hexanes) to afford 29 mg of 3.50b 
in 67% yield. 
Data for 3.50b 
1H NMR (400 MHz, CDCl3) 
7.77 (d, J = 7.6 Hz, 2H), 7.60 (d, J = 7.6 Hz, 2H), 7.41 (t, J = 7.6 Hz, 2H), 7.32 (t, 
J = 7.6 Hz, 2H), 6.13 (s, 1H), 5.66 (d, J = 7.6 Hz, 1H), 4.66 (dt, J = 7.6, 5.0 Hz, 
1H), 4.44-4.35 (m, 2H), 4.28-4.22 (m, 3H), 3.99 (s, 2H), 3.19 (dd, J = 14.0, 4.8 
Hz, 1H), 3.09 (dd, J = 14.0, 5.2 Hz, 1H), 1.32 (t, J = 7.2 Hz, 3H) ppm; 
13C NMR (125 MHz, CDCl3)  
199.5 (6 C), 170.7, 155.9, 143.93, 143.86, 141.5 (2 C), 127.9 (2 C), 127.2 (2 C), 
125.2 (2 C), 120.2 (2 C), 92.1, 73.4, 67.5, 62.3, 53.9, 47.3, 36.9, 35.1, 14.3 ppm; 
IR  (thin film) 
3345, 3070, 2923, 2094, 2053, 2023, 1726, 1507, 1450, 1339, 1204, 1052, 759, 
741 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C29H24O10NCo2S, 695.9779; found, 695.9745; 
TLC  Rf = 0.36 (20% ethyl acetate in hexanes) 
Silica gel, visibile, UV 
Ethyl N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(prop-2-yn-1-yl)-ʟ-
cysteinate (3.51b). Followed general procedure D: Co2(CO)6-alkyne 3.50b 
(22 mg, 0.032 mmol), acetone (3.5 mL), and CAN (69 mg, 0.13 mmol). The reaction was 
O
O
S
N
H
Fmoc
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complete after 10 min of stirring. The work-up afforded 12 mg of alkyne 3.51b in 92% yield as 
an off white oil. Further purification was not performed. 
Data for 3.51b 
1H NMR (400 MHz, CDCl3) 
7.77 (d, J = 7.4 Hz, 2H), 7.61 (d, J = 7.4 Hz, 2H), 7.41 (t, J = 7.4 Hz, 2H), 7.32 
(app tt, J = 7.4, 1.2 Hz, 2H), 5.64 (d, J = 7.6 Hz, 1H), 4.65 (dt, J = 8.0, 5.2 Hz, 
1H), 4.46-4.38 (m, 2H), 4.28-4.23 (m, 3H), 3.32-3.22 (m, 2H), 3.22 (dd, J = 14.4, 
4.8 Hz, 1H), 3.14 (dd, J = 14.0, 5.6 Hz, 1H), 2.26 (t, J = 2.6 Hz, 1H), 1.31 (t, J = 
7.2 Hz, 3H) ppm; 
Impurities observed at 1.2, 0.9 ppm. 
13C NMR (125 MHz, CDCl3) 
170.8, 155.9, 144.0, 143.9, 141.5 (2 C), 127.9 (2 C), 127.2 (2 C), 125.2 (2 C), 
120.2 (2 C), 79.4, 72.1, 67.3, 62.2, 53.7, 47.3, 34.0, 20.1, 14.3 ppm; 
Impurity observed at 29.8 ppm. 
IR  (thin film) 
 3291, 2924, 1723, 1517, 1450, 1339, 1210, 1051, 760, 741 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C23H24O4NS, 410.1421; found, 410.1424; 
TLC  Rf = 0.26 (20% ethyl acetate in hexanes) 
Silica gel, UV 
Co2(CO)6-N-[(1,1-dimethylethoxy)carbonyl]-O-(prop-2-yn-1-
yl)-ʟ-tyrosine methyl ester (3.56a). Method A: Follows general 
procedure 3C.2: propargyl alcohol (11 mg, 0.20 mmol), DCM (1.1 
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mL), Co2(CO)8 (69 mg, 0.20 mmol), N-Boc-ʟ-tyrosine methyl ester 3.55a (30 mg, 0.10 mmol)106 
and BF3•OEt2 (32 µL, 0.26 mmol). The reaction stirred for 2 h. Both 3.56a and 3.57 were 
observed by TLC. The crude residue was purified by silica gel flash column chromatography 
(gradient of 5-20% EtOAc in hexanes) to afford 20 mg of 3.56a in 32% yield as a dark 
red/brown oil. Byproduct 3.57 was only isolated in trace amounts. The 1H NMR of this sample 
of S6 is included in the spectra section. Further characterization was not obtained due to small 
amounts.  
This experiment was also performed by John Widen who consistently obtained 3.56a in 45% 
yield. 
Method B: Follows general procedure 3C.2: methyl propargyl ether (19 mg, 0.27 mmol), 
dichloromethane (2.0 mL), Co2(CO)8 (93 mg, 0.27 mmol), N-Boc-ʟ-tyrosine methyl ester 3.55a 
(40 mg, 0.14 mmol) and BF3•OEt2 (42 µL, 0.34 mmol). The reaction stirred for 3 h. Both 3.56a 
and 3.57 were observed by TLC. The crude residue was purified by silica gel flash column 
chromatography (gradient of 15-30% ethyl acetate in hexanes) to afford 19 mg of 3.56a in 23% 
yield as a dark red/brown oil. Large amounts of baseline material was observed. 
Data for 3.56a (obtained by John Widen) 
1H NMR (500 MHz, CDCl3):  
7.05 (d, J = 7.0 Hz, 2H), 6.88 (d, J = 8.0 Hz, 2H), 6.05 (s, 1H), 5.15 (s, 2H), 4.95 
(bs, 1H), 4.55 (bs, 1H), 3.72 (s, 3H), 3.03 (m, 2H), 1.42 (s, 9H) ppm 
13C NMR (125 MHz, CDCl3): 
199.3 (6 C), 172.4, 157.3, 155.1, 130.4 (2C), 128.6, 114.7 (2C), 89.5, 79.9, 71.7, 
68.2, 54.5, 52.2, 37.5, 28.3 (3 C) ppm 
Impurities seen at 129.7, 124.2, 28.8, 26.7 
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IR  (thin film) 
3445, 3368, 2979, 2956, 2929, 2097, 2056, 1746, 1716, 1612, 1585, 1510, 1445, 
1392, 1367, 1244, 1216, 1172, 1111, 1059, 1018, 839, 779, 519, 497 cm-1; 
HRMS  (FTMS + p ESI Full ms)  
[M+Na]+ calc’d for C24H23Co2NO10Na 625.9878 m/z; found 625.9877 m/z; 
TLC  Rf = 0.44 (20% ethyl acetate in hexanes) 
Silica gel, visible, UV 
Data for 3.57 (obtained by Sarah Wells) 
1H NMR (400 MHz, CDCl3) 
6.95 (s, 1H), 6.88 (d, J = 8.0 Hz, 1H), 6.70-6.62 (m, 1H), 6.07 (s, 1H), 4.91-4.87 
(m, 1 H), 4.79-4.71 (m, 1H), 4.58-4.49 (m, 1H), 4.10 (s, 1H), 3.72 (s, 3H), 3.08-
2.92 (m, 2H), 1.43 (s, 9H) ppm; 
TLC   Rf = 0.26 (20% ethyl acetate in hexanes) 
Silica gel, visible, UV 
Dicobalt hexacarbonyl prop-2-yn-1-yl benzoylphenylalaninate 
complex (3.60). Follows general procedure 3C.2: propargyl alcohol (11 
mg, 0.20 mmol), DCM (1.1 mL), Co2(CO)8 (69 mg, 0.20 mmol), N-benzoyl-ᴅ-phenylalanine 
(3.59) (27 mg, 0.10 mmol, 1 equiv), dissolved in DCM (1.0 mL), and BF3•OEt2 (32 µL, 0.26 
mmol). The reaction stirred for 2 h. The crude residue was purified by silica gel flash column 
chromatography (10% EtOAc in hexanes) to afford 35 mg of 3.60 in 60% yield as a dark red oil. 
Data for 3.60  
1H NMR (400 MHz, CDCl3) 
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7.72-7.70 (m, 1H), 7.51 (t, J = 7.6 Hz, 1H), 7.42 (t, J = 7.6 Hz, 2H), 7.31-7.28 (m, 
3H), 7.17-7.15 (m, 2H), 6.55 (d, J = 7.2 Hz, 1H), 6.08 (s, 2H), 5.44 (d, J = 14.4 
Hz, 1H), 5.24 (d, J = 14.0 Hz, 1H), 5.18 (dt, J = 7.6, 5.6 Hz, 1H), 3.36 (dd, J = 
14.0, 5.6 Hz, 1H), 3.27 (dd, J = 14.0, 6.0 Hz, 1H) ppm; 
13C NMR (125 MHz, CDCl3) 
199.1 (6C), 171.5, 166.9, 135.9, 134.0, 131.9, 129.5 (2C), 128.9 (2C), 128.8 (2C), 
127.5, 127.2 (2C), 87.2, 72.4, 66.8, 53.8, 38.0 ppm; 
IR  (thin film) 
 3031, 2925, 2097, 2056, 2025, 1746, 1647, 1531, 1487, 1178, 700 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+Na]+ calcd for C25H17O9NCo2, 615.9460; found, 615.9453; 
TLC  Rf = 0.34 (20% ethyl acetate in hexanes) 
Silica gel, visible, UV 
Prop-2-yn-1-yl benzoylphenylalaninate (3.61). Followed general procedure 
3D: Co2(CO)6-alkyne 3.60 (20 mg, 0.034 mmol), acetone (2.5 mL), and CAN 
(75 mg, 0.138 mmol). The reaction was complete after 10 min of stirring. Reaction work up 
afforded 10 mg of pure alkyne 3.61 as a white sticky solid in 90% yield. Purification by silica gel 
column was not performed. 
Data for 3.61   
1H NMR (400 MHz, CDCl3) 
7.72-7.70 (m, 2H), 7.53-7.47 (m, 1H), 7.45-7.41 (m, 2H), 7.32-7.26 (m, 3H), 
7.19-7.17 (m, 2H), 6.53 (d, J = 7.6 Hz, 1H), 5.14 (dt, J = 7.6, 5.6 Hz, 1H), 4.82 
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(dd, J = 15.6, 2.6 Hz, 1H), 4.73 (dd, J = 15.6, 2.6 Hz, 1H), 3.33 (dd, J = 13.8, 5.8 
Hz, 1H), 3.27 (dd, J = 13.8, 5.4 Hz, 1H), 2.54 (t, J = 2.4 Hz, 1H) ppm; 
Impurities seen at 1.43, 1.25, 0.88 ppm. 
13C NMR (125 MHz, CDCl3) 
171.0, 167.0, 135.7, 134.0, 132.0, 129.6 (2C), 128.83 (2C), 128.80 (2C), 127.5, 
127.2 (2C), 77.1, 75.8, 53.5, 53.0, 37.9 ppm; 
IR  (thin film) 
 3396, 3277, 3070, 2920, 2851, 2131, 1762, 1647, 1521, 1488, 1205, 1171 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C19H17O3N, 308.1281; found, 308.1282; 
TLC   Rf = 0.21 (20% ethyl acetate in hexanes) 
Silica gel, UV 
Dicobalt hexacarbonyl complexed prop-2-
yn-1-yl N-((benzyloxy)carbonyl)-O-(prop-
2-yn-1-yl)-ʟ-serinate (3.63) and Dicobalt 
hexacarbonyl complexed prop-2-yn-1-yl ((benzyloxy)carbonyl)-ʟ-serinate (3.64). Follows 
general procedure C2: propargyl alcohol (23 mg, 0.42 mmol), DCM (3.5 mL), Co2(CO)8 (143 
mg, 0.42 mmol), N-benzyloxycarbonyl-ʟ-serine 3.62 (50 mg, 0.21 mmol), additional DCM (0.7 
mL), and BF3•OEt2 (65 µL, 0.52 mmol). The reaction stirred for 1.5 h. The crude residue was 
purified by silica gel flash column chromatography (gradient of 5-30% EtOAc in hexanes) to 
afford 78 mg of 3.63 in 42% yield as a dark red oil and11 mg of 3.64 (9% yield) as a dark red oil.  
Data for 3.63  
1H NMR (400 MHz, CDCl3) 
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7.35 (s, 5H), 6.07 (s, 1H), 6.00 (s, 1H), 5.65 (d, J = 8.4 Hz, 1H), 5.37 (d, J = 14.4 
Hz, 1H), 5.24 (d, J = 14.4 Hz, 1H), 5.14 (d, J = 12.4 Hz, 1H), 5.09 (d, J = 12.4 
Hz, 1H), 4.68-4.65 (m, 1H), 4.63 (s, 2H), 4.16 (d, J = 8.4 Hz, 1H), 3.91 (d, J = 7.2 
Hz, 1H), ppm; 
13C NMR (100 MHz, CDCl3) 
199.5 (6C), 199.1 (6C), 169.8, 156.1, 136.4, 128.7 (2C), 128.3 (2C), 128.1, 90.2, 
87.5, 72.3, 72.1, 71.4, 70.8, 67.2, 67.0, 54.6 ppm; 
IR  (thin film) 
 3452, 3093, 2934, 2097, 2055, 1024, 1729, 1507, 1332, 1195, 1112, 1065 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+Na]+ calcd for C29H17O17NCo4Na, 909.7717; found, 909.7753; 
TLC  Rf = 0.27 (10% ethyl acetate in hexanes) 
Silica gel, visible, UV 
Data for 3.64 
1H NMR (400 MHz, CDCl3) 
7.37-7.33 (m, 5H), 6.08 (s, 1H), 5.70 (d, J = 6.4 Hz, 1H), 5.43 (d, J = 14.2 H, 1H), 
5.33 (d, J = 14.2 Hz, 1H), 5.15 (d, J = 12.0 Hz, 1H), 5.11 (d, J = 12.0 Hz, 1H), 
4.54 (br s, 1H), 4.11-3.92 (m, 2H), 2.05 (br s, 1H) ppm; 
13C NMR (125 MHz, CDCl3) 
199.1 (6C), 170.3, 156.3, 136.2, 128.7 (2C), 128.4 (2C), 128.3, 87.4, 72.4, 67.4, 
66.9, 63.4, 56.2 ppm; 
IR  (thin film) 
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3439, 3091, 2933, 2360, 2098, 2057, 2026, 1725, 1521, 1456, 1333, 1191, 1063, 
971, 698 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+Na]+ calcd for C20H15O11NCo2Na, 585.9201; found, 585.9205; 
TLC  Rf = 0.30 (30% ethyl acetate in hexanes) 
Silica gel, visible, UV 
Prop-2-yn-1-yl N-((benzyloxy)carbonyl)-O-(prop-2-yn-1-yl)-ʟ-serinate 
(3.66). A single-necked, 10 mL, round-bottomed flask, equipped with a stir 
bar and a septum pierced with a needle was charged with the Co2(CO)6-dialkyne 3.63 (35 mg, 
0.04 mmol, 1 equiv), dissolved in acetone (4 mL).  The solution was cooled to 0° C in an ice 
bath. CAN (87 mg, 0.16 mmol, 4 equiv) was added to the flask in a single portion. After stirring 
for 10 min, the reaction was not complete as determined by TLC, and additional CAN (87 mg, 
0.16 mmol, 4 equiv) was added. The reaction was stirred for 15 min. Upon completion, the 
reaction was diluted with distilled water (4 mL). The mixture was transferred to a separatory 
funnel. The aqueous layer was extracted with Et2O (3 x 6 mL). The combined organics were 
dried over MgSO4, filtered, and concentrated under reduced pressure rotary evaporation to afford 
12 mg of 3.66 in 94% yield as a colorless oil. Purification of the crude material was not 
performed. 
Data for 3.66  
1H NMR (400 MHz, CDCl3) 
7.37-7.31 (m, 5H), 5.62 (d,  J = 8.4 Hz, 1H), 5.17-5.10 (m, 2H), 4.81-4.72 (m, 
2H), 4.58 (dt, J = 8.4, 2.8 Hz, 1H), 4.15-4.10 (m, 2H), 4.01 (dd, J = 9.2, 2.8 Hz, 
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1H), 3.81 (dd, J = 9.2, 2.8 Hz, 1H), 2.50, (t, J = 2.4 Hz, 1H), 2.43 (t, J = 2.4 Hz, 
1H) ppm; 
Impurities present at 1.43, 1.25, 0.88 ppm 
13C NMR (100 MHz, CDCl3) 
169.6, 156.1, 136.3, 128.7, 128.4, 128.3, 78.8, 77.2, 75.6, 75.4, 69.5, 67.3, 58.8, 
54.3, 53.3 ppm; 
IR  (thin film) 
 3288, 2915, 2850, 2129, 1750, 1715, 1515, 1456, 1342, 1260, 1027 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C17H18O5N, 316.1180; found, 316.1181; 
TLC  Rf = 0.27 (30% ethyl acetate in hexanes) 
Silica gel, UV, potassium permanganate 
Co2(CO)6-N-propargyl-ʟ-proline methyl ester (3.68). Follows general 
procedure 3C.3: Tetrafluoroborate salt 3.30d (140 mg, 0.340 mmol), DCM (5 
mL), ʟ-proline methyl ester 3.67 (57 mg, 0.44 mmol) dissolved in DCM (1.8 mL). The reaction 
stirred for 1.5 h. The crude residue was purified by silica gel flash column chromatography 
(gradient of 5-10% Et2O in hexanes) to afford 75 mg of cobalt complexed alkyne 3.68 in 46% 
yield as a red oil. 
Data for 3.68 
1H NMR (300 MHz, CDCl3) 
6.05 (s, 1H), 4.23 (d, J = 15.6 Hz, 1H), 3.97 (d, J = 15.3 Hz, 1H), 3.71 (s, 3H), 
3.53 (dd, J = 8.1, 5.1 Hz, 1H), 3.23-3.14 (m, 1H), 2.71 (q, J = 8.1 Hz, 1H), 2.13, 
1.78 (m, 4H) ppm; 
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13C NMR (100 MHz, CDCl3) 
199.9 (6C), 174.3, 91.8, 73.4, 64.2, 56.1, 52.8, 51.9, 29.4, 23.5 ppm; 
IR  (thin film) 
 2955, 2798, 2093, 2020, 1736, 1551, 1437, 1356, 1278, 1199, 1173 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C15H14O8NCo2, 453.9378; found, 453.9361; 
TLC   Rf = 0.37 (20% diethyl ether in hexanes) 
Silica gel, UV, potassium permanganate  
N-propargyl-ʟ-proline methyl ester (3.69). Followed general procedure 3D: 
Co2(CO)6-alkyne 3.68 (20 mg, 0.044 mmol), acetone (5.0 mL), and CAN (97 mg, 
0.18 mmol). After 1 h of stirring, 3.69 remained, as evidenced by proton NMR. An additional 
amount of ceric ammonium nitrate (10 mg, 0.018 mmol) was added and stirred for 20 min. The 
work-up afforded 5 mg of alkyne 3.69 in 68% yield as a colorless oil. Further purification was 
not performed. Characterization via 1H NMR, 13C NMR, and HRMS was obtained, however, 
3.69 appears to be unstable leading to decomposition and poor reproducibility of these data. 
Data for 3.69 
1H NMR (400 MHz, CDCl3) 
3.74 (s, 3H), 3.61 (app t, J = 2.4 Hz, 2H), 3.45 (dd, J = 8.8, 6.8 Hz, 1H), 3.09-3.04 
(m, 1H), 2.73 (td, J = 8.8, 7.6 Hz, 1H), 2.21 (t, J = 2.4 Hz, 1H), 2.19-2.11 (m, 
1H), 2.03-1.76 (m, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
174.3, 78.5, 73.3, 62.7, 52.3, 52.2, 41.3, 29.8, 23.4 ppm; 
Impurity present at 30.5 ppm 
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HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C9H14O2N, 168.1019; found, 168.1013; 
Bis(dicobalthexacarbonyl) complexed N,N-di(prop-2-ynyl)-ʟ-
phenylalanine methyl ester (3.71). Follows general procedure 3C.3: 
Tetrafluoroborate salt 3.30d (46 mg, 0.11 mmol, 1 equiv), DCM (2 mL), 
ʟ-phenyl alanine methyl ester 3.70 (20 mg, 0.11 mmol, 1 equiv) dissolved in DCM (0.3 mL). The 
reaction stirred for 1.5 h. The crude residue was purified by silica gel flash column 
chromatography (gradient of 2-20% Et2O in hexanes) to afford 46 mg of cobalt complexed 
dialkyne 3.71 in 59% yield as a red oil.  
Data for 3.71 
1H NMR (300 MHz, CDCl3) 
7.31-7.22 (m, 3H), 7.17 (d, J = 7.2 Hz, 2H), 6.10 (s, 2H), 4.41 (d, J = 15.9 Hz, 
2H), 4.04-3.99 (m, 3H), 3.56 (s, 3H), 3.24-3.17 (m, 1H), 2.93 (dd, J = 13.0, 4.2 
Hz, 1H) ppm; 
13C NMR (100 MHz, CDCl3) 
199.7 (12C), 172.0, 137.3, 129.3 (2C), 128.7 (2C), 126.9, 91.1 (2C), 73.8 (2C), 
64.4, 55.1 (2C), 51.3, 36.5 ppm; 
IR  (thin film) 
 2093, 3052, 2017, 1735, 1425, 1200, 1165 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C28H18O14NCo4, 827.8050; found, 827.8084; 
TLC  Rf = 0.48 (10% diethyl ether in hexanes) 
Silica gel, UV, visible 
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N,N-di(prop-2-ynyl)-ʟ-phenylalanine methyl ester (3.72). Followed general 
procedure 3D: Co2(CO)6-dialkyne 3.71 (21 mg, 0.025 mmol, 1 equiv), acetone 
(4.0 mL), and CAN (111 mg, 0.203 mmol, 8 equiv). The reaction was 
complete after 20 min of stirring. The crude residue was purified using silica gel flash column 
chromatography (gradient of 15-30% Et2O in hexanes), which afforded 4 mg of alkyne 3.72 in 
56% yield as an oil.  
Data for 3.72 
1H NMR (400 MHz, CDCl3) 
7.30-7.26 (m, 2H), 7.23-7.7.18 (m, 3H), 3.75 (t, J = 7.6 Hz, 1H), 3.68 (d, J = 2.4 
Hz, 4H), 3.57 (s, 3H), 3.05 (d, J = 7.6 Hz, 2H), 2.25 (t, J = 2.4 Hz, 2H) ppm; 
13C NMR (100 MHz, CDCl3) 
172.1, 137.5, 129.3 (2 C), 128.6 (2 C), 126.8, 79.3 (2 C), 73.1 (2 C), 65.9, 51.5, 
40.1 (2 C), 36.5 ppm; 
IR  (thin film) 
3250, 2991, 2914, 2813, 2344, 1714, 1478, 1421, 1347, 1199, 1153, 1112, 740, 
692, 623 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C16H18O2N, 256.1332; found, 256.1335; 
TLC  Rf = 0.37 (20% diethyl ether in hexanes) 
Silica gel, UV, potassium permanganate  
Co2(CO)6-N-(1,1-dimethyl-3-propynyl)-ʟ-phenylalanine methyl ester 
(3.S2). Follows general procedure 3C.3: Tetrafluoroborate salt 3.74 (77 
mg, 0.18 mmol. 1.3 equiv), DCM (2.5 mL), ʟ-phenylalanine methyl 
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ester 3.70 (24 mg, 0.14 mmol, 1 equiv) dissolved in DCM (0.5 mL). The reaction stirred for 40 
min. The crude residue was purified by silica gel flash column chromatography (gradient of 5-
20% Et2O in hexanes) to afford 16 mg of cobalt complexed alkyne 3.S2 in 23% yield as a red oil. 
Data for 3.S2 
1H NMR (400 MHz, CDCl3) 
7.29-7.17 (m, 5H), 5.99 (s, 1H), 3.72 (dt, J = 7.6, 3.2 Hz, 1H), 3.62 (s, 3H), 2.92-
2.81 (m, 2H), 1.90 (d, J = 8.4 Hz, 1H), 1.29 (s, 3H), 1.20 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
200.1 (6C), 176.6, 137.6, 129.6 (2C), 128.4 (2C), 126.8, 107.3, 72.2, 58.0, 56.7, 
52.0, 41.9, 32.1, 30.9 ppm; 
IR  (thin film) 
 2973, 2927, 2092, 2050, 2019, 1739, 1455, 1194, 1172, 700 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C21H20O8NCo2, 531.9847; found, 531.9848; 
TLC  Rf = 0.35 (10% diethyl ether in hexanes) 
Silica gel, Visible, UV 
N-(1,1-dimethyl-3-propynyl)-ʟ-phenylalanine methyl ester (3.75). 
Followed general procedure 3D: Co2(CO)6-alkyne 3.S2 (12 mg, 0.023 mmol), 
acetone (4.0 mL), and CAN (50 mg, 0.090 mmol). The reaction was complete 
after 20 min of stirring as indicated by consumption of 3.S2, as evidenced by TLC. However, 
3.75 was not visible by TLC until after the reaction work up. The crude residue was purified by 
silica gel flash column chromatography (10% Et2O in hexanes) which afforded 4 mg of alkyne 
3.75 in 64% yield as an colorless oil.  
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Data for 3.75  
1H NMR (400 MHz, CDCl3) 
7.30-7.26 (m, 2H), 7.23-7.19 (m, 3H), 3.73 (dd, J = 7.8, 6.4 Hz, 1H), 3.63 (s, 3H), 
2.93 (dd, J =13.4, 6.4 Hz, 1H), 2.84 (dd, J = 13.4, 7.8 Hz, 1H), 2.18 (s, 1H), 1.92 
(bs, 1H), 1.31(s, 3H), 1.19 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
176.3, 137.5, 129.6 (2C), 128.4 (2C), 126.8, 88.5, 70.1, 58.9, 51.7, 49.6, 41.4, 
30.3, 29.6 ppm; 
IR  (thin film) 
 3286, 3027, 2977, 2929, 2368, 1736, 1458, 1438, 1196, 1171, 700 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C15H20O2N, 246.1489; found, 246.1478; 
TLC  Rf = 0.33 (20% diethyl ether in hexanes) 
Silica gel, UV, potassium permanganate  
Co2(CO)6-Ethyl N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(1,1-
dimethyl-3-propynyl)-ʟ-cysteinate (3.76). Follows general procedure 
3C.3: Tetrafluoroborate salt 3.74 (62 mg, 0.14 mmol, 1.25 equiv), DCM 
(1.5 mL), N-(((9H-fluoren-9-yl)methoxy)carbonyl)-ʟ-cysteine ethyl ester 3.49b (42 mg, 0.11 
mmol, 1 equiv) dissolved in DCM (0.8 mL). The reaction stirred for 2 h. The crude residue was 
purified by silica gel flash column chromatography (gradient of 15-30% Et2O in hexanes) to 
afford 42 mg of 3.76 in 55% yield as a red oil. 
Data for 3.76  
1H NMR (400 MHz, CDCl3) 
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7.77 (d, J = 7.6 Hz, 2H), 7.60 (d, J = 7.2 Hz, 2H), 7.41 (app t, J = 7.4 Hz, 2H), 
7.32 (app t, J = 7.4 Hz, 2H), 6.23 (s, 1H), 5.59 (d, J = 7.6 Hz, 1H), 4.71-4.66 (m, 
1H), 4.39 (d, J = 7.2 Hz, 2H), 4.27-4.21 (m, 3H), 3.19-3.10 (m, 2H), 1.621 (s, 
3H), 1.616 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H) ppm; 
13C NMR (125 MHz, CDCl3) 
199.8 (6C), 170.5, 155.8, 144.0, 143.9, 141.5 (2C), 127.9 (2C), 127.2 (2C), 125.3 
(2C), 120.2 (2C), 105.0, 73.1, 67.4, 62.2, 53.6, 48.9, 47.3, 32.7 (2C), 32.4, 14.3 
ppm; 
IR  (thin film) 
3338, 3070, 2979, 2092, 2053, 2022, 1725, 1510, 1451, 1200, 1052, 759, 740  
cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+NH4]+ calcd for C31H31O10N2SCo2, 741.0358; found, 741.0379; 
TLC  Rf = 0.18 (20% diethyl ether in hexanes) 
Silica gel, visible, UV 
N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(1,1-dimethyl-3-propynyl)-ʟ-
cysteine ethyl ester (3.77). Followed general procedure 3D: Co2(CO)6-alkyne 
3.76 (47 mg, 0.069 mmol), acetone (6.9 mL), and CAN (152 mg, 0.28 mmol). 
The reaction was complete after 15 min of stirring. The crude residue was purified by silica gel 
flash column chromatography (20% Et2O in hexanes) which afforded 14 mg of alkyne 3.77 in 
46% yield as a colorless oil. 
Data for 3.77 
1H NMR (400 MHz, CDCl3) 
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7.77 (d, J = 7.6 Hz, 2H), 7.63-7.58 (m, 2H), 7.40 (t, J = 7.4 Hz, 2H), 7.30 (t, J = 
7.4 Hz, 2H), 5.65 (d, J = 8.0 Hz, 1H), 4.69 (dt, J = 8.0, 5.2 Hz, 1H), 4.44-4.37 (m, 
2H), 4.27-4.21 (m, 3H), 3.28-3.19 (m, 2H), 2.37 (s, 1H), 1.57 (s, 6H), 1.30 (t, J = 
7.0 Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
170.7, 155.9, 144.0, 143.9, 141.5, 141.4, 127.9 (2C), 127.2 (2C), 125.3 (2C), 
120.1 (2C), 87.8, 70.9, 67.3, 62.1, 53.6, 47.3, 38.7, 33.2, 30.79, 30.75, 14.3 ppm; 
IR  (thin film) 
 3292, 2976, 2925, 2365, 1719, 1509, 1449, 1339, 1208, 1051, 759, 740 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C25H28O4NS, 438.1734; found, 438.1725; 
TLC  Rf = 0.23 (30% diethyl ether in hexanes) 
Silica gel, UV, potassium permanganate 
Dicobalthexacarbonyl complexed guaianolide alkyne probe 
(3.78). Follows general procedure 3C.2: propargyl alcohol (5 mg, 
0.091 mmol), DCM (0.60 mL), Co2(CO)8 (31 mg, 0.091 mmol), 
alcohol 1.83 (16 mg, 0.045 mmol), dissolved in DCM (0.40 mL), and BF3•OEt2 (15 µL, 0.11 
mmol). The reaction was monitored by TLC and stirred for 2 h. The crude residue was purified 
by silica gel flash column chromatography (gradient of 10-30% EtOAc in hexanes) to afford 14 
mg of 3.78 as a mixture of two diastereomers (2.1:1), determined by the integrations for H6 at 
5.78 and 5.38 ppm, in 46% yield as a dark red/brown oil. 
Data for 3.78  
1H NMR (400 MHz, CDCl3) 
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7.40-7.35 (m, 3 H), 7.31-7.26 (m, 2 H), 6.34 (d, J = 3.6 Hz, 1 H)**, 6.24 (d, J = 
3.2 Hz, 1 H)*, 6.09 (s, 1 H), 5.86 (d, J = 3.2 Hz, 1 H)*, 5.78 (d, J = 9.6 Hz, 1 
H)**, 5.47 (d, J = 3.2 Hz, 1 H)**, 5.38 (d, J = 10.4 Hz, 1 H)*, 4.71-4.61 (m, 2H), 
4.33 (d, J = 12.4 Hz, 1 H)*, 4.25 (d, J = 12.8 Hz, 1 H)*, 4.26 (app s, 2 H)**, 4.10-
4.05 (m, 1 H)**, 3.88-3.86 (m, 1 H)*, 3.51 (s, 3 H)*, 3.39 (s, 3H)**, 3.32-3.14 
(m, 4 H), 2.52-2.41 (m, 1 H) ppm; 
13C NMR (100 MHz, CDCl3) 
201.4*, 201.1**, 199.6 (6C), 168.3**, 167.9*, 162.2**, 161.5*, 144.0**, 143.0*, 
137.2*, 135.0**, 134.4*, 133.6**, 131.6*, 130.72**, 130.65*, 130.3**, 130.0*, 
129.9**, 128.84**, 128.77*, 127.8**, 127.7*, 122.8**, 122.2*, 90.7**, 90.6*, 
81.8*, 75.7*, 74.7**, 73.6**, 73.4*, 73.3**, 71.9*, 71.6**, 71.4**, 71.1*, 57.2**, 
56.5*, 49.8, 40.0**, 39.7*, 33.8**, 29.5* ppm; 
IR  (thin film) 
 2927, 2829, 2372, 2093, 2051, 2022, 1773, 1702, 12.68, 1096, 1018, 697 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C30H23O11Co2, 676.9899; found, 676.9903; 
TLC  Rf = 0.26*, 0.22** (30% ethyl acetate/hexanes) 
Silica gel, Visible, UV 
*Major diastereomer, **minor diastereomer 
Guaianolide analog alkyne probe (3.79). Follows general procedure 
3D: cobalt complex 3.78 (14 mg, 0.021 mmol, 1 equiv), acetone (1.5 
mL), and CAN (68 mg, 0.12 mmol, 6 equiv). The reaction stirred for 15 
min. The reaction afforded 9 mg of alkyne 3.79 as a mixture of two diastereomers (2.1:1), 
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determined by the integrations for H6 at 5.78 and 5.38 ppm, in quantitative yield as a colorless 
oil. The crude material was not purified further. 
Data for 3.79  
1H NMR (400 MHz, CDCl3) 
7.38-7.35 (m, 3 H), 7.30-7.24 (m, 2 H), 6.36 (d, J = 3.2 Hz, 1 H)**, 6.24 (d, J = 
3.2 Hz, 1 H)*, 5.88 (d, J = 2.8 Hz, 1 H)*, 5.78 (d, J = 9.6 Hz, 1 H)**, 5.52 (d, J = 
3.2 Hz, 1 H)**, 5.38 (d, J = 10.4 Hz, 1 H)*, 4.23-4.16 (m, 4 H), 4.09-4.06 (m, 1 
H)**, 3.87-3.84 (m, 1 H)*, 3.51 (s, 3 H)*, 3.43 (s, 3 H)**, 3.38-3.12 (m, 4 H), 
2.52-2.46 (m, 2 H) ppm; 
Impurities observed at 2.27, 1.43, 1.25, 0.87 ppm. 
13C NMR (150 MHz, CDCl3) 
201.5*, 201.3**, 168.3**, 167.9*, 161.9**, 161.4*, 144.2**, 143.2*, 137.2*, 
135.8**, 135.4*, 133.6**, 130.9*, 130.73**, 130.65*, 129.93 (2C)*, 129.89 
(2C)**, 129.7**, 128.9**, 128.8*, 127.80 (2C)**, 127.75 (2C)*, 122.9**, 122.2*, 
81.8*, 79.5*, 79.3**, 75.7*, 75.6**, 75.4*, 74.8**, 73.8**, 71.9**, 71.5*, 57.8**, 
57.4**, 57.2*, 56.5*, 49.8*, 49.7**, 40.0**, 39.7*, 34.2*, 30.0* ppm; 
Impurities observed at 67.6, 34.2, 29.9, 24.0, 22.9, 14.3 ppm 
*Major diastereomer, **minor diastereomer 
IR  (thin film) 
 3279, 2933, 2852, 2115, 1769, 1703, 1492, 1445, 1269, 1134, 1095, 699 cm-1. 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C24H23O5, 391.1540; found, 391.1525; 
TLC  Rf = 0.18 (40% ethyl acetate/hexanes)  
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Silica gel, UV, potassium permanganate 
Co2(CO)6-O-(prop-2-ynyl)-MelB (3.80). Method A: Follows general 
procedure 3C.2: Propargyl alcohol (4 mg, 0.076 mmol), DCM (0.5 mL), 
Co2(CO)8 (26 mg, 0.076 mmol), MelB (3.29)115 (10 mg, 0.038 mmol), 
dissolved in DCM (0.3 mL), and BF3•OEt2 (12 µL, 0.095 mmol). The reaction was quenched 
after 10 min of stirring despite a small amount of Mel B remaining in the reaction. The crude 
residue was purified by silica gel flash column chromatography (gradient of 10-20% EtOAc in 
hexanes) to afford 9 mg of 3.80 in 41% yield as a dark red oil. Method B: Follows general 
procedure 3C.2: Methyl propargyl ether (8.0 mg, 0.11 mmol), DCM (0.8 mL), Co2(CO)8 (39 mg, 
0.11 mmol), Mel B (3.29) (15 mg, 0.057 mmol), dissolved in DCM (0.4 mL), and BF3•OEt2 (18 
µL, 0.14 mmol). The reaction was quenched after 40 min of stirring despite a small amount of 
Mel B remaining in the reaction. The crude residue was purified by silica gel flash column 
chromatography (gradient of 10-20% EtOAc in hexanes) to afford 13 mg of 3.80 in 39% yield. 
Data for 3.80 
1H NMR (400 MHz, CDCl3) 
6.25 (s, 1H), 6.04 (s, 1H), 5.67 (bs, 1H), 5.51 (s, 1H), 4.62 (d, J = 13.2 Hz, 1H), 
4.53 (d, J = 12.8 Hz, 1H), 4.25 (d, J = 11.2 Hz, 1H), 3.98 (d, J = 12.0 Hz, 1H), 
3.86 (t, J = 9.6 Hz, 1H), 2.87-2.85 (m, 2H), 2.43-2.31 (m, 4H), 2.22-2,15 (m, 2H), 
1.67-1.64 (m, 1H), 1.55 (s, 3H), 1.12-1.06 (m, 1H) ppm; 
13C NMR (100 MHz, CDCl3) 
199.6 (6C), 169.6, 139.1, 136.8, 129.4, 120.2, 91.1, 81.2, 73.8, 71.8, 70.3, 63.6, 
60.2, 43.2, 36.9, 25.7, 24.3, 23.8, 18.1 ppm; 
IR  (thin film) 
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  2931, 2360, 2095, 2053, 2023, 1770, 1262, 1138, 1075, 995 cm-1; 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C24H23O10Co2, 588.9950; found, 588.9946; 
TLC   Rf = 0.19 (20% ethyl acetate in hexanes)  
Silica gel, visible, UV 
O-(prop-2-ynyl)-Mel B 3.81. Followed general procedure 3D: Co2(CO)6-
alkyne 3.80 (9 mg, 0.015 mmol), acetone (1.5 mL), and CAN (34 mg, 0.061 
mmol). The reaction was complete after 10 min of stirring. Reaction work up 
afforded 4 mg of alkyne 3.81 as a colorless oil in 94% yield. Further purification was not 
performed. 
Data for 3.81 
1H NMR (400 MHz, CDCl3) 
6.24 (d, J = 3.6 Hz, 1H), 5.70-5.66 (m, 1H), 5.55 (d, J = 3.2 Hz, 1H), 4.18 (dd, J = 
16.0, 2.4 Hz, 1H), 4.16 (d, J = 10.8 Hz, 1H), 4.08 (dd, J = 16.0, 2.4 Hz, 1H), 3.90 
(d, J = 11.6 Hz, 1H), 3.86 (t, J = 9.2 Hz, 1H), 2.96-2.82 (m, 1H), 2.86 (d, J = 9.6 
Hz, 1H), 2.53-2.45 (m, 1H), 2.44 (t, J = 2.4 Hz, 1H), 2.40-2.27 (m, 3H), 2.22-2.14 
(m, 2H), 1.68-1.62 (m, 1H), 1.55 (s, 3H), 1.14-1.07 (m, 1H) ppm; 
Impurity observed at 29.8 ppm. 
13C NMR (125 MHz, CDCl3) 
169.6, 139.2, 136.6, 130.4, 120.1, 81.3, 79.7, 74.8, 72.9, 63.6, 60.1, 57.4, 43.1, 
36.9, 25.9, 24.6, 23.9, 18.2 ppm; 
IR  (thin film) 
  3274, 2921, 2850, 2112, 1764, 1261, 1138, 1073, 993, 815 cm-1; 
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HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C18H23O4, 303.1591; found, 303.1595; 
TLC  Rf = 0.20 (30% ethyl acetate in hexanes)  
Silica gel, UV, potassium permanganate  
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4.0  STUDIES ON THE GUAIANOLIDE NF-ĸB MECHANISM OF INHIBITION  
4.1 INTRODUCTION 
Drug candidates containing electrophiles that undergo covalent bond-forming reactions 
with proteins in vivo have traditionally been avoided by pharmaceutical researchers.8c However, 
a resurgence of these covalent drugs can partially be attributed to increased efforts toward 
understanding their molecular mechanisms of biological activity. Sesquiterpene lactones (SLs) 
are known to affect their anti-inflammatory and antiproliferative properties through inhibition of 
the inflammation central transcription factor, nuclear factor kappa B (NF-ĸB).7 However, 
understanding the structural features that are responsible for the potent inhibitory properties as 
well as uncovering the exact mode of inhibition these compounds undergo within the NF-ĸB 
pathway has been more difficult.  
Defined quantitative structure-activity relationships (QSAR) between SL skeletal and 
topological structures with inhibition of NF-ĸB are limited. The most comprehensive QSAR 
study to date evaluated 103 SLs from 6 different skeletal families; among these compounds, 22 
guaianolides and 9 pseudoguaianolides were tested.116 The NF-ĸB inhibition ability of all the 
sesquiterpene families had a strong correlation to the presence of alkylating centers in the form 
of unsaturated carbonyls. However, guaianolides had more specific correlations also related to 
structure coding parameters, attributed to the rigid nature of the guaianolide skeleton. The QSAR 
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analysis revealed that an increased number of hydroxyl groups in guaianolides can lead to 
diminished NF-ĸB inhibition.116-117 While this study provides a good starting point for QSAR 
data, the conclusions are somewhat limited. Continuing to evaluate the NF-ĸB inhibition of 
guaianolide-related compounds will add to the knowledge about the structure-activity 
relationship. This process is necessary to understanding the mechanism of inhibition for the 
development of potent analogs. 
As mentioned, the biological activity, as well as cytotoxicity of SLs is linked to the 
presence of unsaturated carbonyls, seen in the form of α-methylene-γ-butyrolactones, α,β-
unsaturated cyclopentenones, and other, acyclic α,β-unsaturated esters, ketones, and aldehydes. 
These electrophilic groups have been shown to react with biological nucleophiles, particularly 
cysteine sulfhydryl groups, through a hetero-Michael-type addition reaction. For example, when 
helenalin (1.7), which has two possible alkylating centers, is reacted with 1 equiv of cysteine in 
D2O, hetero-Michael addition occurs selectively with the α-methylene-γ-butyrolactone moiety 
(adduct 4.1, Figure 24A). Interestingly, when 1 equiv of glutathione, the most abundant non-
protein thiol in eukaryotic cells, is reacted with helenalin (1.7), it selectively adds to the α,β-
unsaturated cyclopentenone (adduct 4.2). Both of these additions also occurred stereoselectively, 
resulting in the isomers shown in Figure 24A. When excess amounts of either cysteine or 
glutathione are employed, the thiols add to both alkylating centers of helenalin (1.7).9, 118 
Cysteamine (4.4) has also been utilized as a model for biological thiols that can be used to 
quickly ascertain thiol reactivity of unsaturated carbonyls;119 stirring of costunolide (4.3) and 
cysteamine in DMSO formed the corresponding adduct 4.5, determined by the disappearance of 
the alkenyl protons, Ha and Hb, in the crude NMR (Figure 24B).119a These studies lend 
themselves to predict reactivity of SLs that contain unsaturated carbonyl alkylating centers in 
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vivo. However, this does not replace the value that comes from understanding the exact NF-ĸB 
protein targets responsible for biological activity, as well as non-specific targets that could lead 
to cytotoxicity.  
 
Figure 24. Examples of SL reactivity with biological thiols; A) Helenalin (1.7) adducts with cysteine and 
glutathione, B) Costunolide (4.3) adduct with cysteamine (4.4). 
 
In cells, NF-ĸB is comprised, most frequently, of the p50 and p65 (RelA) subunits, and is 
retained in the cytoplasm through binding with its inhibitor protein, IĸB. In response to stimuli 
(over 200 stimuli options), the IKK complex, made up of IKKα, IKKβ, IKKγ, activates IĸB, with 
IKKβ being the primary kinase. This activation results in phosphorylation of two serine residues 
of IĸB (Ser-177, Ser-181), leading to ubiquitination and degradation of the inhibitor protein. In 
turn, the NF-ĸB dimer is now activated and freely translocates to the nucleus, where it binds with 
DNA and initiates transcription (Figure 25).10-11, 59 This cascading pathway has many potential 
sites of inhibition, usually falling into one of three categories: 1) blockage of incoming stimuli 
that activates the IKK complex, or early stage inhibition, 2) interference with one of the 
cytoplasmic events (phosphorylation of IĸB), 3) blockage of NF-ĸB nuclear activity (either by 
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preventing its translocation from the cytoplasm to the nucleus, or by inhibiting NF-ĸB/DNA 
binding.  
 
Figure 25. The NF-ĸB pathway leading to gene transcription.11 Reprinted by permission from Macmillan Publishers 
Ltd: Nature Reviews Drug Discovery, 2008, 7, 1031-1040, copyright 2008. 
 
Thiol reactive compounds, including SLs, have been characterized to inhibit NF-ĸB 
signaling by either blocking IĸB-degradation or by interfering with the NF-ĸB/DNA binding 
event.59 A case has been made that parthenolide (PTL, 1.3) inhibits the IĸB degradation event by 
binding a cysteine (Cys-179) in the IKKβ activation loop.120 Gel shift assays performed by the 
Hehner group did not show that PTL blocked NF-ĸB/oligonucleotide interactions.120a, 120b Kwok 
and coworkers also studied the mechanism of inhibition for parthenolide; coming to a similar 
conclusion that it prevents IĸB degradation. Reduced PTL 4.6 was not effective for inhibition of 
NF-ĸB signaling, supporting the importance of the α-methylene lactone moiety (Figure 26). A 
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biotinylated PTL derivative (4.7) confirmed IKK-β as a molecular target of PTL using protein 
profiling experiments. Finally, a mutant protein of IKK-β where Cys-179 was replaced with a 
serine was no longer sensitive to the inhibitory properties of PTL. This cysteine residue is 
positioned between the two serine residues (Ser-177,181) that undergo phosphorylation leading 
to IKKβ degradation.120c  
 
Figure 26. Structures of parthenolide derivatives used by Kwok to investigate the SL mechanism of inhibition. 
On the other hand, a series of reports by the Merfort group have shown that PTL, as well 
as helenalin (1.7) and a few other SLs, inhibit NF-ĸB by preventing the DNA/NF-ĸB binding 
event. The Merfort group claims that their results, detailed within, contradict reports that 
parthenolide inhibits NF-ĸB activation solely by preventing IĸB degradation.7 First, confocal 
laser scanning microscopy was used to examine cells that were activated using tumor necrosis 
factor-α (TNF- α) followed by treatment with helenalin (1.7). The results confirmed the presence 
of NF-ĸB in the nucleus of the cells, showing that IĸB degradation was not inhibited, nor was the 
translocation of NF-ĸB from the cytoplasm to the nucleus.121  
Molecular docking studies were utilized to propose that helenalin covalently binds to NF-
ĸB with a cysteine residue (Cys-38) of the p65 unit.117 Experimental evidence for this proposal 
was achieved by the construction of NF-ĸB/p65 mutants, where the proposed reactive cysteine 
residues were interchanged for serine residues. The inhibition of the NF-ĸB mutants was 
evaluated by various SLs, including helenalin, PTL, and two other SLs (Figure 27); gel shift 
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assays (EMSA) were used to visualize the presence of the p65-oligonucleotide complex. For all 
SLs tested (at varying concentrations), the binding of the wild type NF-ĸB to oligonucleotides 
was completely inhibited (contrary to reports by Hehner)120a, 120b, however, when Cys-38 was 
replaced with a serine residue, no inhibition was observed, supporting evidence for a covalent 
binding event that occurs between Cys-38 and the SL inhibitor, and that this interaction is 
essential to the prevention of NF-ĸB/DNA binding.122 Slight inhibition of IĸB degradation was 
also observed for all SLs tested, however, this mechanism of action was secondary to the 
prevention of NF-ĸB/DNA binding; the amount of un-degraded IĸB was not sufficient to account 
for complete inhibition of NF-ĸB/DNA binding. Finally, surface plasmon resonance confirmed 
interactions between helenalin and NF-ĸB/p65 unit, but not between helenalin and the IKK 
complex.123 
 
Figure 27. Sesquiterpene lactones evaluated in NF-ĸB mutant (Cys→ Ser) experiments. 
Merfort concludes that SLs inhibit NF-ĸB primarily through the prevention of NF-
ĸB/DNA binding by alkylating Cys-38 in the binding domain of NF-ĸB through a Michael-type 
addition; this mechanism of action can also be assumed as a general mechanism of action for all 
SLs containing α,β-unsaturated carbonyls.7 Merfort also hypothesized that the contradictory 
results for SLs acting by two different mechanisms of action could be contributed to the fact 
inhibition of IĸB degradation is observed when higher concentrations of the SL are used. This 
might hide the effect the SL has on p65, which is more visible at lower concentrations.7 
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In light of these studies, it is clear that understanding molecular mechanism of inhibition 
is of crucial importance when in the process of developing potential NF-ĸB inhibitors. While 
these studies have focused on SLs and lend themselves to make conclusions about a wide range 
of α-methylene-γ-butyrolactone containing NPs, mechanism of NF-ĸB inhibition studies 
pertaining specifically to 6,12-guaianolides are limited. Due to the potent NF-ĸB inhibition that 
was demonstrated by trans-guaianolide analog 1.83 (Section 2.1), synthesized in our lab, we 
sought to further examine the structure-activity relationship of 1.83 analogs and the mechanism 
of action. Our goals included the following; 1) determine if the relative stereochemistry of the C8 
methoxy group had an impact on the NF-ĸB inhibition ability, 2) show whether or not the α-
methylene lactone moiety was necessary for activity and if the group was thiol reactive, 3) 
identify protein targets of 1.83 through ABPP experiments. 
4.2 EFFECT OF C8 STEREOCHEMISTRY ON NF-ĸB INHIBITION 
Trans-guaianolide 1.83 was previously established as a potent NF-ĸB inhibitor, with 
comparable activity to parthenolide. However, trans-1.83 was evaluated as a mixture of 
diastereomers in relation to the C8 methoxy group. To evaluate if the two diastereomers had 
differing or consistent NF-ĸB inhibitory properties, they were separated via HPLC and 
characterized using NMR and computational techniques (Section 2.2.5). The major diastereomer 
was assigned as the 8βH-isomer 1.83a, while the minor diastereomer was assigned as the 8αH-
isomer 1.83b (Figure 28). These compounds are still racemic mixtures of the designated relative 
stereochemistry.  
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Our collaborators in the Harki group at the University of Minnesota evaluated the 
separated diastereomers of 1.83 for inhibition of induced NF-ĸB activity using a luciferase 
luminescence assay. A549 cells are treated with the potential inhibitors at varying 
concentrations, and then induced using TNF-α. This activation increases the luminescence which 
is then diminished in the presence of an NF-ĸB inhibitor.  Non-induced cells and cells induced 
without the presence of a potential inhibitor were used as control standards for the determination 
of relative NF-ĸB activity of cells treated with 8βH-1.83a and 8αH-1.83b.119b  
 
Figure 28. Structures of the two trans-1.83 diastereomers. 
The cells were treated with 1, 5, 10, and 20 µM of both diastereomers (Table 14). At 20 
µM, 8βH-1.83a lowered the induced NF-ĸB levels to 31% while 8αH-1.83b lowered NF-ĸB 
levels to 41.5%. Inhibition was also observed at 10 µM, with reduced NF-ĸB levels at 66% and 
75% for 8βH-1.83a and 8αH-1.83b respectively. While it was evident that the 8βH-1.83a may be 
slightly more potent than 8αH-1.83b, these two compounds were considered to be effectively 
equal inhibitors of NF-ĸB. Interestingly, the values reported for the separated diastereomers of 
trans-1.83 are slightly less potent that the previously reported data obtained from analysis of the 
mixture; which lowered induced NF-ĸB activity to 57% when dosed at 10 µM. The data from 
Table 14 is represented pictorially in Figure 29, with comparisons to the induced and non-
induced controls.  
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Table 14. Relative NF-ĸB activity of cells treated with 8βH-1.83a and 8αH-1.83b. 
8βH-1.83a 1 µM 5 µM 10 µM 20 µM 8αH-1.83b 1 µM 5 µM 10 µM 20 µM 
Trial 1 102.8 84.4 60.5 29.1 Trial 1 75.4 80.3 75.7 30.8 
Trial 2 106.9 92.9 70.3 28.9 Trial 2 88.1 88.9 71.0 47.9 
Trial 3 101.6 86.2 67.3 34.7 Trial 3 99.1 90.1 79.3 45.8 
Average 103.8 87.8 66.0 30.9 Average 87.5 86.4 75.3 41.5 
Values shown are the relative NF-kB activity (%) of A549 cells induced with TNF-α 30 min after treatment with 1.83a  and 
1.83b compared to induced A549 cells induced with no inhibitor treatment. 
 
 
Figure 29. Pictorial representation of relative NF-ĸB activity for cells treated with 8βH-1.83a and 8αH-1.83b. 
4.3 THE IMPORTANCE OF THE α-METHYLENE-γ-BUTYROLACTONE FOR NF-
ĸB INHIBITION 
To confirm that the biological activity of guaianolide analog trans-1.83 is dependent on 
the presence of the α-methylene-γ-butyrolactone moiety, we set out to synthesize the reduced α-
methyl-γ-butyrolactone analog 4.10. If obtained, 1.83 and 4.10 could be directly compared for 
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NF-ĸB inhibition. We envisioned that 4.10 could be obtained in a single step from 1.83 via 
conjugate reduction (Scheme 75).  
 
Scheme 75. Retrosynthetic analysis of 4.10. 
Conjugate reductions of α-methylene-γ-butyrolactones have most commonly been 
achieved using a reducing agent, such as sodium borohydride, or via a metal catalyzed 
hydrogenation, such as H2/Pd/C or H2/Wilkinson’s catalyst.99, 124 However, we had concerns that 
these methods would not be compatible with our functionally dense system, which contains 
multiple carbonyls and unsaturated C-C bonds. Metal hydride reagents, such as Stryker’s reagent 
([CuH(PPh3)]6) have also been employed as a reducing agent, and have been shown selectivity 
for α-methylene-γ-butyrolactones within highly complex molecules. For example, eremantholide 
4.13 was synthesized in one bio-mimetic synthetic step from furanoheliangolide 1.11 using 
Stryker’s reagent; selective reaction with the α-methylene-γ-butyrolactone affords an enolate 
intermediate 4.12, which then undergoes cyclization with the available unsaturated ester to give 
4.12 (Scheme 76).125 The conjugate hydride addition was determined to be the fast step while the 
enolate cyclization was the slow step. Premature quenching of 4.12 afforded 4.14, therefore, 
without an available electrophilic group to react with the enolate intermediate, Stryker’s reagent 
is also a viable reagent for the chemoselective reduction of α-methylene lactones to α-methyl 
lactones. 
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Scheme 76. Synthesis of α-methyl lactone 4.14 and eremantholide 4.13 from furanoheliangolide 4.11. 
4.3.1 Synthesis of reduced methylene guaianolide analog 4.10 
 In light of the reported selectivity of Stryker’s reagent for α-methylene-γ-butryolactones, 
this methodology was applied to trans-1.83. Synthetic investigations began by determining the 
appropriate solvent system (Table 15). Toluene is a traditional solvent for conjugate reductions 
using Stryker’s reagent, however, THF has been reported to increase reaction rates presumably 
by coordination with the copper reagent.125c Reacting trans-1.83 with the 1 equiv of Stryker’s 
reagent in 100% THF resulted in decomposition of 1.83 (Entry 1). Changing the solvent to a 5:1 
mixture of toluene and THF gave a 31% yield of 4.10 while use of 100% toluene afforded 4.10 
in 55% yield (Entries 2 and 3). Unfortunately, for both entries, the products were contaminated 
with triphenylphosphine (Ph3P) and triphenylphosphine oxide (Ph3PO), even after multiple 
attempts to purify via flash column chromatography. The conversion of trans-1.83 to 4.10 
occurred diastereoselectively; this was evidenced by the presence of only 2 diastereomers, as 
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seen in the starting material, pertaining to the stereochemistry of the C8 methoxy group (See 
Section 4.3.2 for further discussion).  
 Additional purification methods other than silica gel flash column chromatography were 
tried in an effort to remove the Ph3P and Ph3PO impurities. HPLC purification was effective for 
removing Ph3P, but 4.10 was still contaminated with Ph3PO, as both compounds are quite polar. 
Crystallization of the Ph3P and Ph3PO was attempted by dissolving 4.10 in a minimal amount of 
cold diethyl ether, and filtering off the observed crystals. This method was not effective for 
removing impurities in their entirety.  
Table 15. Initial attempts to reduce methylene of trans-1.83: Solvent effects. 
 
Entry Solvent (0.0095 M) Approx. yield 4.10 
1 THF 0% (decomposition) 
2 Toluene/THF (5:1) 31%a 
3 Toluene 55%a 
a4.10 contaminated with Ph3P and Ph3PO. 
  
Next, we applied the hydride conjugate addition reaction to silyl-protected trans-
guaianolide 2.24 (Scheme 77). 2.24 is significantly less polar (Rf = 0.18, 20% EtOAc in hexanes) 
than the silyl-deprotected 1.83 (Rf = 0.41, 100% EtOAc), so we predicted it would be more 
easily separated from Ph3PO via chromatography methods. The methylene group was 
successfully reduced diastereoselectively in the presence of Stryker’s reagent to afford 4.15. The 
crude NMR spectra of these experiments again showed significant impurities related to the Ph3P. 
For one experiment, column chromatography afforded both C8 diastereomers of 4.15, with some 
separation, in quantitative yield with only trace impurities. However, this result was not 
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reproducible; while using the same reaction conditions, other experiments required more 
extensive purifications, resulting in diminished yield of 4.15 (Scheme 77). It was clear that 
removal of Ph3P and Ph3PO still required tedious chromatography strategies despite the less-
polar nature of 4.15 compared to 4.10. 
 
Scheme 77. Reduction of 2.24 with [CuH(PPh3)]6 gave impure 4.15. 
Stryker’s reagent is a copper hydride hexamer complex, so by using 1 equivalent of the 
reagent, 6 equiv of copper hydride are actually employed. Therefore, in attempts to limit the 
presence of impurities, the amount of Stryker’s reagent required to fully consume the α-
methylene-γ-butyrolactone starting material was optimized. Due to limited availability of our 
guaianolide analogs, we optimized the required amount of Stryker’s reagent using cis-lactone 
4.16 (Table 16).43 To begin, 4.16 was stirred with 1 equiv of Stryker’s reagent in toluene at 0 °C; 
100% conversion to 4.17 was observed via crude 1H NMR spectroscopy after 1 h (Entry 1). Both 
0.8 and 0.4 equivalents also gave 100% conversion, but required 2 h of stirring (Entries 2 and 3). 
However, by employing 0.25 equiv of Stryker’s reagent and stirring for 14 h, 4.16 was converted 
to 4.17 in only 70% (Entry 4). We concluded that at least 0.4 equiv Stryker’s reagent should be 
employed to efficiently reduce α-methylene-γ-butryrolactones.  
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Table 16. Optimization of Stryker’s reagent equiv using model system 4.16. 
 
Entry Equiv Stryker’s reagent Time % conversiona 
1 1 equiv 1 h 100 
2 0.8 equiv 2 h 100 
3 0.4 equiv 2 h 100 
4 0.25 equiv 14 h 70 
aPercent conversion determined by crude 1H NMR spectroscopy. 
 
A solid supported scavenger was also tested for the removal of Ph3P and Ph3PO. In 2001, 
Lipshutz described a simple, expedient procedure for scavenging both Ph3P (4.18) and Ph3PO 
(4.21) using commercially available Merrifield’s resin (4.19) along with sodium iodide.126 
Merrifield’s resin is a polystyrene based resin made as a copolymer with styrene and 
chloromethylstyrene. When the benzylchloride groups are modified with sodium iodide, they can 
efficiently undergo substitution reactions with the Ph3P derivatives, displacing the iodide 
(Scheme 78).  
 
Scheme 78.  Reactions of Merrifield's resin/ NaI scavenging system with Ph3P 4.18 and Ph3PO 4.21. 
 
 181 
 
Scheme 79. Reduction of 4.16 to afford 4.17 after triphenylphosphine scavenging. 
The iodine-modified Merrifield’s resin purification method was first tested on model 
system cis-α-methylene-γ-butyrolactone 4.16. The resulting crude mixture of 4.17 and the Ph3P 
related impurities obtained from reacting 4.16 and Stryker’s reagent was taken up in acetone, 
followed by the addition of Merrifield’s resin and sodium iodide. A self-stirring incubator was 
used to swirl the mixture; a magnetic stir bar was not used because this would break down the 
resin, resulting in a more difficult separation. The process was monitored by TLC and after 16 h, 
Ph3P and Ph3PO were no longer observed. After filtration and washing of the resin, 4.17 was 
purified via column chromatography and afforded in 70% yield over the two steps (Scheme 79).  
Next, iodine-modified Merrifields’ resin was applied to the purification of reduced 
methylene guaianolide analog trans-4.15 (Scheme 80). Trans-methylene lactone 2.24 was 
reduced using 0.5 equiv of the copper hydride hexamer to give 4.15 with 100% conversion. The 
crude residue was swirled with Merrifield’s resin and sodium iodide to remove the Ph3P 
impurities and trans-4.15 was afforded in 43% yield over the two steps. In turn, trans-4.15 was 
desilylated using trimethylamine trihydrofluoride to afford the reduced methylene guaianolide 
analog 4.10 in 71% yield. Cis-2.25 (single diastereomer) was also tested during the process of 
optimizing this reaction sequence; cis-4.22 was afforded in 34% yield (as a 9.6:1 mixture of 
diastereomers) after the two step process of 1,4-reduction and purification (Scheme 80). 
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Scheme 80. Synthesis and purification of trans-4.15, 4.10 and cis-4.22. 
We originally proposed that reduced analog 4.10 could be obtained from a single 
synthetic step from trans-1.83 with the unprotected allylic alcohol. While we showed previously 
that Stryker’s reagent was efficient for converting trans-1.83 to 4.10, but the impurities had 
rendered the process ineffective. With the ability to remove the Ph3P and Ph3PO impurities using 
a scavenger system, we revisited the direct conversion of trans-1.83 to reduced analog 4.10. 
Guaianolide 1.83 was efficiently reduced using 0.5 equiv of Stryker’s reagent (100% conversion 
by crude 1H NMR), however, purification via with iodine-modified Merrifield’s resin did not 
afford 4.10, which was presumably unstable to the purification conditions (Scheme 81). Another 
possibility is that 4.10 was scavenged by the resin, however, iodine-modified Merrifield’s resin 
has been shown to not scavenge free amines which are more nucleophilic than alcohols. 126 In the 
future, IR or MS analysis of the resin could confirm this hypothesis. 
 
Scheme 81. Guaianolide analog 4.10 is not compatible with iodine-modified Merrifield's resin. 
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4.3.2 Assignment of relative C11 stereochemistry for α-methyl lactones 4.15 and 4.10. 
As mentioned, the transformation of the trans-α-methylene lactones to the α-methyl 
lactones occurred diastereoselectively for our substrates. For example, the reduction of the two 
C8 diastereomers of trans-lactone 2.24 (8βH-2.24a and 8αH-2.24b) resulted in two 
diastereomers trans-lactone 4.15 (11βH,8βH-4.15a and 11βH,8αH-4.15b) where C11 was 
reduced diastereoselectively to have a trans-relationship with C7 for both diastereomers. The 
relative stereochemistry of the methyl group at C11 was determined by comparing calculated and 
experimental 1H NMR spectral data.  
The two diastereomers of the reduced, silyl protected guaianolide analog 4.15a and 4.15b 
were isolated via chromatography. The major isomer of the silyl deprotected analog 4.10a was 
also isolated (Figure 30). 1H NMR data was obtained for these single isomers which allowed for 
resolution of additional coupling constants that could not be observed for the corresponding 
mixtures. 
 
Figure 30. Isolated diastereomers of 4.15 and 4.10 for which experimental 1H NMR spectra were obtained. 
Calculations were performed for the possible isomers for the reduction of trans-α-
methylene lactone 4.10 without the silyl protecting group; 8βH-4.10a could possibly result in 
11βH,8βH-4.10a or 11αH,8βH-4.10c while 8αH-4.10b could result in 11βH,8αH-4.10b or 
11αH,8αH-4.10d (Figure 31). The structures were drawn in Spartan and the lowest energy 
conformers of each were determined using MMFF calculations. Then, 1H NMR data was 
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calculated for the lowest energy conformer using B3LYP/6-31G* functionals. The chemical 
shifts shown in Table 17 and Table 18 are corrected chemical shifts. 
 
Figure 31. Diastereomers of 4.10 evaluated computationally. 
Comparison of the calculated and experimental 1H NMR data led to the stereochemical 
assignments of 11βH,8βH-4.15a, 11βH,8αH-4.15b and 11βH,8βH-4.10a. For all examples the 
methylene was reduced to afford a 7,11-trans relative stereochemistry. Experimentally, 4.15a 
(with the silyl protecting group) and 4.10a both had J7,11 values of 11.6 Hz. This matched the 
computationally calculated coupling constant for 4.10a (J7,11 = 11.6 Hz), whereas isomer 4.10c 
with a 7,11-cis relationship, has a smaller calculated J7,11  of 9.2 Hz (Table 17). Similarly, 4.15b 
(with silyl protecting group) has an experimentally observed J7,11 of 12.0 Hz, which corresponds 
favorably to the calculated J7,11 of 11.5 Hz for 4.10b. 4.10d had a smaller J7,11  value of 8.0 Hz 
(Table 18). In addition, the chemical shift for the H6 proton of 4.15b (5.61 ppm) was much closer 
to the calculated chemical shift for 4.10b (5.67 ppm) than for isomer 4.10d (6.14 ppm). 
Complete NMR assignments for experimental spectra of guaianolide analogs 4.15 and 4.10 can 
be found in Appendix A. 
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Table 17. 1H NMR calculations compared to experimental data for 4.15a and 4.10a. 
Position 11βH,8βH-4.10a Calc 
ppm 
11αH,8βH-4.10c Calc 
ppm 
11βH,8βH-4.15a Exp 
ppm 
11βH,8βH-4.10a Exp 
ppm 
6 5.28 
(J = 10.3 Hz) 
5.39 
(J = 10.2 Hz) 
 
5.29 
(d, J = 11.6 Hz) 
5.36 
(d, J = 11.2 Hz) 
7 2.10 
(J = 8.4, 10.3, 11.6 Hz) 
 
2.48 
(J = 8.8, 9.2, 10.2 Hz) 
2.21 
(ddd, J = 7.2, 11.6, 
11.6 Hz) 
 
2.27 
(ddd, J = 7.4, 11.6, 
11.6 Hz) 
8 3.35 
(J = 2.6, 3.5, 8.4 Hz) 
 
3.56 
(J = 2.7, 3.5, 8.8 Hz) 
3.73-3.68 (m) 3.73-3.69 (m) 
11 2.21 
(J = 6.6, 11.6 Hz) 
2.47 
(J = 6.7, 9.2 Hz) 
2.50 (qd, J = 6.8, 11.6 
Hz) 
2.59-2.48 (m) 
 
Table 18. 1H NMR calculations compared to experimental data for 4.15b. 
Position 11βH,8αH-4.10b Calc  
ppm 
11αH,8αH-4.10d Calc  
ppm 
11βH,8αH-4.15b Exp ppm 
(consistent with 4.10b) 
6 5.67 (J = 10.1 Hz) 6.14 (J = 11.1 Hz) 
 
5.61 (d, J = 10.8 Hz) 
7 2.28 (J = 4.6, 10.1, 11.5 Hz) 2.42 (J = 0.6, 8.0, 11.1 Hz) 
 
~2.3 (m) 
8 3.74 (J = 4.6, 5.8, 9.8 Hz) 3.69 (J = 0.6, 3.0, 3.4 Hz) 
 
3.69 (td, J = 6.0, 9.2 Hz) 
11 2.95 (J = 6.6, 11.5 Hz) 2.24 (J = 6.7, 8.0 Hz) 3.00 (qd, J = 6.8, 12.0 Hz) 
 
4.3.3 NF-ĸB inhibition of α-methyl-γ-butyrolactone analog 4.10a 
The reduced methylene analog 11βH,8βH-4.10a was evaluated using the same 
luminescence reporter assays used to evaluate the diastereomers of trans-1.83 for inhibition of 
induced NF-ĸB activity. A549 cells were treated with 11βH,8βH-4.10a (racemic) at 1, 5, 10, and 
20 µM concentrations and induced with TNF-α. For all concentrations, no reduction of the 
induced activity was observed. Triplicate data is shown in Table 19, while pictorial 
representations with a comparison to the controls (induced and non-induced cells) are shown in 
Figure 32. It was concluded that α-methyl lactone analog 11βH,8βH-4.10a is unable to inhibit 
induced NF-ĸB activity. Given that 8βH-1.83a showed potent NF-ĸB inhibition at similar 
concentrations, and the only structural difference between 8βH-1.83a and 11βH,8βH-4.10a is the 
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presence of the α-methylene-γ-butyrolactone moiety, it is clear this functional group is required 
and essential to the mechanism of inhibition.  
Table 19. Relative NF-ĸB activity of cells treated with 11βH,8βH-4.10a. 
11βH,8βH-4.10a 1 µM 5 µM 10 µM 20 µM 
Trial 1 101.2 90.9 79.8 94.7 
Trial 2 147.9 116.4 123.0 122.5 
Trial 3 103.2 95.7 109.2 101.4 
Average 117.4 101.0 104.0 106.2 
Values shown are the relative NF-kB activity (%) of A549 cells induced with TNF-
a 30 min after treatment with 4.10a (at varying concentrations) compared to 
induced A549 cells induced with no inhibitor treatment. 
 
 
Figure 32. Pictorial representation of relative NF-ĸB activity for cells treated with 4.10a. Induced cells 
were treated with TNF-α (15 ng/mL). 
4.4 REACTIVITY OF GUAIANOLIDE ANALOG 1.83 WITH CYSTEINE 
Merfort proposed that SLs inhibit NF-ĸB by selectively alkylating a cysteine residue 
(Cys-38) in the DNA binding domain of NF-ĸB.7  To show this is a possible mechanism of 
inhibition for our the guaianolide analogs, trans-1.83 was reacted with ʟ-cysteine in an aqueous 
phosphate buffer (pH 7.2). A small amount of acetone was also used to solubilize 1.83. The 
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reaction was monitored by both TLC and 1H NMR spectroscopy. Complete consumption of 
trans-1.83 was observed after 2 h. In the NMR, this was confirmed by the complete 
disappearance of the signals corresponding to the methylene protons at 6.25 and 5.85 ppm. 
Purification of the crude material afforded adduct 4.23 in 75% yield (Scheme 82). The reaction 
occurred diastereoselectivity, as was seen for the previously reported reaction of helenalin with 
cysteine.118 Also, analysis of the adduct 4.23 by NMR spectroscopy confirmed that the cysteine 
selectively reacted with the α-methylene-γ-butyrolactone; the dienone moiety was still intact.  
 
Scheme 82. Reaction of trans-1.83 with ʟ-cysteine to afford adduct 4.23. 
4.5 ABPP TARGET IDENTIFICATION STUDIES 
Our goal of determining the molecular targets of trans-guaianolide 1.83 required the 
synthesis of an activity based probe (ABP). An ABP must contain either an analytical reporter 
group or ligation handle, such as an alkyne, that can later be modified through a bioorthogonal 
reaction. Alkynes have become the preferred modification group due to their small size, 
compatibility with biological systems, and success in bioorthogonal reactions (for more 
information on ABPs, see Section 3.1). To this end, we envisioned that an alkynyl group could 
be installed onto trans-guaianolide 1.83 through propargylation of the allylic alcohol, to afford 
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alkyne probe 3.79 (Figure 33). To account for non-specific binding interactions in the protein 
pull-down experiments, we also set out to synthesize the analogous inactive probe 4.24, which 
has an α-methyl lactone rather than an α-methylene lactone. By performing the same protein 
pull-down experiments with both 3.79 and 4.24, a comparison can be made between the two 
probes to understand what proteins interact specifically with the α-methylene-γ-butyrolactone of 
the active probe 3.79. 
 
Figure 33. Proposed structures for an active and inactive activity based probe related to guaianolide analog 1.83. 
4.5.1 Synthesis of active and non-active guaianolide alkyne probes 
Propargylation of hydroxyl groups is commonly achieved using the Williamson ether 
synthesis, where a hydroxyl group is deprotonated to form the corresponding alkoxide and then 
reacted with propargyl bromide to afford the corresponding propargyl ether. When 1.83 was 
stirred with sodium hydride for 1 h, decomposition was observed. As a result, we turned to the 
Nicholas reaction as an acid-mediated alternative for propargylation of hydroxyl groups. As 
previously discussed in Section 3.2.4, alkyne probe 3.79 was available from 1.83 in 46% yield 
over the 2 step process (Scheme 83). The Nicholas reaction was also utilized to synthesize the 
inactive probe via propargylation of the allylic alcohol of 4.10. α-Methyl lactone 4.10 was 
reacted with Co2(CO)8, propargyl alcohol, and BF3•OEt2 at 0 °C to afford 4.25 in 38% yield. In 
turn, 4.24 was achieved in 70% yield after decomplexation of 4.25. 
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Scheme 83. Synthesis of active alkyne probe 3.79 and inactive probe 4.24. 
4.5.2 NF-ĸB inhibition of guaianolide alkyne probe 3.79. 
One concern when designing ABPs for protein target identification is that the biological 
activity of the probe should be similar to that of the original parent bioactive molecule for which 
the probe was made.77 The reporter group or ligation handle that is installed should not interfere 
with the covalent binding events in vivo, which could result in diminished bioactivity. For this 
reason, alkyne probe 3.79 was evaluated for inhibition of induced NF-ĸB activity and compared 
to trans-1.83, the parent biomolecule of interest.  
Table 20. Relative NF-ĸB activity averages for cells treated with alkyne probe 3.79. 
Alkyne probe 
3.79 
 
1 µM 
 
5 µM 
 
10 µM 
 
20 µM 
Trial 1 101.9 71.3 41.1 5.9 
Trial 2 102.1 66.9 48.7 8.7 
Trial 3 97.8 72.9 47.3 10.6 
Average 100.6 70.4 45.7 8.4 
Values shown are the relative NF-ĸB activity (%) of A549 cells induced with TNF-
α 30 min after treatment with 3.79 compared to induced A549 cells induced with 
no inhibitor treatment. 
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Interestingly, alkyne probe 3.79, evaluated as a 2.2:1 mixture of diastereomers, showed 
increased inhibition ability compared to the alcohol containing trans-1.83 (Table 20, Figure 34). 
At 20 µM, 3.79 lowered NF-ĸB activity to 8%, comparative to non-induced levels. The relative 
NF-ĸB inhibition of 8βH-1.83a and 8αH-1.83b reduced NF-ĸB to 31% and 42% respectively at 
this concentration, also shown in Figure 34 for comparison. When cells were treated with 3.79 at 
10 µM, the relative NF-ĸB activity was reduced to 46% compared to non-treated cells. Given the 
potency of alkyne probe 3.79, it is clear the alkyne ligation handle does not prevent the activity 
of the compound, and therefore can be used as a chemical tool for understanding the molecular 
targets of guaianolide analogs with an α-methylene-γ-butyrolactone.  
 
Figure 34. Pictorial representation of relative NF-ĸB activity for cells treated with alkyne probe 3.79. Data obtained 
for cells treated with both diastereomers of trans-1.83 are also included for comparison.  Cells were induced with 
TNF-α (15ng/mL). 
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4.6 CONCLUSIONS 
In conclusion, progress has been made towards understanding the means by which trans-
guaianolide 1.83 asserts its inhibitory properties toward NF-ĸB. The separated diastereomers 
8βH-1.83a and 8αH-1.83b were evaluated using relative NF-ĸB inhibition assays which revealed 
that the two diastereomers had similar biological properties. Due to this assessment, other 
analogs could continue to be evaluated as mixture of diastereomers, with relation to the C8 
methoxy group.  
Previous reports have discussed the importance of the α-methylene-γ-butyrolactone for 
the inhibitory properties of sesquiterpene lactones. In efforts to show this was also the case for 
guaianolide analog 1.83, a reduced methylene derivative 4.10 was prepared. This was achieved 
by reacting 2.24 with Stryker’s reagent, a copper hydride complex that selectively reduced the α-
methylene-γ-butyrolactone diastereoselectively to afford 11βH,8βH-4.15a and 11βH,8αH-4.15b. 
Due to triphenylphosphine and triphenylphosphine oxide impurities that resulted from using 
Stryker’s reagent, a solid supported scavenger, iodine-modified Merrifield’s resin, was used in 
the purification process of 4.15, which was then desilylated to afford 4.10. The reduced analog 
4.10a has no ability to inhibit induced NF-ĸB activity, thereby revealing the necessity of the α-
methylene-γ-butyrolactone for this bioactivity. Selective covalent modification of the α-
methylene-γ-butyrolactone upon stirring of trans-1.83 and ʟ-cysteine also supports this 
conclusion. 
Determining the molecular targets of trans-1.83 in vivo would add to the knowledge 
about this compounds mechanism of inhibition. Toward this end, an alkyne probe derivatives 
3.79 and 4.24 were designed for use in ABPP experiments. Due to the base-sensitive nature of 
trans-1.83, the Nicholas reaction was employed to successfully synthesize these probes. 
 192 
Effective ABP probes must have similar biological properties compared to their parent 
biomolecule to indicate that the installed alkynyl group does not interfere with the binding events 
responsible for the NF-ĸB inhibition. Alkyne probe 3.79 actually displayed increased potency 
toward NF-ĸB compared to its parent molecule 1.83. Therefore, the alkynyl group does not 
interfere with the potency of these guaianolide analogs for NF-ĸB inhibition. In fact, an ether 
group at this position may be superior to the allylic alcohol present in 1.83. Both alkyne probes 
will be used for ABPP to determine their molecular targets in the NF-ĸB pathway.  
4.7 EXPERIMENTALS 
4.7.1 General Methods 
All commercially available compounds were used as received unless otherwise noted. 
Dichloromethane (DCM), diethyl ether (Et2O), and tetrahydrofuran (THF) were purified by 
passing through alumina using a solvent purification system. Deuterated chloroform (CDCl3) 
was stored over 4 Å molecular sieves. Stryker’s reagent ([HCu(PPh3)]6) was purchased from 
Acros organics and was stored and handled in a nitrogen filled glove box. Boron trifluoride 
diethyl etherate (BF3•OEt2) was redistilled under a nitrogen atmosphere. Dicobalt octacarbonyl 
(Co2(CO)8) was used as purchased and was stored at -20 ºC and opened only in a nitrogen filled 
glove box. Purification of the compounds via manual flash column chromatography was 
performed using silica gel (40-63 μm particle size, 60 Å pore size) purchased from Sorbent 
Technologies. TLC analyses were performed on Silicycle SiliaPlate G silica gel glass plates (250 
μm thickness) and visualized by UV irradiation (at 254 nm), KMnO4 stain, and/or Ninhydrin 
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stain. 1H NMR and 13C NMR spectra were recorded on Bruker Avance 300 MHz, 400 MHz, 500 
MHz, or 600 MHz. Spectra were referenced to residual chloroform (7.26 ppm, 1H; 77.16 ppm, 
13C). Chemical shifts are reported in ppm, multiplicities are indicated by s (singlet), bs (broad 
singlet), d (doublet), t (triplet), q (quartet), p (pentet), and m (multiplet). Coupling constants, J, 
are reported in hertz (Hz). All NMR spectra were obtained at room temperature.  IR spectra were 
obtained using a Nicolet Avatar E.S.P. 360 (NaCl plate) FT-IR. ESI mass spectrometry was 
performed on a Waters Q-TOF Ultima API, Micromass UK Limited.  
4.7.2 General Procedures 
General procedure 4A: Reduction of α-methylene lactone with Stryker’s reagent 
followed by scavenging of triphenylphosphine and triphenylphosphine oxide with 
Merrifield’s resin. A flame-dried, single-necked, round-bottomed flask equipped with a stir bar 
was charged with Stryker’s reagent ([CuH(PPh3)]6, 0.5 equiv) in a N2 filled glove box. The flask 
was fitted with a rubber septum, transferred to a fume hood, and the septum was pierced with a 
N2 inlet needle. The flask was charged with toluene and cooled to 0 °C on an ice/water bath. The 
α-methylene-γ-butyrolactone (1 equiv) was dissolved in toluene (0.01 M overall) and added to 
the reaction flask via syringe. The reaction stirred until the methylene lactone was consumed, as 
evidenced by TLC or crude 1H NMR spectroscopy. The reaction was quenched by the addition 
of saturated aqueous solution of NH4Cl. The mixture was transferred to a separatory funnel and 
the aqueous layer was extracted with diethyl ether (3x). The combined organics were dried over 
MgSO4, filtered, and concentrated using reduced pressure rotary evaporation. The crude material 
was taken up in acetone (0.02 M) and transferred to a microwave vial. Sodium iodide (6 equiv) 
was added followed by Merrifield’s resin (4.4 mmol/g loaded resin, 6.6 equiv). The vial was 
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sealed and swirled (no stir bar) in an incubator at rt for 18 h. The slurry was filtered through a 
fritted filter and the resin was rinsed successively with THF, water, acetone, and methanol (2x 
each solvent). The filtrate was reduced to half volume using reduced pressure rotary evaporation 
and then extracted with Et2O (3x). The combined organics were dried over MgSO4, filtered, and 
concentrated. The crude residue was purified using silica gel flash column chromatography to 
afford the α-methyl lactone. 
4.7.3 General Calculations Procedure for 4.10 isomers. 
The calculations performed for the compounds in Section 4.3.2 were performed using 
MacSpartan ’14 Mechanics Program. The lowest energy conformation was defined using MMFF 
calculations. The lowest energy conformers were then used to calculate 1H NMR spectral data 
using B3LYP/631G* functionals with NMR options. These calculations generated chemical 
shifts (both corrected and uncorrected) for all atoms, as well as coupling constants for proton-
proton coupling. 
4.7.4 Experimental procedures with compound characterization data 
4-(1-(methoxymethoxy)heptyl)-3-methyl-5-
(phenylethynyl)dihydrofuran-2(3H)-one 4.17. Follows general 
procedure 4A: Stryker’s reagent (110 mg of a 1.3:1 ratio of 
diastereomers, 0.056 mmol, 1.0 equiv), toluene (2.0 mL), cis-guaianolide 4.16 (20 mg, 0.056 
mmol) dissolved in toluene (3.6 mL). The reactions stirred for 1 h before the first work up. The 
crude 1H NMR spectrum revealed formation of 4.17 with contamination of Ph3P and Ph3PO. The 
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second step was performed in acetone (2.0 mL), with sodium iodide (101 mg, 0.672 mmol, 12 
equiv), and Merrifield’s resin (168 mg, 0.224 mmol, 13.2 equiv). The crude residue from the 
second work up was purified using silica gel flash column chromatography (15% EtOAc in 
hexanes) to afford the title compound (14 mg, 70%) as a colorless oil and as a 1.3:1 ratio of 
diastereomers. 
Data for 4.17. 
1H NMR (300 MHz, CDCl3) 
7.46-7.39 (m, 2H), 7.37-7.28 (m, 3H), 5.46 (d, J = 7.2 Hz, 1H), 5.43 (d, J = 6.6 
Hz, 1H)*, 4.82-4.04 (m, 2H), 4.12-4.04 (m, 1H)*, 4.03-3.97 (m, 1H), 3.40 (s, 3H), 
3.39 (s, 3H)*, 2.99-2.89 (m, 1H)*, 2.61-2.56 (m, 2H), 1.96-1.80 (m, 1H), 1.62-
1.22 (m, 11H), 0.92-0.83 (m, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
179.2, 178.8*, 131.8, 131.7*, 129.3*, 129.2*, 128.64*, 128.59, 121.8, 97.1, 97.0*, 
89.5*, 89.3, 84.6*, 83.3, 78.7, 76.4*, 71.6*, 70.6, 56.2, 50.2, 46.0, 36.7*, 35.9, 
32.3, 32.2*, 31.9, 29.8*, 29.6, 24.2, 23.8*, 22.7, 15.2, 14.2, 12.4 ppm; 
*Discernable signal for the minor diastereomer 
HRMS  (FTMS + p ESI Full ms) 
  [M+H]+ calculated for C22H31O4, 359.2217; found, 359.2203; 
IR  (thin film) 
  2929, 2854, 2238, 1784, 1491, 1463, 1156, 1037, 987, 758, 692 cm-1; 
TLC  Rf = 0.43 (20% EtOAc in hexanes) 
  Silica gel, UV visible 
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α-Methyl cis-lactone 4.22. Follows general procedure 4A: Stryker’s 
reagent (33 mg, 0.017 mmol), toluene (2.0 mL), cis-guaianolide analog 
2.25 (20 mg of a single diastereomer, 0.034 mmol) dissolved in toluene 
(1.4 mL). The reaction stirred for 20 min before the first work up. The crude NMR revealed 
formation of 4.22 with contamination of Ph3P and Ph3PO. The second step was performed in 
acetone (1.5 mL), with sodium iodide (36 mg, 0.204 mmol), Merrifield’s resin (51 mg, 0.224 
mmol). The crude residue from the second work up was purified using silica gel flash column 
chromatography (gradient of 15-20% EtOAc in hexanes) to afford the title compound (7 mg, 
34%) as a colorless oil and as a 9.6:1 ratio of diastereomers, determined by the integrations for 
H6 at 5.63 and 5.44 ppm. 
Data for 4.22.  
1H NMR (400 MHz, CDCl3) 
7.70-7.62 (m, 4H), 7.49-7.37 (m, 9H), 7.26-7.22 (m, 2H), 5.63 (d, J = 7.2 Hz, 
1H)*, 5.44 (d, J = 6.0 Hz, 1H), 4.27 (d, J = 13.0 Hz, 1H), 4.20 (d, J = 13.0 Hz, 
1H), 3.64 (dd, J = 9.4, 4.2 Hz, 1H), 3.38 (s, 3H)*, 3.37 (s, 3H), 3.27-3.18 (m, 1H), 
3.03-2.88 (m, 3H), 2.78 (d, J = 20.8 Hz, 1H), 2.61-2.48 (m, 1H), 1.44 (d, J = 7.2 
Hz, 3H), 1.38 (d, J = 7.2 Hz 3H)*, 1.07 (s, 9H) ppm; 
* Discernable signal for minor diastereomer 
13C NMR (125 MHz, CDCl3) 
201.7, 178.6, 158.0, 135.8, 135.7, 133.2, 132.9, 130.4, 130.2, 130.1, 129.70, 
129.65, 129.3, 128.83, 128.77, 128.1, 128.0, 74.4, 65.7, 57.1, 45.1, 40.5, 38.5, 
31.7, 30.5, 27.0, 19.4, 11.9 ppm; 
HRMS  (FTMS + p ESI Full ms) 
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[M+H]+ calcd for C37H41O5Si, 593.2718; found, 593.2719; 
IR  (thin film) 
  3035, 2898, 2824, 1756, 1686, 1454, 1412, 1150, 1093, 983, 726, 693 cm-1; 
TLC  Rf = 0.15 (20% EtOAc in hexanes) 
  Silica gel, UV visible 
α-Methyl trans-lactone 4.15. Follows general procedure 4A: Stryker’s 
reagent (50 mg, 0.025 mmol, 0.5 equiv), toluene (3.8 mL), trans-
guaianolide analog 2.24 (30 mg of a 1.6:1 mixture of diastereomers, 
0.051 mmol) dissolved in toluene (1.2 mL). The reaction stirred for 1 h before the first work up. 
The crude NMR revealed formation of 4.15 with contamination of Ph3P and Ph3PO. The second 
step was performed in acetone (1.8 mL), with sodium iodide (46 mg, 0.31 mmol), Merrifield’s 
resin (76 mg of a 4.4 mmol/g loaded resin, 0.33 mmol). The crude residue from the second work 
up was purified using silica gel flash column chromatography (gradient of 15-30% EtOAc in 
hexanes) to afford the title compound (13 mg, 43%) as a 1.4:1 mixture of diastereomers. 
• When the iodine-modified Merrifield’s resin was not used, extensive purification via 
silica gel column chromatography was required. This allowed slight separation of the two 
diastereomers 11βH,8βH-4.15a and 11βH,8αH-4.15b, which were used for NMR 
characterization. 
Data for 11βH,8βH-4.15a.  
1H NMR (400 MHz, CDCl3) 
7.72-7.64 (m, 4 H), 7.50-7.33 (m, 9 H), 7.24-7.20 (m, 2 H), 5.29 (d, J = 11.2 Hz, 
1 H), 4.33 (d, J = 13.0 Hz, 1 H), 4.21 (d, J = 13.0 Hz, 1 H), 3.73-3.68 (m, 1 H), 
3.36 (s, 3 H), 3.31 (dd, J = 16.0, 2.4 Hz, 1 H), 2.88 (d, J = 20.8 Hz, 1 H), 2.72 (d, 
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J = 20.8 Hz, 1 H), 2.50 (dq, J = 11.6, 6.8 Hz, 1 H), 2.41-2.34 (m, 1 H), 2.21 (ddd, 
J = 11.6, 11.6, 7.2 Hz, 1 H), 1.29 (d, J = 6.8 Hz, 3 H), 1.09 (s, 9 H) ppm; 
Impurity seen at 1.25 ppm. 
13C NMR (100 MHz, CDCl3) 
201.8, 176.5, 162.2, 142.6, 135.7, 133.6, 133.1, 132.3, 131.3, 130.3, 130.2, 129.8, 
128.5, 128.03, 127.97, 127.7, 82.9, 75.9, 66.5, 56.6, 53.4, 41.9, 39.4, 29.6, 27.0, 
19.5, 14.6 ppm; 
TLC  Rf = 0.13 (20% EtOAc in hexanes) 
  Silica gel, UV visible 
Data for 11βH,8αH-4.15b. 
1H NMR (400 MHz, CDCl3) 
7.70-7.65 (m, 4H), 7.51-7.32 (m, 9H), 7.26-7.24 (m, 2H), 5.61 (d, J = 10.8 Hz, 
1H), 4.27 (app s, 2H), 3.69 (dt, J = 9.2, 6.0 Hz, 1H), 3.45 (s, 3H), 3.27 (dd, J = 
14.0, 6.4 Hz, 1H), 3.00 (dq, J = 12.0, 6.8 Hz, 1H), 2.81 (d, J = 20.8 Hz, 1H), 2.74 
(d, J = 20.8 Hz, 1H), 2.39-2.26 (m, 2H), 1.18 (d, J = 6.8 Hz, 3H), 1.10 (s, 9H) 
ppm; 
Impurities seen at 4.12, 2.05, and 1.26 ppm due to the presence of EtOAc. 
13C NMR (100 MHz, CDCl3) 
201.4, 177.2, 162.6, 143.7, 135.69, 135.65, 133.13, 133.09, 133.0, 132.0, 131.3, 
130.3, 129.7, 128.6, 128.09, 128.06, 127.8, 74.8, 72.8, 66.0, 57.5, 53.1, 39.5, 35.0, 
32.9, 27.0, 19.5, 13.5 ppm; 
Impurities seen at 60.6, 29.9, 21.2, 14.4 ppm 
TLC  Rf = 0.16 (20% EtOAc in hexanes) 
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  Silica gel, UV visible 
HRMS, IR data obtained using from the 1.4:1 mixture of diastereomers: 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C37H41O5Si, 593.2718; found, 593.2721; 
IR  (thin film) 
  2930, 2856, 1783, 1703, 1460, 1428, 1164, 1105, 701 cm-1; 
11αH-trans-guaianolide analog 4.10. A flame-dried, 5 mL, single-necked 
flask with a stir bar and septum was charged with silyl ether 4.15 (16 mg of a 
1.4:1 mixture of diastereomers, 0.027 mmol, 1 equiv), dissolved in 
acetonitrile (0.9 mL). NEt3•3HF was added dropwise (11 mg, 0.068 mmol, 2.5 equiv). The 
reaction flask was lowered into a pre-heated oil bath (50 °C) and stirred for 17 h. The reaction 
was cooled to rt and diluted with water (2 mL) and Et2O (2 mL). The reaction mixture was 
transferred to a separatory funnel and the flask was rinsed with additional water and Et2O. The 
organic layer was separated and the aqueous layer was extracted with Et2O (2 x 5 mL). The 
combined organics were dried over MgSO4, filtered, and concentrated using reduced pressure 
rotary evaporation.  The crude reaction mixture was purified by silica gel flash column 
chromatography (50 mL of 50% EtOAc in hexanes followed by 100 mL 100% EtOAc) to afford 
the title compound (6.5 mg, 71%) as a colorless oil and as a 1.2:1 mixture of diastereomers.  
• When 11βH,8βH-4.15a (15 mg, 0.0253 mmol, 1 equiv) as a single diastereomer was 
stirred with NEt3·3HF using the same procedure, 6 mg of 11βH,8βH-4.10a was afforded 
in 63% yield. 
Data for 4.10 as a 1.2:1 mixture of diastereomers (4.10a : 4.10b). 
1H NMR (500 MHz, CDCl3) 
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7.41-7.31 (m, 3H), 7.29-7.24 (m, 2H), 5.66 (d, J = 10.5 Hz, 1H)*, 5.36 (d, J = 
11.0 Hz, 1H), 4.29 (d, J = 12.0 Hz, 1H), 4.28 (app s, 2H)*, 4.18 (d, J = 12.0 Hz, 1 
H), 3.77-3.69 (m, 1H), 3.48 (s, 3H), 3.46 (s, 3H)*, 3.32-3.13 (m, 2H), 3.08 (dd, J 
= 15.5, 2.5 Hz, 1H), 3.05-2.98 (m, 1H)*, 2.58-2.49 (m, 2H), 2.47-2.36 (m, 2H)*, 
2.27 (ddd, J = 11.5, 11.5, 4.5 Hz, 1H), 1.30 (d, J = 7.0 Hz, 3H), 1.18 (d, J = 
7.0Hz, 3H)* ppm; 
Impurities seen at 9.20, 6.25, 5.30, 5.11, 2.13, 2.04, 1.43, 1.26, 0.88 ppm. 
13C NMR (125 MHz, CDCl3) 
201.5, 201.3*, 177.1*, 176.3, 162.6*, 162.0, 144.4*, 143.7, 134.2*, 133.9, 132.8, 
131.7*, 131.2*, 131.1, 129.8, 129.7*, 128.73*, 128.69, 127.84*, 127.78, 82.9, 
75.8, 74.7*, 72.8*, 65.3*, 65.2, 57.6*, 57.1, 53.6, 53.1*, 41.9, 39.8*, 39.6, 35.1*, 
33.5*, 31.2, 14.6, 13.4* ppm; 
Impurities seen at 171.3, 60.5, 14.4 ppm. 
* Minor 4.10b diastereomer 
HRMS  (FTMS + p ESI Full ms) 
[M+H]+ calcd for C21H23O5, 355.15400; found, 355.15417; 
IR  (thin film) 
  3433, 2923, 2853, 1778, 1696, 1457, 1392, 1227, 1166, 1095, 1032 cm-1; 
TLC  Rf = 0.21 (100% EtOAc) 
  Silica gel, UV visible 
Data for 4.10a as a single diastereomer  
1H NMR (400 MHz, CDCl3) 
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7.40-7.33 (m, 3 H), 7.27-7.22 (m, 2 H), 5.36 (d, J = 11.2 Hz, 1 H), 4.30 (d, J = 
12.4 Hz, 1 H), 4.18 (d, J = 12.4 Hz, 1 H), 3.73-3.69 (m, 1 H), 3.48 (s, 3 H), 3.29 
(d, J = 20.4 Hz, 1 H), 3.16 (d, J = 20.4 Hz, 1 H), 3.08 (dd, J = 15.6, 2.4 Hz, 1 H), 
2.59-2.48 (m, 2 H), 2.27 (ddd, J = 11.6, 11.6, 7.4 Hz, 1 H), 1.31 (d, J = 7.4 Hz, 3 
H) ppm; 
Impurities seen at 7.69, 7.52, 7.49, 4.14, 2.04, 1.25, 0.88 ppm; 
13C NMR (125 MHz, CDCl3) 
201.4, 176.3, 162.0, 143.6, 133.9, 132.8, 131.1, 129.8, 128.7, 127.8, 82.9, 75.8, 
65.2, 57.1, 53.5, 41.9, 39.5, 31.2, 14.6 ppm; 
Cysteine adduct 4.23.  In a vial, 1.83 (12 mg of a 4:1 ratio of 8βH-
1.83a: 8αH-1.83b, 0.034 mmol, 1 equiv) was dissolved in 1 mL 
DCM. This solution was transferred to a 5 mL flask, the DCM was 
evaporated off using reduced pressure rotary evaporation, and the 1.83 was dried under high 
vacuum. The flask was equipped with a stir bar and charged with acetone (0.069 mL) followed 
by aqueous phosphate buffer with a pH of 7.2 (1 mL). ʟ-Cysteine (4 mg, 0.034 mmol, 1 equiv) 
was added and stirred for 2 h while the reaction was monitored by TLC (solvent system was the 
bottom layer of CHCl3/methanol/water, 7:3:1, product visible using ninhydrin stain). Upon 
completion of the reaction, the solvent was evaporated under reduced pressure giving a yellow 
orange crude material (22 mg). The crude material was purified using silica gel flash 
chromatography (bottom layer of CHCl3, methanol, water solution; 7:3:1) to give 12 mg of 
adduct 4.23 in 75% yield. 1H NMR of the crude material had shown the presence of both 
diastereomers, however only the 8βH-adduct was obtained after purification. The purified 
material of 4.23 became contaminated with DMF through unknown means. 
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Data for 4.23 
1H NMR (600MHz, D2O) 
7.43-7.41 (m, 3 H), 7.24-7.22 (m, 2 H), 5.74 (d, J = 11.0 Hz, 1 H), 4.29 (d, J = 
13.2 Hz, 1 H), 4.15 (dd, J = 13.2, 2.4 Hz, 1 H), 4.06-4.02 (m, 1 H), 3.89-3.86 (m, 
1H), 3.46 (s, 3 H), 3.40 (d, J = 21.0 Hz, 1 H), 3.39-3.30 (m, 1 H), 3.32 (d, J = 21.0 
Hz, 1 H), 3.19-2.91 (m, 5 H) 2.67-2.60 (m, 2 H) ppm; 
Impurities seen at 7.91, 2.99, and 2.83 ppm due to the presence of DMF. 
13C NMR (150 MHz, D2O) 
208.2, 178.8, 173.3, 165.9, 142.04, 136.2, 133.8, 132.3, 130.3, 129.1, 128.7, 82.5, 
78.0, 65.1, 56.8, 54.6, 49.6, 47.6, 39.7, 35.0, 31.0, 30.5 ppm; 
Impurities seen at 165.7, 129.3, 37.7, and 32.2 ppm. 
TLC   Rf = 0.14 (bottom layer of a chloroform, methanol, and water solution; 7:3:1)  
Silica gel, UV, Ninhydrin stain. 
Co2(CO)6-reduced methylene alkyne probe 4.25. Follows general 
procedure 3C.2 (Section 3.4.2): Propargyl alcohol (2 mg, 0.037 mmol), 
DCM (0.3 mL), Co2(CO)8 (13 mg, 0.037 mmol), guaianolide analog 4.10 (7 
mg of a 1.2:1 mixture of diastereomers, 0.018 mmol), dissolved in DCM (0.2 
mL), and BF3•OEt2 (7 mg, 0.046 mmol). The reaction was stirred for 45 min. The crude residue 
was purified by silica gel flash column chromatography (gradient of 20-50% ethyl acetate in 
hexanes) to afford 5 mg of 4.25 in 38% yield as a dark red oil and as a ~1 :1 mixture of 
diastereomers. 1H NMR showed that 4.25 was 85% pure, due to contamination with an unknown, 
but structurally related by-product. 
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• When 11βH,8βH-4.10a (4 mg of a single diastereomer, 0.013 mmol) was subjected to the 
same procedure, 1 mg of the corresponding 11βH,8βH-4.25a was afforded in 16% yield. 
Data for 4.25 as mixture of diastereomers. 
1H NMR (500 MHz, CDCl3) 
7.49-7.32 (m, 3 H), 7.30-7.25 (m, 2 H), 6.08 (s, 1 H), 5.66 (d, J = 11.0 Hz, 1 H)*, 
5.35 (d, J = 11.0 Hz, 1 H), 4.72-4.62 (m, 2 H), 4.35-4.21 (m, 2 H), 3.80-3.65 (m, 
1 H), 3.45 (s, 3 H), 3.42 (s, 3 H)*, 3.31-2.96 (m, 3 H), 2.58-2.48 (m, 1 H), 2.46-
2.34 (m, 1 H), 2.33-2.23 (m, 1 H), 1.30 (d, J = 7.0 Hz, 3 H), 1.15 (d, J = 7.0 Hz, 3 
H)* ppm;  
Impurities seen at 10.0, 5.78, 5.59, 5.26, 4.12, 3.50, 3.43, 2.80-2.68, 2.04, 1.43, 
1.26, 0.88 ppm.  
*Discernable signal for the 11βH,8αH-4.25b diastereomer. 
13C NMR (125 MHz, CDCl3) 
201.7, 201.2*, 199.8, 177.2, 176.4*, 162.7, 162.1*, 144.5*, 143.4, 135.2, 134.3*, 
133.1, 131.4*, 131.2, 131.1*, 129.8*, 129.7, 128.8*, 128.7, 127.9, 127.8*, 91.7, 
91.4*, 83.0, 75.9, 74.6*, 73.3*, 73.2, 72.4*, 71.5, 71.1*, 57.4, 56.7*, 53.5*, 53.1,  
42.0, 40.0, 39.8*, 35.0*, 33.7*, 29.9, 14.6*, 13.3 ppm; 
Impurities seen at 130.1, 128.0, 60.5, 21.2 14.4 ppm; 
  *Discernable signal for one of the diastereomers. 
TLC  Rf = 0.38 (40% EtOAc in hexanes) 
  Silica gel, UV visible 
Data for 11βH,8βH-4.25a as a single diastereomer. 
1H NMR (400 MHz, CDCl3) 
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7.40-7.32 (m, 3 H), 7.28-7.24 (m, 2 H), 6.08 (s, 1 H), 5.35 (d, J = 10.8 Hz, 1 H), 
4.68 (d, J = 12.0 Hz, 1 H), 4.63 (d, J = 13.6 Hz, 1 H), 4.33 (d, J = 12.4 Hz, 1 H), 
4.22 (d, J = 12.8 Hz, 1 H), 3.76-3.69 (m, 1 H), 3.45 (s, 3 H),  3.25 (app s, 2 H) 
3.23-3.16 (m, 1 H), 2.58-2.47 (m, 1 H), 2.44-2.38 (m, 1 H), 2.27 (ddd, J = 11.6, 
11.6, 7.0 Hz, 1 H), 1.30 (d, J = 7.0 Hz, 3 H) ppm;  
Reduced methylene alkyne probe 4.24. Follows general procedure 3D 
(Section 3.4.2): cobalt complex 4.25 (5 mg of a 1:1 mixture of diastereomers, 
0.0066 mmol, 1 equiv), acetone (0.5 mL), and ceric ammonium nitrate (15 
mg, 0.027 mmol, 4 equiv). The reaction stirred for 15 min. The crude residue 
was purified by silica gel flash column chromatography (gradient of 30-50% Et2O in hexanes to 
afford 2 mg of propargyl ether 4.24 as a mixture of two diastereomers (1.2:1) in 70% yield as a 
colorless oil. 1H NMR revealed the material was 78% pure with an inseparable, unidentified 
impurity. The mixture was sent to collaborators Dan Harki and John Widen for further 
purification, characterization, and biological evaluation.  
Data for 4.24. 
1H NMR (500 MHz, CDCl3) 
7.49 -7.31 (m, 3 H), 7.29-7.25 (m, 2 H), 5.66 (d, J = 11.0 Hz, 1 H)*, 5.34 (d, J = 
11.0 Hz, 1 H), 4.28-4.15 (m, 4 H), 3.84-3.62 (m, 1 H), 3.46 (s, 3 H)*, 3.45 (s, 3 
H), 3.36-2.97 (m, 3 H), 2.59-2.44 (m, 3 H), 2.43-2.09 (m, 1 H), 1.30 (d, J = 6.3 
Hz, 3 H). 1.19 (d, J = 6.3 Hz, 3 H)* ppm; 
* Discernable signal for one of the diastereomers. 
Impurities seen at 10.0, 5.77, 5.46, 4.12, 3.49, 3.43, 2.70, 2.04, 1.54, 1.38, 1.25, 
0.87 ppm. 
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TLC  Rf = 0.34 (50% Et2O in hexanes) 
  Silica gel, UV visible 
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APPENDIX A 
TABLES OF NMR DATA FOR GUAIANOLIDE ANALOGS 
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Table 21. 1H and 13C NMR data for 1.83a and 1.83b. 
 
Compound 8βH-1.83a 8αH-1.83b 
Position 1H signal(s) ppm 13C signal(s) 
ppm 
1H signal(s) ppm 13C signal(s) 
ppm 
1 --- 133.9 --- 133.7 
2 3.29 (d, J = 21.0 Hz, 1 H), 
3.17 (d, J = 21.0 Hz, 1 H) 
 
39.5  3.28-3.15 (m, 2 H) 39.9  
3 --- 201.4 --- 201.3 
4 --- 143.3 --- 144.1 
5 --- 161.6 --- 162.2 
6 5.39 (d, J = 10.5 Hz, 1 H) 75.8 5.78 (d, J = 9.2 Hz, 1 H) 74.9 
7 3.18-3.13 (m, 1 H) 50.0 3.37-3.31 (m, 1H) 49.8 
8 3.86 (ddd, J = 8.0, 4.0, 2.5 Hz, 
1 H) 
81.7 4.14-4.07 (m, 1 H) 74.0 
9 3.16-3.12 (m, 1 H) 
2.56 (dd, J = 15.8, 2.5 Hz, 1 H) 
30.6 3.27 (dd, J = 15.2, 6.8 Hz, 1 H) 
2.53 (dd, J = 15.2, 8.4 Hz, 1 H) 
33.9 
10 --- 133.0 --- 132.2 
11 --- 137.2 --- 134.2 
12 --- 167.8 --- 168.4 
13 6.25 (d, J = 3.5 Hz, 1 H) 
5.85 (d, J = 3.0 Hz, 1 H) 
122.1 6.36 (d, J = 3.6 Hz, 1 H) 
5.52 (d, J = 3.2 Hz, 1 H) 
123.0 
14 4.31 (d, J = 12.5 Hz, 1H),  
4.19 (d, J = 12.5 Hz, 1 H) 
65.3 4.34-4.26 (m, 2 H) 65.6 
-OMe 3.54 (s, 3 H) 56.9 3.45 (s, 3 H) 57.5 
Phenyl ring 7.40-7.32 (m, 3 H) 
 7.27-7.24 (m, 2 H) 
130.7, 130.0, 
128.8, 127.8,  
7.45-7.32 (m, 3 H),  
7.30-7.26 (m, 2 H) 
130.8, 130.0, 
128.9, 127.9 
 
 
 
 
 
 208 
Table 22. 1H and 13C NMR data for 3.78 and 3.79. 
 
Compound 3.78 3.79 
Position 1H signal(s) ppm 13C signal(s) ppm 1H signal(s) ppm 13C signal(s) ppm 
1 --- 134.0, 133.6*  --- 135.4, 133.6* 
2 3.32-3.14 (m, 2 H) 40.0*, 39.7 3.39-3.24 (m, 2 H) 40.0*, 39.7 
3 --- 201.4, 201.0* --- 201.5, 201.3* 
4 --- 144.0*, 143.0 --- 144.2*, 143.2 
5 --- 162.2*, 161.5 --- 161.9*, 161.4 
6 5.78 (d, J = 9.6 Hz, 1 H) 
5.38 (d, J = 10.4 Hz, 1 H) 
75.7, 74.7* 5.78 (d, J = 9.6 Hz, 1 H)* 
5.38 (d, J = 10.4 Hz, 1 H) 
75.7, 74.8* 
7 3.32-3.14 (m, 1 H) 49.8 3.22-3.11 (m, 1 H) 49.8, 49.7* 
8 4.10-4.05 (m, 1 H)* 
3.88-3.86 (m, 1 H) 
81.8, 73.6* 4.09-4.06 (m, 1 H)* 
3.87-3.84 (m, 1 H) 
81.8, 73.8* 
9 3.32-3.14 (m, 1 H) 
2.52-2.41 (m, 1 H) 
33.8*, 29.5 3.22-3.11 (m, 1 H) 
2.52-2.46 (m, 1 H) 
34.2*, 30.0 
10 --- 131.6, 130.3* --- 130.9, 129.7* 
11 --- 137.2, 135.0* --- 137.2, 135.8* 
12 --- 168.3*, 167.9 --- 168.3*, 167.9 
13 6.34 (d, J = 3.6 Hz, 1 H)* 
6.24 (d, J = 3.2 Hz, 1 H) 
5.86 (d, J = 3.2 Hz, 1 H) 
5.47 (d, J = 3.2 Hz, 1 H)* 
122.8*, 122.2 6.36 (d, J = 3.2 Hz, 1 H)* 
6.24 (d, J = 3.2 Hz, 1 H) 
5.88 (d, J = 2.8 Hz, 1 H) 
5.52 (d, J = 3.2 Hz, 1 H)* 
122.9*, 122.2 
14 4.33 (d, J = 12.4 Hz, 1H),  
4.25 (d, J = 12.8 Hz, 1 H) 
4.26 (app s, 2 H)* 
73.4, 73.3* 4.23-4.16 (m, 2 H) 75.6, 75.4* 
15 4.71-4.61 (m, 2 H) 71.4*, 71.1 4.23-4.16 (m, 2 H) 71.9*, 71.5 
16 --- 90.7*, 90.6 --- 79.5, 79.3* 
17 6.09 (s, 1 H) 71.9, 71.6* 2.52-2.46 (m, 1 H) 57.8*, 57.2 
Co2(CO)6 --- 199.6   
-OMe 3.51 (s, 3 H) 
3.39 (s, 3 H)* 
57.2*, 56.5 3.51 (s, 3 H) 
3.43 (s, 3 H)* 
57.4*, 56.5 
Phenyl ring 7.40-7.35 (m, 3 H) 
7.31-7.26 (m, 2 H) 
130.72*, 130.65, 
130.0, 129.9*, 
128.84*, 128.77, 
127.8*, 127.7 
7.38-7.35 (m, 3 H) 
 7.30-7.24 (m, 2 H) 
130.73*, 130.65, 
129.93, 129.89*, 
128.9*, 128.8, 
127.80*, 127.75 
 *Discernable signal for minor diastereomer. 
 
*Discernable signal for minor diastereomer. 
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Table 23. 1H and 13C NMR data for 4.15a and 4.15b. 
 
Compound                       4.15a                                                         4.15b 
Position 1H signal(s) ppm 13C signal(s) 
ppm 
1H signal(s) ppm 13C signal(s) 
ppm 
1 --- 133.6 --- b 
2 2.88 (d, J = 20.8 Hz, 1 H),  
2.72 (d, J = 20.8 Hz, 1 H) 
39.4 2.81 (d, J = 20.8 Hz, 1 H) 
2.74 (d, J = 20.8 Hz, 1 H) 
39.5 
3 --- 201.8 --- 201.4 
4 --- 142.6 --- 143.7 
5 --- 162.2 --- 162.6 
6 5.29 (d, J = 11.6 Hz, 1 H) 75.9 5.61 (d, J = 10.8 Hz, 1 H) 74.8 
7 2.21 (ddd, J = 11.6, 11.6, 7.2 
Hz, 1 H) 
53.4 2.39-2.26 (m, 1 H) 53.1 
8 3.73-3.68 (m, 1 H) 82.9 3.69 (dt, J = 9.2, 6.0 Hz, 1 H) 72.8 
9 3.31 (dd, J = 16.0, 2.4 Hz, 1 H) 
2.41-2.34 (m, 1 H) 
29.6 3.27 (dd, J = 14.0, 6.4 Hz, 1 
H) 
2.39-2.26 (m, 1 H) 
32.9 
10 --- a --- b 
11 2.50 (dq, J = 11.6, 6.8 Hz, 1 H) 41.9 3.00 (dq, J = 12.0, 6.8 Hz, 1 
H) 
35.0 
12 --- 176.5 --- 177.2 
13 1.29 (d, J = 6.8 Hz, 3 H), 14.6 1.18 (d, J = 6.8 Hz, 3 H) 13.5 
14 4.33 (d, J = 13.0 Hz, 1 H),  
4.21 (d, J = 13.0 Hz, 1 H) 
66.5 4.27 (app s, 2 H) 66.0 
-OMe 3.36 (s, 3 H) 56.6 3.45 (s, 3 H) 57.1 
Phenyl 
ring 
7.72-7.64 (m, 4 H) 
7.50-7.33 (m, 9 H) 
7.24-7.20 (m, 2 H) 
a, 129.8, 128.5, 
127.7 
7.70-7.65 (m, 4 H) 
7.51-7.32 (m, 9 H) 
7.26-7.24 (m, 2 H) 
b, 129.7, 128.6, 
127.8 
TBDPS 
phenyl 
135.7, 133.1, 
130.3, 130.2 
128.03, 127.97 
 135.69, 135.65, 
133.13, 133.09, 
130.03, 130.00, 
128.09, 128.06 
TBDPS 
tert-butyl 
1.09 (s, 9 H) 27.0, 19.5 1.10 (s, 9 H) 27.0, 19.5 
 aC10, and the substituted aromatic carbon are the 
signals at 132.3, and 131.3, but could not be 
assigned. 
bC1, C10, and the substituted aromatic carbon 
are the signals at 133.0. 132.0, and 131.3 but 
could not be assigned. 
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Table 24. 1H and 13C NMR data for 4.10a and 4.10b. 
 
Compound 4.10a 4.10bb 
Position 1H signal(s) ppm 13C signal(s) 
ppm 
1H signal(s) ppm 13C signal(s) 
ppm 
1 --- 133.9 --- 134.2 
2 3.29 (d, J = 20.4 Hz, 1 H),  
3.16 (d, J = 20.4 Hz, 1 H) 
39.5 (3.31-3.14 m, 2H) 39.8  
3 --- 201.4 --- 201.3 
4 --- 143.6 --- 144.4 
5 --- 162.0 --- 162.6 
6 5.36 (d, J = 11.2 Hz, 1 H) 75.8 5.66 (d, J = 10.5 Hz, 1 H) 74.7 
7 2.27 (ddd, J = 11.6, 11.6, 7.4 
Hz, 1 H) 
53.5 2.47-2.36 (m, 1 H) 53.1 
8 3.73-3.69 (m, 1 H) 82.9 3.78-3.70 (m 1 H) 72.8 
9 3.08 (dd, J = 15.6, 2.4 Hz, 1 H) 
2.59-2.48 (m, 1 H) 
31.2 c 
2.47-2.36 (m, 1 H) 
33.5 
10 --- a --- d 
11 2.59-2.48 (m, 1 H) 41.9 3.05-2.98 (m, 1 H) 35.1 
12 --- 177.1 --- 177.1 
13 1.31 (d, J = 7.4 Hz, 3 H) 14.6 1.18 (d, J = 7.0 Hz, 3 H) 13.4 
14 4.30 (d, J = 12.4 Hz, 1 H),  
4.18 (d, J = 12.4 Hz, 1 H) 
65.2 4.28 (app s, 2 H) 65.3 
-OMe 3.48 (s, 3 H) 57.1 3.46 (s, 3 H) 57.6 
Phenyl ring 7.40-7.33 (m, 3 H), 
7.27-7.22 (m, 2 H) 
a, 129.8, 
128.7, 127.8 
7.40-7.33 (m, 3 H), 7.27-7.22 (m, 
2 H) 
129.7, 128.7, 
127.8, d 
 aC10, and the substituted aromatic carbon are the 
signals at 132.8 and 131.1, but could not be 
assigned. 
b4.10b was not isolated. Assignments based upon 
spectrum obtained for a mixture of 4.10a and b 
c1 H of position 9 buried in multiplet from 3.31-
3.12 ppm 
dC10, and the substituted aromatic carbon are the 
signals at 131.7, and 131.2 but could not be 
assigned. 
 
 
 
 211 
Table 25. 1H and 13C NMR data for cysteine adduct 4.23. 
 
Position 1H Signal(s) 13C signal(s) 
1 --- 136.2 
2 3.40 (d, J = 21.0 Hz, 1 H) 
3.32 (d, J = 21.0 Hz, 1 H) 
39.7 
3 --- 208.2 
4 --- 142.0 
5 ---   165.9 
6 5.74 (d, J = 11.0 Hz, 1 H) 78.0 
7 2.67-2.60 (m, 1 H) 49.6 
8 4.06-4.02 (m, 1 H) 82.5 
9 3.39-3.30 (m, 1 H) 
2.67-2.60 (m, 1 H) 
35.0 
10 --- 133.8 
11 3.19-2.91 (m, 1 H) 47.6 
12 --- 178.8 
13 3.19-2.91 (m, 2 H) a 
14 4.29 (d, J = 13.2 Hz, 1 H), 
4.15 (dd, J = 13.2, 2.4 Hz, 1 H) 
65.1 
15 3.19-2.91 (m, 2 H) a 
16 3.89-3.86 (m, 1H) 54.6 
17 --- 173.3 
OMe 3.46 (s, 3 H) 56.8 
Phenyl 7.43-7.41 (m, 2 H),  
7.24-7.22 (m, 3 H) 
132.3, 130.3, 129.1, 128.7 
  aC13 and C15 are represented by the 
signals at 31.0 and 30.5 ppm 
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Table 26. 1H NMR data for 4.25 and 4.24. 
 
Compound 11βH,8βH-4.25a 4.25a  4.24a  
Position 1H signal(s) 1H signal(s) 13C signal(s) 1H signal(s) 
1 --- --- 135.2, 134.3* --- 
2 3.25 (app s, 2 H) 3.31-2.96 (m, 2H) 40.0, 39.8* 3.36-2.97 (m, 2H) 
3 --- --- 201.7, 201.2* --- 
4 --- --- 144.5, 143.4* --- 
5 --- --- 162.7, 162.1* --- 
6 5.35 (d, J = 10.8 Hz, 1 H) 5.66, (d, J = 11.0 Hz, 1 
H)* 
5.35 (d, J = 11.0 Hz, 1 
H) 
75.9, 74.6* 5.66, (d, J = 11.0 Hz, 1 
H)* 
5.34 (d, J = 11.0 Hz, 1 
H) 
7 2.27 (ddd, J = 11.6, 11.6, 
7.0 Hz, 1H) 
2.33-2.23 (m, 1H) 53.5*, 53.1 b 
8 3.76-3.69 (m, 1H) 3.80-3.65 (m, 1H) 83.0, 73.3* 3.84-3.62 (m, 1H) 
9 3.23-3.16 (m, 1 H) 
2.44-2.38 (m, 1 H) 
3.31-2.96 (m, 2H) 
2.46-2.34 (m, 1H) 
33.7*, 29.9 b 
10 --- --- 133.1, 131.4* --- 
11 2.58-2.47 (m, 1H) 2.58-2.48 (m, 1H) 42.0, 35.0* b 
12 --- --- 177.2, 176.4* --- 
13 1.30 (d, J = 7.0 Hz, 3H) 1.30 (d, J = 7.0 Hz, 3H) 
1.15 (d, J = 7.0 Hz, 
3H)* 
14.6*, 13.3 1.30 (d, J = 6.3 Hz, 
3H) 
1.19 (d, J = 6.3 Hz, 
3H)* 
14 4.33 (d, J = 12.4 Hz, 1H),  
4.22 (d, J = 12.8 Hz, 1 H) 
 
4.35-4.21 (m, 2H) 73.2, 72.4* 4.28-4.15 (m, 2H) 
15 4.68 (d, J = 12.0 Hz, 1 H) 
4.63 (d, J = 13.6 Hz, 1 H) 
4.72-4.62 (m, 2H) 71.5, 71.1* 4.28-4.15 (m, 2H) 
16 --- --- 91.7, 91.4* --- 
17 6.08 (s, 1H) 6.08 (s, 1H) 71.9, 71.6* 2.59-2.44 (m, 1H) 
Co2(CO)6 --- --- 199.8 --- 
-OMe 3.45 (s, 3H) 
 
3.45 (s, 3H) 
3.42 (s, 3H)* 
57.4, 56.7* 3.46 (s, 3H) 
3.45 (s, 3H)* 
Phenyl ring 7.40-7.32 (m, 3 H) 
7.28-7.24 (m, 2 H) 
7.49-7.32 (m, 3H) 
7.30-7.25 (m, 2H) 
131.2, 131.1*, 
129.8*, 129.7, 
128.8*, 128.7, 
127.9, 127.8* 
7.49-7.31 (m, 3H) 
7.29-7.25 (m, 2H) 
 *Discernable signal for one diastereomer. aSpectrum obtained of an impure mixture of diastereomers. 
bH7, H9, H11 are represented by 3.36 (m, 1H), 2.59-2.44 (m, 2H), and 2.43-2.09 (m, 1H) but could not be 
assigned due to the impure nature of the spectrum and possible overlap of signals for the 2 diastereomers. 
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APPENDIX B 
1H AND 13C NMR SPECTRA 
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